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Abstract 
 
Medicinal plants are widely used as a source of primary health care by the rural inhabitants of 
northern Maputaland, KwaZulu-Natal, South Africa. A recent (2013) ethnobotanical study 
conducted specifically in four rural communities of Maputaland (Mabibi, Mbazwana, Mseleni 
and Tshongwe) revealed that lay people use plants individually and in combinations to treat 
various skin diseases. Based on the extensive use and lack of scientific evidence, the current 
study established the scientific validity of the documented plants by investigating their 
antimicrobial effects (individually and combinations) against dermatological relevant pathogens. 
The chemical profiles of the most antimicrobial active plants and the chemical compounds 
capable of permeating the skin were also investigated. 
Aqueous and organic (1:1 dichloromethane-methanol) extracts were prepared from plants 
collected from Maputaland. Antimicrobial screening (micro-titre plate dilution assay) was 
performed on bacteria and fungi known to cause skin infections. Efficacy of the plants used in 
combinations was evaluated using the sum of Fractional Inhibitory Concentration (ΣFIC). The 
combinations that displayed mostly synergistic interactions when combined in equal ratios were 
studied further in varied ratio studies to determine possible interactions when combined in 
various mixtures. Qualitative chemical analysis of the most active plant extracts (aqueous and 
organic extracts) was performed using phytochemical screening tests, UV-Vis spectrometry and 
a reverse-phase High Performance Liquid Chromatography (RP-HPLC). The permeation of 
compounds through the skin was investigated in vitro on intact porcine skin using the ILC07 
automated system and qualitatively analysed through RP-HPLC prior and after the permeation 
assay.  
When investigated individually, all the organic extracts proved to be active (MIC<1.00 mg/ml) 
on at least four of the 12 test pathogens. Other plant species such as Anonna senegalensis, 
Elephantorrhiza elephantina, Garcinia livingstonei, Kigelia africana, Ozoroa engleri, Parinari 
capensis subsp. capensis, Schotia brachypetala, Sclerocarya birrea, Syzygium cordatum, 
Terminalia sericea, and Zanthoxylum capense demonstrated broad-spectrum activities giving the 
mean MIC values<1.00 mg/ml. The organic extract of G. livingstonei was found to be the most 
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antimicrobial active extract displaying a mean MIC of 0.27 mg/ml. It was worth noting that 
plants such as A. senegalensis, O. Engleri and P. capensis subsp. capensis investigated for the 
first time against skin pathogens demonstrated broad-spectrum antimicrobial effects. The 
efficacy of the aqueous extracts was mostly moderate with 66% of the extracts exhibiting 
pathogen specific noteworthy effects (MIC<1.00 mg/ml). Staphylococcus aureus proved to be 
the least susceptible pathogen while T. mentagrophytes was the most susceptible with 98% of 
organic extracts displaying noteworthy effects.  
When the ΣFICs of plants combined in equal ratios was calculated, the combinations were found 
to display synergistic (27%), additive (31%), non-interactive (25%) and antagonistic (17%) 
interactions. The most synergistic effect was observed for the organic extract combination of 
Hypoxis hemerocallidea and Solanum rigescens against Staphylococcus epidermidis giving the 
ΣFIC value of 0.04. In varied ratio studies, the combinations combined in various mixtures 
mostly displayed additive interactions. The organic extract combination of H. hemerocallidea 
and S. rigescens displayed synergistic interaction regardless of the ratios when tested against S. 
epidermidis.  
All the antimicrobially active topically applied plants (aqueous and organic extracts) 
phytochemically analyzed possessed anthraquinones, flavonoids, tannins and saponins. The UV-
Vis spectra of all the tested extracts gave an initial absorption peak at 212-218 nm which might 
be characteristic of saponins. These compounds were detected in all the extracts. The second 
absorption maxima occurred between 250-268 for all the extracts and may confirm the presence 
of flavonoids that are usually absorbed between a range of 250 and 300 nm. From the in vitro 
permeation assay, it was observed that several compounds present in the crude extracts were able 
to diffuse across intact porcine skin. Both aqueous and organic extracts of K. africana proved to 
have more compounds capable of permeating the skin than the other tested extracts.  
Overall, more than 80% of plants tested displayed a correlation between antimicrobial efficacy 
and the diseases they were reported to treat. Interesting antimicrobial effects were also noted 
from the plant combinations. Some compounds present in the extracts are capable of 
permeating the intact skin in vitro. Thus, the current investigation supported the ethnobotanical 
claims of the documented plants.    
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Chapter one: General introduction 
 
1.1 Overview of skin diseases 
The skin is one of the largest and most versatile organs of the body. It consists of three layers, 
the outer epidermis, the thick inner dermis and the underlying subcutaneous tissue (Hwa et al., 
2011). Its complex and multi-layered nature serves as a mechanical barrier that protects the 
underlying cells from desiccation, chemical and mechanical injury as well as microbial and 
parasitic invasion (Evans et al., 2013). Apart from being an inert barrier, the skin also serves 
other important functions, such as percutaneous absorption, body temperature regulation, as a 
neuro-receptor and as an excretory organ (Abbasi et al., 2010). The skin also forms part of both 
specific and non-specific defences by virtue of Langerhans cells found in the mid epidermis 
(Weideman, 2005). 
A large amount of different types of micro-organisms exist naturally on the skin and constitute 
the normal flora. Several bacterial species of the genera Staphylococcus, Corynebacterium, 
Propionibacterium, Micrococcus, Streptococcus, Brevibacterium, Acinectobacterium and 
Pseudomonas are considered the normal microbiota of the skin. These resident (originating from 
the skin) and transient (originating from exogenous sources) micro-organisms are beneficial 
commensals to humans. When in the correct balance, the normal flora performs a protective 
function by competitively excluding harmful micro-organisms. However, the same micro-
organisms can become pathogenic and fatal in the wrong place. The disturbance of the 
individual’s flora by use of antibiotics or lotions may permit the overgrowth of pathogenic 
members which then interact with the host and cause a disease (Rosenthal et al., 2011). A breach 
in the integrity of the skin through cuts, burns or bites also provides an entry route for micro-
organisms to infect the skin and underlying tissues (Weideman, 2005). Other factors such as 
immunodeficiency diseases, diabetes mellitus, poor hygiene and vascular insufficiency also 
contribute in the initiation of skin infections (Dinubile and Lipsky, 2004; Chanda and Baravallia, 
2010). As a result, many microbial strains, considered as the normal skin flora such as 
Staphylococcus aureus and Staphylococcus epidermidis have emerged as multi-drug resistant 
skin pathogens (Rosenthal et al., 2011). 
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Skin infections are amongst the most common ailments that account for 34% of all occupational 
diseases (Abbasi et al., 2010). Micro-organisms responsible for skin infections can be bacterial, 
fungal, parasitic or viral in nature. These infections may arise spontaneously as primary 
infections or due to disorders such as eczema and psoriasis providing a means of entry for 
virulent microbes to initiate secondary infections. Such infections can be present for a few days 
or a week (acute) or persist for months (chronic), especially in cases of secondary infections 
(Dinubile and Lipsky, 2004). 
1.1.1 Bacterial skin infections  
Bacterial skin infections are more prevalent than any other skin infections. Such infections are 
particularly common in developing countries as they are often associated with poor hygienic 
conditions (Oumeish et al., 2001). Infections may cause irritation and some discomfort or may 
penetrate through the skin posing a severe effect on human health (Jamson et al., 2006). Thus, 
these infections vary in importance ranging from mild to severe and life threatening. Mild 
infections are usually attributed to Staphylococcus aureus and Streptococcus pyogenes and may 
occur in any parts of the body. They range from small pimples to very large lesions accompanied 
by tissue destruction and abscess formation. Common bacterial infections associated with these 
two strains are impetigo, folliculitis, erysipelas and cellulitis (Bhagavutta and Powell, 2010; 
Torok and Conlon, 2013). Complications from burns and wounds are normally associated with S. 
aureus and Pseudomonas aeruginosa (Gul et al., 2012). 
Impetigo is the most contagious skin infection that commonly affects children between two and 
five years of age (Bhagavutta and Powell, 2010). It is the third most common infection in 
children after dermatitis and viral warts. Overcrowding, hot and humid living conditions 
accelerate an impetigo infection. The causative agents are S. aureus and group A Streptococci. 
The most susceptible body parts are the face, hands and areas around nose and mouth, where the 
infection may manifest in a bullous or non-bullous form (Dawson et al., 2012). The infection 
begins as intra-epidermal vesicles containing clear fluid which eventually change to pustules or 
bullae. The pustules burst and become encrusted causing lesions which harbour a large number 
of bacteria that are highly contagious. As the lesions rupture, the bacteria spread to other parts of 
the body and initiate further infection (Lim, 1998; Oumeish et al., 2001). In some cases the 
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lesions may penetrate the epidermis and form ulcerations called ecthyma (Dawson et al., 2012). 
Ecthyma usually affects the lower limbs and is mostly associated with trauma, insect bites, 
eczema pediculosis, diabetes and immune compression (Bhagavutta and Powell, 2010; Torok 
and Conlon, 2013). 
Folliculitis originates through the Staphylococcal infection of the hair follicle, with pus 
accumulating in the epidermis. The infection may extend into the subcutaneous tissue to form 
furuncles commonly known as boils (Dawson et al., 2012). In some instances, a deep-seated 
infection of several contagious hair follicles may occur where infected follicles become 
interconnected by subcutaneous abscesses, resulting in the formation of carbuncles. Commonly 
affected body parts are the buttocks, neck, axilla and the scalp. Adolescents are most susceptible 
and poor hygiene, hyperhidrosis as well as obesity are predisposing factors (Bhagavutta and 
Powell, 2010). 
An erysipelas infection presents as bright red edematous patches that appear on the skin (Abbasi 
et al., 2010). This Streptococcal infection of the dermis also involves cutaneous lymphatics. 
Other pathogens such as Klebsiella pneumoniae, Heamophilus influenza, Yersinia enterocolitica 
and Moraxella species have also recently been described as the causative agents of erysipelas. 
Cellulitis, like erysipelas is also a Streptococcal infection, but goes deeper and causes 
inflammation across the dermis and subcutaneous tissue. Cellulitis is characterized by erythema 
and edema and usually occurs as a result of skin disruption either by injury or when the 
pathogens breach the skin due to primary infections such as ulcers, eczema, psoriasis or 
ringworm. It affects the limbs and the resulting lesions are not well demarcated as with 
erysipelas (Bhagavutta and Powell, 2010; Dawson et al., 2012; Torok and Conlon, 2013). 
Apart from skin infections associated with poor hygienic conditions, a number of bacterial 
pathogens are also associated with wound and burn infections, leading to sever inflammation and 
delayed healing. Commonly isolated pathogens are the Gram-negative Escherichia coli and P. 
aeruginosa, as well as the Gram-positive S. aureus. Escherichia coli is frequently isolated in 
surgical wounds while S. aureus infects diabetic wounds and foot ulcers. Infected wounds are 
usually characterized by a colour change and formation of lesions around the injured area. In the 
case of P. aeruginosa, the infected wounds are manifested by green pigment which later changes 
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to black (Lekganyane et al., 2012). Psuedomonas aeruginosa infections are fatal especially in 
victims with third-degree burns (Chiller et al., 2000). 
1.1.2 Fungal skin infections 
Fungal skin infections occur in all environments and may be superficial, subcutaneous or 
systemic (Jamison et al., 2006). Certain fungi are opportunistic such as Candida albicans, 
affecting the immune compromised individuals while others are true pathogens such as 
Epidermophyton, Microsporum and Trichophyton species, affecting immune competent 
candidates. With superficial infections, the pathogen infects and remains limited to the stratum 
corneum of the skin (Schwartz, 2004). In subcutaneous infections such as chromomycosis and 
sporotrichosis, the pathogen affects the subcutaneous tissue and the dermis and often extends to 
the bones. Systemic mycoses such as blastomycosis and cryptococcosis occur when the pathogen 
is disseminated into the bloodstream. Most fungi responsible for systemic mycoses usually affect 
Human Immunodeficiency Virus/ Acquired Immune Deficiency Syndrome (HIV/AIDS) patients. 
However, true systemic mycoses affect normal individuals when the pathogen penetrates the 
body and spreads via the bloodstream to other organs including the skin (Rivitti and Aok, 1999). 
Although systemic infections rarely occur, they have been associated with considerable 
morbidity and mortality (Hay, 2006).   
Superficial mycoses are the most common fungal infections affecting 20 to 25% of the world’s 
population. They are predominantly caused by the dermatophytes belonging to the genera, 
Epidermophyton, Microsporum and Trichophyton (Ameen, 2010). These pathogens typically 
affect the stratum corneum resulting in tinea or ringworm. Susceptible body parts are the body 
skin (tinea corporis), scalp (tinea capitis), beard (tinea barbae), hands (tinea minus), nails (tinea 
unguium) and feet (Tinea pedis). Tinea corporis manifests as small circumscribed lesions which 
slowly form an inflamed ring with a clear centre. The inflamed borders became scaly and may be 
patched with blisters (Lim, 1998; Bhagavutta and Powell, 2010). 
Tinea capitis, ringworm of the scalp is the most contagious fungal infection caused by 
Microsporum canis and Trichophyton tonsurans. It commonly infects children and is spread 
from child to child particularly in schools or from animals to children. Tinea capitis produces 
highly inflammatory lesions with suppuration followed by complete or partial loss of hair 
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accompanied by scaling of the scalp. In some children, the infected scalp becomes bald with 
localised patches. These patches are erythrematous, postulated and may become elevated into a 
boggy mass (Jamson et al., 2006; Bhagavutta and Powell, 2010). 
Tinea pedis, also called athlete’s foot, is an infection of the feet and is also caused by the fungal 
species of the genus Scytalidium. In Scytalidium infections, the infected feet are presented by 
fractured and inflamed interspaces between the toes (Jamson et al., 2006). The infection may 
also affect the palms of hands and cause interdigital scaling. When the infection spreads to the 
nails, this may result in extensive oncholysis and fracture of the nails. The presented symptoms 
resemble those of Trichophyton rubrum infections and may be prone to secondary bacterial 
infections (Hay, 2006).  
Cutaneous Candidiasis is another class of fungal skin infection predominately caused by a yeast-
like fungus, Candida albicans. Other species such as C. parapsilosis, C. tropicalis and C. 
glabarata may also occasionally cause cutaneous candidiasis.  Candida albicans is a normal 
flora of the mouth, vagina and gastrointestinal tract. However, in HIV infected individuals or 
patients undergoing prolonged antibiotic therapy, C. albicans overgrow and may initiate 
infection. The infection manifests as acute or chronic mucocutaneous candidiasis. The former 
presents as satellites, which are red and edematous pustules with creamy exudates. Such pustules 
usually occur in moist folded parts of the skin. The chronic mucocutaneous candidiasis may last 
for years producing continual and periodical infections on the skin, mucous membranes and 
nails. Such conditions are severe and resistant to treatments (Staab and Wong, 2009; Watts et al., 
2009). Cutaneous candidiasis also affects healthy neonates and young infants usually causing 
oral thrush and candidal diaper dermatitis. The latter affects moist macerated parts of the skin of 
the diaper region and usually starts on the perineum and spreads to the lower abdomen and 
thighs. The infection is manifested by scaly papules which become weeping eroded lesions 
associated with satellite pustules (Watts et al., 2009). 
1.1.3 Viral skin infections  
Common viral skin infections include chicken pox, measles, herpatic sores, warts and HIV 
related infections. Chicken pox, also called varicella, is usually encountered during childhood via 
the respiratory tract. In most cases, the condition may not be severe and resolves spontaneously. 
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However, in some cases, the virus causing the infection may remain viable and in latent form in 
nerve cells. It then reactivates as herpes zoster or shingles later in life (Lim, 1998; Jamson et al., 
2006). In immunocompromised individuals, the virus can also be disseminated to the lungs, 
liver, adrenal glands and other internal organs (Arvin et al., 1996). 
Measles or rubella, caused by the measles virus, is a highly infectious disease that is also 
encountered through the respiratory tract and sometimes through the conjunctiva. The virus then 
enters the lymphatic system and disseminates to the reticuloendothelial system where the skin 
and respiratory tract become infected. Such infection results in the development of the measles 
rash (Duke and Mgone, 2003). German measles is similar to measles but is not severe and was 
believed to be harmless for many years. It has, however, been found to cause congenital defects 
in infants, collectively known as congenital rubella syndrome. Fever blisters or cold sores caused 
by the Herpes Simplex Type 1 virus are also acquired during childhood through oral or 
respiratory secretions. The virus remains in the body following childhood disease and can re-
appear throughout one’s lifetime as a result of diet, trauma, sunlight, cold or emotional 
disturbances (Lim, 1998).  
Warts and warts of the genitalia are caused by human papilloma viruses that induce the growth 
of their host cells. Warts can also result from hyperkeratosis, an excessive cornification of the 
palms and the soles (Van Wyk and Wink, 2004).  
HIV-related skin diseases are usually the Kaposi’s sarcoma as well as the toxic epidermal 
necrolysis. Epidermal necrolysis is usually rare and induced by body’s reaction to drugs. The 
condition is severe and resembles that of severe burns. It is life-threatening as it leaves the body 
susceptible to severe infections. Other HIV-related skin disease includes the itchy papular 
eruption or papular pruritic eruption which manifests itself with severe papules on the face and 
upper trunk that tingle (Jamson et al., 2006). 
1.1.4 Inflammatory skin disorders 
Acne vulgaris is among the most prevalent inflammatory skin condition. It is a chronic 
inflammatory disease of the pilosebaceous unit commonly affecting adolescents, but it may 
persist up to the age of 30 years or lifelong. The condition occurs as a result of an increase in 
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sebum production in certain body parts such as the face and upper trunk. This leads to the 
blockage of sebaceous gland ducts and the formation of comedones. The comedones associated 
with hair follicles form an anaerobic and lipid-rich environment for colonization by 
Propionibacterium acnes. Such colonization result in dysbiosis of the facial tissue. 
Consequently, comedones progress to inflammatory papules, pustules and nodules. Sometimes, 
the condition may become severe with acne lesions blending to form large inflammatory cysts 
with scars (Von Hees and Naafs, 2001; Schommer and Gallo, 2013). 
Psoriasis is another chronic inflammatory skin disorder. It is non-infectious and occurs 
spontaneously as a result of genetic and environmental factors. However, Gram-positive bacteria 
usually colonize the diseased skin (Schommer and Gallo, 2013). Psoriasis is manifested by an 
abnormal fast turnover of the skin. The skin layers become extremely thick, especially the 
stratum corneum causing it to become scaly, erythrematous and inflamed. The condition is 
usually localized on the scalp, elbows, knees and buttocks, but palms and soles may also be 
affected. They usually become thick, form scales and crack (Von Hees and Naafs, 2001). 
Eczema, also known as dermatitis, is a non-infectious inflammation of the skin although in some 
cases secondary bacterial infection may occur. Eczema is influenced by irritants such as 
ointments, detergents, heat or stress. When the condition is acute, it is usually presented by red, 
edematous papules and blisters which ooze and crust. This may progress to a subacute phase 
where the skin becomes drier, scaler and the pigment changes. In the chronic stage, the skin 
thickens, excoriates and cracks. Itching is the major complaint in all the stages. Common types 
of eczema are atopic and seborrhic dermatitis (Von Hees and Naafs, 2001). Atopic dermatitis is 
common in infants and tends to occur on the face, neck, trunk, hands and feet. The condition 
occurs as a result of hypersensitivity reactions due to genetic pre-disposure to the disease. 
Contact with allergens and emotional stress worsen the disease. Affected individuals become 
susceptible to secondary infections with S. aureus, herpes and vaccinia viruses. Seborrhic 
dermatitis is characterized by red patches associated with greasy scaling. Commonly affected 
body parts are the eyebrows, chest and scalp. In HIV infected individuals, the condition may 
affect the entire skin and the patient may easily become infected. Sometimes, the condition 
appears concomitantly with atopic dermatitis leading to treatment complications (Schommer and 
Gallo, 2013). 
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1.1.5 Prevalence of skin diseases  
Skin diseases are common worldwide. Most skin infections have been self-limiting with low 
mortality rates. However, these infections have recently been responsible for significant 
morbidity due to their association with HIV/AIDS (De Wet et al., 2013). Skin and mucosal 
infections affect more than 90% of HIV infected individuals (Steenkamp et al., 2007). Herpes 
Zoster, the causative agent of shingles affects 8 to 13% of patients with AIDS, while HIV 
infected individuals experience the recurrent episodes of Herpes Zoster throughout the cause of 
infection. About 10% of AIDS patients develop fungal mucocutaneous lesions as well as deep 
fungal infections. Seborrhic dermatitis affects 20-40% of HIV patients and in those with AIDS, 
the prevalence is 40-80% (Tschachler et al., 1996). Such morbidity rates necessitate expensive 
treatments and result in a high number of hospitalizations as well as mortality in AIDS patients 
(Steenkamp et al., 2007). 
The prevalence of skin infections also seems high even in immunocompetent individuals. In 
developed countries, for instance, secondary skin infections are common, predominantly caused 
by resistant microbial strains. For example, in the United States (US), Methicillin resistant-
Staphylococcus aureus (MRSA) has been responsible for more than 50% cases of supurative 
skin infections. Such infections are of concern due to potential deadliness of their manifestations 
which include necrotizing fasciitis and severe sepsis (Boucher et al., 2010). Quave et al. (2008) 
mentioned that MRSA skin and soft tissue infections are responsible for 126 000 hospitalizations 
and 18 650 deaths each year in the US, a rate which even exceeds that of AIDS. Atopic 
dermatitis is also prevalent in developed countries, affecting 15 to 20% of children (Tadeg, 
2004). In northern Europe, atopic dermatitis affects 15.6% children of seven years of age 
(Williams et al., 1998). 
In developing countries, bacterial and fungal skin infections are prevalent. The prevalence rate 
ranges from 20 to 80% (Al-Hoqail, 2012). These infections are usually exacerbated by a low 
socio-economic status, synonymous with unhygienic living conditions and overcrowded living 
spaces. Such conditions provide greater incidence of skin-skin contact and co-habitation with 
pets (Havlickova et al., 2008). A study done on outpatients in the Al-Majmaah region in India 
revealed that dermatological disorders were the leading causes of hospital visits. In the reported 
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study, eczema was the most common diagnosis, responsible for 15.8% of cases followed by acne 
(14.7%). Viral (13.3%), fungal (7.6%) and bacterial infections (16.96%) contributed frequently 
to the occurrence of infectious diseases (Al-Hoqail, 2012). In another study by Chen et al. (2008) 
involving school children in Taiwan, acne vulgaris was the most common dermatosis with a 
prevalence rate of 17.3%. Ephelides, atopic dermatitis, warts, keloids and vitiligo were also 
identified, comprising 4.3%, 2.8%, 0.3% and 0.09% prevalence respectively. In Nigeria, the 
prevalence of MRSA infections was found to be 75% and 51.4% on wounds and skin 
respectively (Udobi et al., 2013). 
Dermatophytes alone affect more than 25 % of the population in African countries. Figuera et al. 
(1997), for instance, observed a high prevalence of cutaneous infections in a study on school 
children in Ethiopia. Dermatophytosis was reportedly common with tinea capitis being the most 
prevalent, followed by favus and tinea corporis. Tinea capitis is also common amongst black 
South African children especially those residing in rural areas, especially in the KwaZulu-Natal 
province which has a subtropical climate and is densely populated (De Wet et al., 2013).  
Despite the prevalence of dermatophytes in South Africa, other skin infections are also quite 
prevalent. A study conducted in five academic hospitals in Johannesburg area examined 1029 
patients in which the prevalence of eczema, acne and superficial fungal infections were found to 
be high affecting 76% of black patients. Eczema was also high in Indian patients followed by 
fungal infections and psoriasis accounting for 30.4%, 11.8% and 9.6% respectively (Hartshorne, 
2003). Another study in 33 schools in Cape Town Metropolis revealed the frequent occurrence 
of impetigo, fungal infections, papular urticaria and scabies in black South African girls 
compared to the white girls (Mercer et al., 2004). Atopic eczema was also found to be prevalent 
among adolescents in the same geographical area which affected this age group’s life quality 
(Zar et al., 2007).  
The study by Hartshorne, (2003), also found an increase in the prevalence of HIV related skin 
infections among black patients compared to the other surveyed races. For instance, Herpes 
Zoster was found to affect 3.4% of the patients while Kaposi’s sarcoma affected 74%, a rate 
which is 50% higher than the rate observed 30 years back.  
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1.2 Treatment of skin diseases 
1.2.1 Conventional approaches and their limitations 
The high incidence of skin infections and their association with HIV/AIDS necessitates the need 
for effective treatment options in healthcare centres around the world. In most cases, 
dermatologists rely on antimicrobial preparations to treat various skin conditions. Therapy may 
be topical or systemic, directed against the suspected pathogen or the affected part. Antibiotics 
are commonly prescribed for the treatment of bacterial infections. Topical antibiotics are used to 
treat superficial infections while systemic antibiotics such as tetracycline, doxycycline, 
minocycline, erythromycin and clindamycin are active against systemic or deep skin infections. 
Superficial fungal infections caused by dermatophytes may be treated using topically or orally 
administrated antifungal agents. For Candidal infections, treatment is accomplished through 
topical applications of clotrimazole, miconazole, econazole, ketoconazole, exiconazole, nystatin 
or intravenous or intramuscular administration of amphotericin B (Tadeg, 2004). 
There are few effective treatments available for viral infections. Acyclovir and valacyclovir are 
usually employed when treating herpes simplex and varicella infections. Condyloma warts are 
treated with podophyllin, and podofilox. Inflammatory skin diseases such as eczema and 
psoriasis are treated with anti-inflammatory topical steroids. In severe cases of eczema, a 
stronger steroid such as betamethasone valerate is required. Staphylococcal infected dermatitis is 
treated with systemic antibiotics (flucloxacillin or erythromycin) or corticosteroids. When 
antibiotics fail, cyclosporin A and azathioprine are employed. Acne vulgaris is usually treated 
with retinoids and tretinoin which help loosen and prevent the formation of new comedones. 
Antimicrobials such as erythromycin, clindamycin and benzoyl peroxide are also the mainstays 
of treating acne. However, such antimicrobials have been reported to be particularly effective 
when used in combination with retinoids. Systemic therapy with retinoids, antimicrobials and 
hormones are used when inflammatory lesions develop (Tadeg, 2004). 
Although antimicrobials are important treatments for fighting microbial infections, they have 
become less effective against certain illness due to the emergence of multi-drug resistant 
pathogens. Infectious diseases caused by these drug resistant pathogens are of global concern 
(Rakholiya and Chanda, 2012). For example, S. aureus as well as group A Streptococci which 
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cause common infections such as impetigo, folliculitis, carbuncles and furuncles, as well as 
severe necrotizing fasciitis to mention a few, have developed resistance to methicillin and 
erythromycin (Torok and Conlon, 2013). Adwan et al. (2010) also reported the difficulties in 
treating severe and life threatening secondary skin infections caused by P. aeruginosa due to the 
emergence of multi-drug resistant strains. Even antifungal agents such as the azole drugs have 
been associated with treatment failures due to the development of resistant strains of C. albicans 
(Watts et al., 2009). Other fungal species of the genera Candida and Trichosporin which cause 
invasive infections have also developed resistance to amphotericin B (Masoko et al., 2007). 
Apart from the problem of resistance, many antimicrobials are associated with undesirable side 
effects (Rakholiya and Chanda, 2012). Many patients with eczema require a prolonged treatment 
with topical glucocorticoides which leads to cutaneous atrophy while cessation of the therapy 
worsens the condition. The use of neomycin by patients with extensive skin damage results in 
systemic toxicity and contact allergy or deafness. Patients with severe psoriasis are treated with 
systemic retinoid etretinate, but the drug is contraindicated in pregnant women as it is a potent 
teratogen (Tadeg, 2004). Thus, the high prevalence of antibiotic resistance and the presence of 
unwanted side effects are further major factors necessitating the search for effective and safer 
alternatives to manage skin infections (Chanda and Baravallia, 2010). 
1.2.2 Medicinal plants commonly used to treat skin inflictions 
Medicinal plants have been found to play an important role in treatment of skin disease (Abbasi 
et al., 2010). The traditional treatment of dermatological conditions with plant-derived 
therapeutic preparations existed for centuries prior to the development of Western medicine. 
Currently, the use of medicinal plants is gaining popularity as people seek for alternative cheap 
and safe treatments for skin infections. Efficacy studies involving various plant species indicated 
that many species do indeed possess biological effects against various microbial infections 
(Steenkamp et al., 2004; Njoroge and Bussmann, 2007; Mabona et al., 2013). An infusion made 
from the roots of Cucurbita pepo for example, is used in Central America to treat syphilitic 
sores, herpes lesions, acne vulgaris and blackheads.  Allium cepa is employed as an antibacterial 
treatment for boils, abscesses, acne and blackheads where it draws out the infection, decrease 
inflammation and promote healing (Aburjai and Natsheh, 2003). In Indian, they use Avena sativa 
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as well as Calotropis procera to treat warts. Chelidonium majus is also used in China for the 
same purpose (Bedi and Shenefelt, 2002). 
In addition to their antimicrobial potential, medicinal plants are also popular alternative therapies 
of chronic inflammatory skin disorders such as eczema, which do not respond to the standard 
treatments (Tadeg, 2004). Plants species such as Artemisia vulgaris and Artemisia absinthum for 
instance, are used in the Philippines to treat eczema, ulcerative sores and purulent scabies. The 
powdered rhizome of Curcuma longa is employed for psoriasis and eczema (Aburjai and 
Natsheh, 2003). In China, traditional treatment of dermatitis and psoriasis is widely practiced as 
plants are believed to possess anti-inflammatory, antibacterial, antifungal and corticosteroid 
effects. Aloe vera and Capsicum frutescens are the potential treatments of psoriasis in China 
(Bedi and Shenefelt, 2002). Centaurium erythraea is a popular remedy in India for the treatment 
of eczema and all types of sores (Tadeg, 2004). 
Apart from their possible antimicrobial properties, certain plants species are known to possess 
wound healing activities. The active ingredients present in these plants are responsible for 
stimulating healing by inducing skin cell proliferation (Agyare et al., 2009). In this instance, the 
healing of wounds or sores can be enhanced through topical application of medicinal plants that 
have antiseptic activity. Plants with mucilage seem to promote healing by providing a physical 
barrier that protects the wound or any open sore from drying out. In some cases, plants with 
analgesic activity are used in relieving pain from burns, boils and abscesses. In fresh bleeding 
wounds, plants with stringent tannins are used to promote shrinking of the tissues as well as  
blood clotting, where antimicrobial activity prevent wounds from being infected (Van Wyk and 
Gerick, 2000). Several plant species such as Quercus infectoria, Catharanthus roseus, 
Lycopodium serratum, Sesamium indicum, Morinda citrifolia, Terminalia liabellirica and 
Moringa oleifera are commonly known around the world as the potent treatment affording the 
healing of skin wounds (Rawat et al., 2012). 
In South Africa, traditional medicinal plant use is also vital for the treatment of skin inflictions. 
Several species of the genus Aloe are commonly employed by South Africans to treat various 
skin diseases. One example is the Aloe ferox which is used in the Eastern Cape Province to treat 
skin cancer, burns, eczema and psoriasis. Aloe aborescens is used by the Zulu speaking people to 
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treat burns, cuts, scrapes, rashes and sores (Coopoosamy and Naidoo, 2013). Artemisia afra is 
also a popular remedy for skin ailments in South Africa, commonly employed to treat acne, boils 
and carbuncles. Another plant, Borreria natalensis is used in the KwaZulu-Natal province to 
cure leprosy and furuncles while B. campacta is used for eczema. Plumbago zeylanica is also 
extremely popular in South Africa as a treatment of various skin diseases such as leprosy, acne, 
scabies, sores and leg ulcers. The antimicrobial potential of this species is attributable to 
plumbagin, a compound which is affective to a wide spectrum of bacterial and fungal pathogens 
(Tadeg, 2004). Senecio serratuloides is also popularly used in South Africa to treat various skin 
conditions (Van Wyk et al., 2009; Pooley, 2003, De Wet et al., 2013). 
1.2.3 Ethnobotanical and ethnopharmacological approaches to the healing of skin diseases 
A number of ethnobotanical studies have been conducted around the world based on the 
traditional use of medicinal plants to treat skin ailments and have provided insight in traditional 
treatment of such ailments (Martinez and Barboza, 2010). Among such studies, were the studies 
on the plants that promote wound healing. An example is the study conducted by Adetutu et al. 
(2011) in south western Nigeria where 33 plant species were shown to have wound healing 
properties. In Mali, West Africa, 73 plant species have been documented which are used in the 
washing of wounds, extraction of pus, as a coagulants, as well as for the treatment of infected 
wounds (Inngjerdingen et al., 2004). In another survey by Agyare et al. (2009), 104 plant species 
used in wound healing have been recorded. In Pakistan, the survey conducted by Abbasi et al. 
(2010) recorded 66 plants that cure various skin ailments including boils, wounds, pimples, 
gums, scabies, warts, carbuncles, eczema, ringworms, abscesses, measles and leprosy. Quave et 
al. (2008), revealed a total of 38 plant species used to treat various dermatological conditions 
such as ulcerations, burns, wounds, inflammation, rash, dental abscesses, furuncle, dermatitis and 
other conditions. Saikia et al. (2006) documented 85 medicinal plants for 18 skin ailments in 
Assam, in northern India. In Kenya, 57 plants species have been documented which are used in 
the management of 14 skin conditions (Njoroge and Bussmann, 2007). 
In addition to the ethnobotanical surveys, other studies have been conducted with the intention to 
validate the ethnotherapeutic claims of plants against skin associated pathogens. For example, in 
a study by Jeevan Ram et al. (2004) conducted in India, ethanol extracts from 23 plant species 
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were assayed for antimicrobial activity against bacterial and fungal pathogens with 
dermatological relevance. The selected plants exhibited antimicrobial activity against five tested 
micro-organisms. In Pakistan, Tadeg et al. (2005) screened hydro-alcoholic extracts of eight 
plant species for their antimicrobial potential against bacteria associated with skin infections. 
Two of the eight selected plant species showed a broad-spectrum antimicrobial activity. Other 
species were also found to have activity on at least one of the five tested microbial strains. In 
another study in North Punjab, 12 plants were selected, based on the ethnobotanical information 
from local people, for their use against skin diseases. The plants showed antimicrobial activity 
against 50% of the micro-organisms tested (Gul et al., 2012).  
With most of the South African studies done on plants used to treat skin infections, the focus has 
been on plants that treat wounds and sores taking into account the possible impact of bacterial 
infections (Grieson and Afolayan 1999; Steenkamp et al., 2004; Mthethwa, 2009). In one such 
study conducted in the Eastern Cape Province, traditional healers as well as nurses and doctors 
were interviewed about the plants used to treat wounds. Four of the most commonly used plants 
were selected and tested against bacteria known to infect wounds. Of the four selected plants, 
three (Grewia occidentalis, Polystichum pungens and Cheilanthes viridis) showed broad-
spectrum antibacterial activity against the tested strains (Grieson and Afolayan, 1999). 
Steenkamp et al. (2004) selected nine previously recorded plant species that promote wound 
healing and tested their antimicrobial activity. Two plant species namely, Terminalia sericea and 
Gunnera perpensa which showed broad-spectrum antimicrobial activity were further tested for 
antioxidant activities and effects on fibroblast growth. Mthethwa (2009) screened 18 plant 
species used to treat wounds and sores in the Ongoye area, KwaZulu-Natal, for their antibacterial 
activity against wounds and sores. Six plant species were found to be effective against the micro-
organisms tested such as E. coli, Klebsiella pneumoniae and S. aureus. Even though these studies 
have shown antimicrobial potential of plants used against skin associated bacteria, they have, 
however, not been studied in great depth. In a review by Van Vuuren (2008) on antibacterial 
activity of South African medicinal plants, the need for further testing of plants used for skin 
inflictions against dermatophytic pathogens was emphasized. Even though these pathogens were 
included in the study by Mabona et al. (2013) on the antimicrobial activity South African 
medicinal with dermatological relevance, however, more than 80% of plants investigated in this 
study have never been investigated against the dermatophytic pathogens. 
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1.2.4 Plant combinations used to treat skin diseases 
In most traditional medicine systems of the world including African traditional medicine, 
different plant species are often combined for better efficacy (Van Vuuren and Viljoen, 2011). 
The concept of combining different plant species to treat diseases have been practiced since 
ancient times in traditional medicine systems. With the global problem of antibiotic resistance, 
combination therapy is not only practiced in traditional medicine, but it is also employed in 
western medicine (Zonyane et al., 2013). Certain antimicrobial drugs may also be used in 
combination with bioactive plant extracts in order to enhance their effect. Synergistic effects 
resulting from such combinations have been beneficial in treating serious infections caused by 
drug resistant pathogens. In one study by Rakholiya and Chanda, (2012), a strong synergistic 
effect was observed between medicinal plants and standard antimicrobial drugs against S. 
aureus, S. epidermidis and other enteric pathogens. In another in vivo study, the combination of 
plant extracts with acyclovir demonstrated a combined therapeutic effect by suppressing the 
development of herpatic skin lesions in rats (Kurowaka et al., 1995). 
Several in vitro antimicrobial reports have shown the role of synergism where certain plants are 
used in combinations to treat various infectious diseases (Van Vuuren and Viljoen, 2008; Van 
Vuuren et al., 2009; Suliman et al., 2010; York et al., 2012; Zonyane et al., 2013). However, 
studies dedicated in validating the use of South African plant species in combination against skin 
diseases are limited. In the study by Mabona et al. (2013) on the antimicrobial activity of 
southern African medicinal plants with dermatological relevance, the selected plant 
combinations showed antimicrobial activity against a number of skin associated pathogens. The 
information on the use of selected plants was, however, obtained from the readily available 
literature only. Thus, there is still a need for further scientific evidence on plant combinations 
used by the local ethnic people. Investigating the interactive efficacy of the ethno-directed plant 
combinations may serve as the foundation for novel chemotherapeutic agents effective against 
skin pathogens.  
1.3 Phytochemical evaluation of topically administered plant preparations  
Another aspect to be considered in the scientific evaluation of plants used against skin infections 
is the phytochemical investigation of antimicrobially active compounds that are capable of 
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permeating the skin. It is known that for most plant preparations, topical application is the 
convenient way of treating superficial skin conditions. For the treatment of deep skin infections 
such as furuncles and carbuncles, percutaneous absorption is necessary.Some studies have 
evaluated the in vitro permeability of certain pharmacological active compounds present in plant 
extracts. For instance, Heard et al. (2006) evaluated the transdermal delivery of caffeine, 
theobromine, theophylline and catechin (the active constituents of a plant Pullinia cupana) 
across pig’s ear skin. The active constituents were found to penetrate the skin simultaneously 
with theobromine having a high permeability rate favoured by the delivery vehicle (water) used. 
Boonen et al. (2010) evaluated the transdermal permeation behaviour of an N-alkylamide 
spilanthol compound from Spilanthes acmella extract.  The compound showed steady state 
permeation behaviour with 0.08-18.31% that permeated the skin after 24 hours of topical 
application. Park et al. (2012) compared the permeation profiles of the flavonoids, astragalin and 
kaempferol isolated from a plant Suaeda asparagoides. The degree of permeation of the 
compounds was found to increase linearly with kaempferol having greater penetration than 
astragalin after a 24 hour period of application. However, more studies are needed to identify 
chemical compounds permeating the skin after topical application.  Phytochemical permeation 
investigations may provide insight on the pharmacokinetic charecteristics of the chemical 
compounds present in topically applied plant preparations, and whether these compounds diffuse 
across the intact skin or not.   
1.4 Overview of the study area and the context of this study 
The study area, northern Maputaland is considered a region with low socioeconomic status in 
South Africa with 47% of unemployed population. The majority of people in this remote area 
live together in confined dwellings where infectious diseases are easily spread (York et al., 
2011). Skin infections are problematic since the high HIV infection rate (15.2%), makes people 
susceptible to a wide range of skin pathogens (Statistic South Africa, 2007). Lack of proper 
infrastructure, humidity, heat and unsanitary living conditions facilitate bacterial and fungal skin 
infections.  These factors are of concern in South African rural communities, where, for example, 
78 million people in 2002 become infected with ringworm, Tinea capitis (Bank, 2002). The 
majority of the population in northern Maputaland also depend on wood fires for cooking which 
increases the risks of burn wounds while other wounds are inflicted during wood collection and 
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field cultivation (De Wet et al., 2013). Burns and wounds provide an entry route for pathogens 
such as P. aeruginosa to infect the underlying tissues and initiate deep skin infections 
(Weideman, 2005). 
As in most developing countries, the indigenous people of South Africa especially in rural 
communities still depend on medicinal plants for their primary health care. Although health care 
is available free of charge in centres situated in rural communities, people still prefer traditional 
approaches of treating diseases due to cultural beliefs and ease of availability (Grieson and 
Afolayan, 1999). These observations were also apparent in northern Maputaland where skin 
infections are among the ailments treated traditionally using medicinal plants, despite the 
availability of 13 clinics and two hospitals in the area. In an ethnobotanical study by De Wet et 
al. (2013) in four rural communities (Mabibi, Mbazwana, Mseleni and Tshongwe) of northern 
Maputaland (Figure 1.1), lay people were interviewed about the plants they use to treat skin 
diseases. The focus was on plants that grow in and around the immediate vicinity of their 
homesteads. Forty seven plant species were documented as treatments against 11 skin ailments 
(abscesses, acne, boils, burns, incisions, rash, ringworm, shingles, sores, warts and wounds).  
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Map of the study area, northern Maputaland (De Wet et al., 2013). 
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From the survey by De Wet et al. (2013) nine plant species (Acacia burkei, Brachylaena 
discolor, Ozoroa engleri, Parinari capensis subsp. capensis, Portulacaria afra, Sida 
pseudocordifolia, Solanum rigescens, Strychnos madagascariensis and Drimia delagoensis) 
were documented for the first time in northern Maputaland as a treatment of skin infections. The 
anti-infective role of these nine plant species has not yet been explored. 
The survey also revealed that some plants were used in combinations to treat six types of skin 
ailments (sores, shingles, burns, boils, acnes and ringworm). Such combinations involved the 
combination of two (e.g. Sclerocarya birrea and Syzygium cordatum), and even multiple plant 
species (e.g. Brachylaena discolor, Euphorbia tirucalli, Hypoxis hemerocallidea, Ozoroa engleri 
and Senecio serratuloides) per medication. The in vitro efficacy information on the interactive 
profiles of such plant combinations is lacking. 
About 48% of the plant species documented by De Wet et al. (2013) are applied topically to treat 
both superficial and deep skin infections. As described in Section 1.3, the phytochemical 
evaluation of topically applied plant preparations is vital so as to comprehend the intended 
therapeutic effect of the chemical compounds present in such preparations. However, from the 
documented plants, specific information about the chemical profiles and the transdermal 
permeation behaviour of the compounds present in the crude extracts are not available. Thus, it 
was pivotal to also assess whether the chemical compounds present within the crude extracts are 
able to diffuse across the skin or not. 
In this study, 37 plants (Table 1.1) from the study undertaken by De Wet et al. (2013) were 
considered for investigation. The documented plants were analyzed based on their ethnobotanical 
uses as claimed by the rural inhabitants of northern Maputaland. Figure 1.2 shows a 
diagrammatic summary of how this study was conducted starting from plant collection and 
identification. Thereafter, antimicrobial screening was undertaken for each plant species and 
those used in combinations. A selection of plants was further subjected to preliminary 
phytochemical analysis and evaluated in in vitro permeability experiments after exposure of 
intact porcine skin to the extracts for 120 min. The results obtained in this study would serve to 
scientifically validate the traditional therapeutic application of these herbal remedies as they 
contribute significantly to the primary health care system of people in rural Maputaland. 
19 
 
Table 1.1: Plants used to treat skin diseases by lay people of northern Maputaland as adapted from De Wet et al. (2013). 
Botanical name/ 
Family 
Part(s) used 
Modes of 
administration 
Medical condition Used in combination 
Acacia burkei Benth 
Fabaceae 
Bark 
Decoction used as 
enema 
Sores 
Combined with Lippia 
javanica, Ozoroa 
engleri, Sclerocarya 
birrea, Syzygium 
cordatum and 
Tabernaemontana 
elegans 
Decoction taken orally Ringworm Kigelia africana 
Albizia adianthifolia 
(Schumach) W. Wight 
Fabaceae 
Bark 
Maceration used for 
bathing 
Burning and itching rash No combination 
Albizia vesicolor Welw. 
ex Oliv 
Fabaceae 
Bark 
Decoction used as 
enema 
Sores No combination 
Annona senegalensis 
Pers. 
Annonaceae 
Roots 
Decoction taken orally 
with soft porridge 
Sores No combination 
Brachyleana discolor 
DC. 
Asteraceae 
Twigs Decoction taken orally Sores 
Euphorbia tirucalli, 
Hypoxis hemerocallidea, 
Ozoroa engleri and 
Senecio serratuloides 
Canthium inerme (L.f) 
Kuntze 
Rubiaceae 
Twigs 
Decoction used for 
steaming 
Acne vulgaris Dichrostachys cinerea 
Dalbergia obovata E. 
Mey. 
Fabaceae 
Leaves Paste applied topically Burns 
 
No combination 
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Botanical name/ 
Family 
Part(s) used 
Modes of 
administration 
Medical condition Used in combination 
Dialium schlechteri 
Harms 
Fabaceae 
Bark Powder applied topically Boils, burns and wounds No combination 
Dichrostachys cinerea 
(L.) Wight & Arm. 
Fabaceae 
Twigs 
Decoction used for 
steaming 
Acne vulgaris Canthium inerme 
Euphorbia tirucalli L. 
Eurphobiaceae 
Modified stems Decoction taken orally Sores 
Brachyleana discolor, 
Hypoxis hemerocallidea, 
Ozoroa engleri and 
Senecio serratuloides 
Elephantorrhiza 
elephantina (Burch.) 
Skeels 
Fabaceae 
Roots Decoction taken orally 
Sores 
Cladostemon kirkii, 
Drimia delagoensis, 
Ficus sir, Sarcophyte 
sanguinea and Senecio 
serratuloides 
Shingles 
Cladostemon kirkii, 
Drimia delagoensis, 
Sarcophyte sanguinea 
and Ranunculus 
multifidus 
Garcinia livingstonei T. 
Anderson 
Clusiaceae 
Bark Paste applied topically Burns No combination 
Hewittia malabarica L. 
(Suresh) 
Convolvulaceae 
Leaves Paste applied topically Abscesses and boils No combination 
Hibiscus surratensis L. 
Malvaceae 
Roots 
Paste applied topically Burns 
No combination 
 
Decoction taken orally Sores 
No combination 
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Botanical name/ 
Family 
Part(s) used 
Modes of 
administration 
Medical condition Used in combination 
Hypoxis hemerocallidea 
Fisch., C.A. Mey. & 
Avelall. 
Hypoxidaceae 
Corms Decoction taken orally 
Boils Solanum rigescens 
Ringworm Ledebouria revoluta 
Sores 
Brachyleana discolor, 
Euphorbia tirucalli, 
Ozoroa engleri and 
Senecio serratuloides 
Kigelia africana (Lam) 
Benth. 
Bignoniaceae 
Bark Decoction taken orally 
New surgical incisions No combination 
Ringworm Acacia burkei 
Fruits Ash applied topically Ringworm No combination 
Lippia javanica (Burm. 
F.) Spreng 
Verbenaceae 
Twigs 
Decoction used as 
enema 
Sores 
Acacia burkei, Ozoroa 
engleri, Sclerocarya 
birrea, Syzygium 
cordatum and 
Tabernaemontana 
elegans 
Mormodica balsamina 
L. 
Curcubitaceae 
Leaves 
Maceration used for 
bathing 
Rash 
 
 
No combination 
 
 
Paste applied topically Ringworm 
Ozoroa engleri R.Fern. 
& A.Fern 
Anacardaceae 
Bark 
Decoction used as 
enema 
Sores 
Acacia burkei, Lippia 
javanica, Ozoroa 
engleri, Sclerocarya 
birrea, Syzygium 
cordatum and 
Tabernaemontana 
elegans 
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Botanical name/ 
Family 
Part(s) used 
Modes of 
administration 
Medical condition Used in combination 
Ozoroa engleri R.Fern. 
& A.Fern 
Anacardaceae 
Twigs Decoction taken orally Sores 
Brachyleana discolor, 
Euphorbia tirucalli, 
Hypoxis hemerocallidea 
and Senecio 
serratuloides 
Parinari capensis Harv. 
subsp. capensis 
Chrysobalanaceae 
Rhizome Decoction taken orally Sores No combination 
Portulacaria afra Jacq. 
Portulacaceae 
Leaves 
Maceration used for 
bathing 
Rash and chronic sores No combination 
Ranunculus multifidus 
Forssk. 
Ranunculaceae 
Whole plant 
Maceration taken orally 
 
Shingles No combination 
Decoction taken orally 
Sores 
Cladostemon kirkii, 
Drimia delagoensis, 
Ficus sir, Sarcophyte 
sanguinea and Senecio 
serratuloides 
Shingles 
Cladostemon kirkii, 
Drimia delagoensis, 
Sarcophyte sanguinea 
and Ranunculus 
multifidus 
Schotia brachypetala 
Sond. 
Fabaceae 
Bark 
Decoction used as 
enema 
Sores Sclerocarya birrea 
Sclerocarya birrea (A. 
Rich.) Hotsch. 
Anacardaceae 
Bark Powder applied topically 
Burns Syzygium cordatum 
Boils No combination 
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Botanical name/ 
Family 
Part(s) used 
Modes of 
administration 
Medical condition Used in combination 
Sclerocarya birrea (A. 
Rich.) Hotsch. 
Anacardaceae 
Bark 
 
Decoction used as 
enema 
Sores 
Acacia burkei, Lippia 
javanica, Ozoroa 
engleri, Syzygium 
cordatum and 
Tabernaemontana 
elegans 
Senecio serratuloides 
DC. 
Asteraceae 
Leaves 
Paste applied topically 
Abrasions, burns, cuts 
and open sores 
No combination 
Decoction taken orally Rash 
No combination 
 
Maceration used for 
bathing 
Rash 
Drimia delagoensis 
 
Decoction taken orally Sores 
Cladostemon kirkii, 
Drimia delagoensis, 
Ficus sir, 
Elephantorrhiza 
elephantina and 
Sarcophyte sanguinea 
Solanum panduriforme 
E. Mey. 
Solanaceae 
Fruits Topically Warts No combination 
Solanum rigescens Jacq. 
Solanaceae 
Fruits Decoction taken orally  
No combination 
Hypoxis hemerocallidea 
Strychnos 
madagascariensis Poir 
Strychnaceae 
Leaves Paste applied topically Sores Strychnos spinosa 
Bark 
Powder applied topically Sores and burns No combination 
Decoction used topically Ringworm 
No combination 
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Botanical name/ 
Family 
Part(s) used 
Modes of 
administration 
Medical condition Used in combination 
Strychnos spinosa Lam. 
Strychnaceae 
Fruits 
Topically Warts No combination 
Bark Paste applied topically Sores 
Strychnos 
madagascariensis 
Syzygium cordatum 
Hochst. Ex C. Krauss. 
Myrtaceae 
Bark 
Decoction taken orally Sores No combination 
Powder applied topically Burns Syzygium cordatum 
Decoction used as 
enema 
Sores 
Acacia burkei, Lippia 
javanica, Ozoroa 
engleri, Sclerocarya 
birrea and 
Tabernaemontana 
elegans 
Tabernaemontana 
elegans Stapf. 
Apocynaceae 
Leaves 
Latex applied topically 
Ringworm and new 
wounds 
No combination 
Decoction used as 
enema 
Sores 
Acacia burkei, Lippia 
javanica, Ozoroa 
engleri, Sclerocarya 
birrea and Syzygium 
cordatum 
Terminalia sericea 
Busch ex. DC 
Combretaceae 
Leaves Paste applied topically Burns No combination 
Waltheria indica L. 
Malvaceae 
Roots 
Paste and powder 
applied topically 
Burns and wounds No combination 
Withania somnifera (L.) 
Solanaceae 
Roots 
Paste applied topically 
and decoction taken 
orally 
Shingles No combination 
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Botanical name/ 
Family 
Part(s) used 
Modes of 
administration 
Medical condition Used in combination 
Ximenia caffra Sond. 
Olacaceae 
Twigs Decoction taken orally Sores No combination 
Zanthoxylum capense 
(Thunb.) Harv. Rutaceae 
Roots Wash New wounds 
 
No combination 
 
Ziziphus mucronata 
Wild. Rhamnaceae 
Leaves and roots Powder applied topically Boils No combination 
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Evaluation of plants used in Maputaland for skin diseases 
Plant collection, identification and 
extraction 
Antimicrobial evaluation of 
individual plants 
Interactive profiles of combined 
plants 
Phytochemical and in vitro 
permeability analysis of a selection 
of plants 
Analysis of a 
combination 
Sum of Fractional 
inhibitory 
concentration (ΣFIC) 
determination 
Varied ratio 
studies 
(isobologram 
construction) 
Figure 1.2: Diagrammatic summary of steps undertaken in validation of plants used in 
Maputaland for skin diseases. 
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1.5 Aims and objectives of the study 
This study intended to validate the traditional use of medicinal plants by lay people of northern 
Maputaland against skin infections. Taking into consideration the ethnobotanical information 
documented by De Wet et al. (2013) and the lack of scientific information validating the 
ethnobotanical claims of the documented plants, the current study was designed to address these 
areas of concern. To achieve the main aim, the following objectives were set; 
 To review an ethnobotanical study by De Wet et al. (2013) in order to obtain information 
related to the traditional use of plants in Maputaland to treat skin infections. 
 To prepare aqueous and organic extracts of the relevant plant material collected from 
northern Maputaland, KwaZulu-Natal Province of South Africa.  
 To evaluate the antimicrobial activity of the plants used independently and in 
combinations to treat skin infections using the Minimum Inhibitory Concentration (MIC) 
assay. 
 To assess the interactions between the plants used in combinations using the sum of the 
fractional inhibitory concentration (ƩFIC) and varied ratio combination studies. 
 To obtain the chemical profiles of the most antimicrobially active topically applied plant 
extracts (independent and combined samples) using Reverse-Phase High Performance 
Liquid Chromatography (RP-HPLC) and indicate the number of chemical compounds 
capable of penetrating the skin after the in vitro permeability experiment using excised 
porcine skin. 
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Chapter two: Antimicrobial screening of individual plants used in 
northern Maputaland to treat skin diseases 
 
2.1 Introduction 
Apart from the ethnobotanical study by De Wet et al. (2013) in northen Maputaland where 47 
medicinal plants were identified by lay people to have curative properties against various skin 
diseases (abscesses, acne, boils, burns, incisions, rash, ringworm, shingles, warts and wounds) 
(Chapter 1, Table 1.1), previous studies in the same geographical area by various authors further 
revealed the vast use of plants for the treatment of various infectious diseases not necessarily 
related to skin ailments. In this instance, the study by De Wet et al. (2010) identified 23 plant 
species which are used to treat diarrhoea, and such usage was validated by subjecting the plant 
extracts to diarrheal pathogens (Van Vuuren et al., 2015). Another study by York et al. (2011) 
documented 33 plant species used for the treatment of respiratory tract infections, and the species 
were evaluated against respiratory tract pathogens (York et al., 2012).  De Wet et al. (2012) also 
identified 33 plant species used for the treatment of sexually transmitted infections (STIs), where 
Naidoo et al. (2013) assessed the plants against the pathogens associated with STIs. This chapter 
is consequently aimed at investigating the antimicrobial properties of 37 plant species selected 
from the 47 species listed by De Wet et al. (2013) against skin associated pathogens so as to 
scientifically support their ethnobotanical claims.  
2.2 Materials and methods 
2.2.1 Collection and preparation of plant material 
Plant samples were collected from northern Maputaland, KwaZulu-Natal Province of South 
Africa during June-July 2012. Information obtained from the ethnobotanical study (De Wet et 
al., 2013) identified 47 plant species that were used for dermatological conditions, however, only 
37 plants were considered for investigation in the present study based on the availability of the 
plant material during the survey. Plant parts used (such as roots, bark, leaves and fruits) from the 
identified plants were collected from around the viccinity of the homesteads during the interview 
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process with the lay people. Voucher specimens were then prepared on site (Figure 2.1) and are 
housed in the herbarium of the Department of Botany at the University of Zululand, South 
Africa. The plants were identified and authenticated by Dr. T.C.H. Morstert from the University 
of Zululand as well as Mr. Mkhipheni Ngwenya from the South African National Biodiversity 
Institute (SANBI), Durban. Samples of the collected plant species used for identification together 
with their voucher specimen numbers are listed in Table 2.1. Collected bulk plant material was 
separated according to the parts used and dried at room temperature. The dried plant material 
was then ground into a fine powder using a Scientec RSA Hammer mill.  
 
 
 
Table 2.1: Voucher specimen numbers, plant parts used and extracts yeilds of plants investigated. 
Plant name/Family 
Voucher 
specimen no. 
Plant part(s) 
used 
Extract yieds (%) 
Aqueous Organic 
Acacia burkei Benth. 
Fabaceae 
S.Nciki 25 Bark 8.9 6.3 
Albizia adianthifolia (Schumach.) W. Wight 
Fabaceae 
S.Nciki 36 Bark 4.2 6.3 
Albizia versicolor Welw. ex Oliv 
Fabaceae 
S.Nciki 5 Bark 18.5 10.5 
Figure 2.1: Collection of plant material and preperation of voucher specimens around 
northen Maputaland homesteads. 
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Plant name/Family 
Voucher 
specimen no. 
Plant part(s) 
used 
Extract yields (%) 
Aqueous Organic 
Annona senegalensi Pers. 
Annonaceae 
S.Nciki 8 Roots 5.4 5.3 
Brachylaena discolor DC. 
Asteraceae 
S.Nciki 6 Twigs 6.7 4.8 
Canthium inerme (L.f) Kuntze 
Rubiaceae 
S.Nciki 3 Twigs 3.3 12.2 
Dalbergia obovata E. Mey.  
Fabaceae 
S.Nciki 9 Leaves 1.7 6.9 
Dialium schlechteri Harms  
Fabaceae 
S.Nciki 31 Bark 2.3 18.3 
Dichrostachys cinerea (L.) Wight & Arn. 
Fabaceae 
S.Nciki 10 Twigs 13.6 30.2 
Elephantorrhiza elephantina 
(Burch.) Skeels  
Eurphobiaceae 
S.Nciki 12 Rhizome 7.3 9.5 
Euphorbia tirucalli L 
Fabaceae 
T.York 37 Stems 6.3 10.4 
Garcinia livingstonei  T. Anderson  
Clusiaceae 
S.Nciki 21 Bark 4.1 2.2 
Hewittia malabarica L. (Suresh)  
Convolvulaceae 
S.Nciki 14 Leaves 6.5 33.3 
Hibiscus surattensis L. 
Malvaceae 
S.Nciki 28 Roots 0.3 8.2 
Hypoxis hemerocallidea Fisch., C.A. Mey. & 
Avé-Lall.  
Hypoxidaceae 
Nzama 38 Corms 18.5 8.4 
Kigelia africana (Lam.) Benth.  
Bignoniaceae 
S.Nciki 27 
Bark 15.0 6.7 
Fruits 1.6 7.0 
Lippia javanica (Burm. F.) Spreng. 
Verbenaceae 
S.Nciki 26 Twigs 9.2 8.0 
Momordica balsamina L.  
Curcubitaceae 
S.Nciki 11 Leaves 19.2 18.1 
Ozoroa engleri R.Fern. & A.Fern  
Anacardaceae 
      S.Nciki 37 
Bark 12.1 17.8 
Leaves 5.6 9.4 
Parinari capensis Harv. subsp. capensis 
Chrysobalanaceae 
S.Nciki 7 Roots 2.4 3.7 
Portulacaria afra Jacq. 
Portulacaceae 
S.Nciki 4 Leaves 4.1 4.5 
Ranunculus multifidus Forssk.  
Ranunculaceae 
 
S.Nciki 23 Whole plant 12.4 11.8 
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Plant name/Family 
Voucher 
specimen no. 
Plant part(s) 
used 
Extract yields (%) 
Aqueous Organic 
Schotia brachypetala Sond.  
Fabaceae 
S.Nciki 22 Bark 11.9 12.1 
Sclerocarya birrea (A. Rich.) Hotsch. 
Anacardaceae 
S.Nciki 17 Bark 9.7 5.4 
Senecio serratuloides DC.  
Asteraceae 
S.Nciki 1 Leaves 11.7 15.2 
Solanum panduriforme E. Mey. 
Solanaceae 
S.Nciki 38 Fruits 21.7 30.2 
Solanum rigescens Jacq.  
Solanaceae 
S.Nciki 39 Fruits 5.4 14.3 
Strychnos madagascariensis Poir  
Strychnaceae 
S.Nciki 35 
Bark 7.6 5.8 
Leaves 5.9 13.6 
Strychnos spinosa Lam. 
Strychnaceae 
S.Nciki 34 Fruits 14.5 14.0 
Syzygium cordatum Hochst. ex C. Krauss. 
 Myrtaceae 
S.Nciki 18 Bark 8.7 4.6 
Tabernaemontana elegans Stapf  
Apocynaceae 
S.Nciki 24 
Fruits 10.2 25.6 
Leaves 16.8 20.7 
Terminalia sericea Busch ex. DC  
Combretaceae 
S.Nciki 16 Leaves 5.6 19.5 
Waltheria indica L.  
Malvaceae 
S.Nciki 29 Roots 1.5 12.1 
Withania somnifera (L.) Dunal.  
Solanaceae 
S.Nciki 15 Roots 20.4 4.2 
Ximenia caffra Sond. 
Olacaceae 
S.Nciki 30 Twigs 6.3 5.8 
Zanthoxylum capense (Thunb.) Harv.  
Rutaceae 
S.Nciki 33 Roots 20.0 20.7 
Ziziphus mucronata Willd.  
Rhamnaceae 
S.Nciki 32 Leaves 4.4 12.6 
 
2.2.2 Extraction of plant material 
Two types of extracts (organic and aqueous) were prepared from the ground plant material. The 
procedures followed to obtain both types of extracts are depicted in Figure 2.2. Organic extracts 
were prepared by submerging a known quantity (of approximately 30 g) of dried, powdered plant  
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 (Dichloromethane: methanol)              (Aqueous) 
  
Evaporating solvents       Freeze dried 
Figure 2.2: Schematic representation of the extraction procedure for aqueous and 
organic extracts. 
 
(i) Weighing ground plant material                          (ii)   Adding solvents 
 
(iii) Filtering solvents 
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material in a 1:1 mixture of dichloromethane and methanol (CH2Cl2: MeOH) in approximately 
200 ml (Merck). Dichloromethane and methanol were used as the solvents of choice as they 
extract both polar and non-polar compounds from plants. Each mixture was agitated at 37 ˚C in a 
shaking incubator for 24 hours to thoroughly mix plant material with organic solvents. 
Thereafter, the solution was filtered using sterile cotton wool. Extraction was repeated twice 
using the same plant material and adding the same amount of fresh solvent followed by agitation 
for another 24 hours. Both resulting filtrates were then combined in one vessel and air-dried to 
evaporate the solvent.  
In the ethnobotanical study (De Wet et al., 2013) it was found that water was the traditionally 
used solvent for preparing the plant remedies. The lay people prepared the plant remedies as 
decoctions (mixing a known amount of plant material, e.g. two handfuls of leaves, with a certain 
amount of water, e.g. 2 litres, and bringing the mixture to boil) and macerations (soaking fresh or 
dried plant material in cold or warm water). Consequently, it was important to include aqueous 
extracts in the current study so as to imitate the actual preparations from the homesteads. 
Aqueous extracts were prepared by submerging a known amount of powdered plant material 
(approximately 30 g) in warm, sterile distilled water of approximately 200 ml. These were then 
left at ambient temperature overnight. Thereafter, they were filtered using Wattman No 1 filter 
paper and the filtrates were frozen at -80 ˚C before lyophilisation.  All extracts were then left in a 
lyophiliser (Labcon) until totally dried. Extracts were thereafter subjected to ultraviolet (UV) 
light overnight to eliminate possible microbial contaminants. The percentage yields of all the 
dried crude extract residues were calculated (Table 2.1) and the extracts then were kept in sealed 
bottles at room temperature until further use. 
2.2.3 Antimicrobial screening 
2.2.3.1 Preparation of crude extracts for antimicrobial screening 
For antimicrobial testing, plant extracts were prepared to a final concentration of 32 mg/ml. 
Acetone was used for reconstituting the dried crude organic extracts due to its almost negligible 
minimal antimicrobial effects (Eloff, 1998). Extracts that could not dissolve adequately in 
acetone were sonicated using a Labcon sonicator for approximately 10 minutes until thoroughly 
dissolved. Aqueous extracts were also prepared to a standard concentration of 32 mg/ml by 
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dissolving the freeze dried plant powder in sterile distilled water. The prepared extracts were 
then stored in a fridge at 4 °C. 
2.2.3.2 Preparation of cultures selected for analysis 
Culture and media preparations were performed according to the Clinical and Laboratory 
standards Institute guidelines (CLSI, 2012). American Type Culture Collection (ATCC) bacterial 
and fungal strains associated with skin infections were selected for analysis. The bacterial strains 
included the Gram-positive Staphylococcus aureus, methicillin resistant Staphylococcus aureus 
(MRSA), gentamycin and methicillin resistant Staphylococcus aureus (GMRSA), 
Staphylococcus epidermidis, Propionibacterium acnes and Brevibacterium agri, as well as the 
Gram-negative Pseudomonas aeruginosa and Escherichia coli. Two dermatophytes 
(Trichophyton mentagrophytes and Microsporum canis) and yeast (Candida albicans) were 
included as fungal pathogens. Brevibacterium linens, another bacterial strain from DSM 
(Deutsche Sammlung von Mikroorganismen), was also included. A waiver for the approval of 
the use of microbial cultures was obtained from the University of the Witwatersrand Human 
Research Ethics Committee (Appendix G). A summary of selected pathogens, their ATTC 
reference numbers, characteristics and associated skin pathogenesis is represented in Table 2.2. 
Bacterial cultures were prepared by transferring 1 ml of inoculum from a frozen stock culture of 
each strain into Tryptone Soya broth (TSB) (Oxoid) followed by incubation at 37 ˚C for 24 
hours. Propionibacterium acnes, a fastidious anaerobe, was grown in Thioglycolate broth 
(Oxoid), which was incubated at 37 ˚C for seven days under anaerobic conditions using a candle 
jar. The yeast, Candida albicans, was grown in TSB and incubated at 37 ˚C for 48 hours. The 
dermatophytes, Trichophyton mentagrophytes and Microsporum canis, were cultured in 
Sabouraud’s Dextrose broth (Oxoid) and incubated at 35 ˚C for seven days under 100% relative 
humidity. 
2.2.3.3 Minimum inhibitory concentration (MIC) assays 
The micro-dilution technique was used to determine the minimum inhibitory concentration 
(MIC) values of the plant extracts. The technique involves the use of 96-well microtitre plates 
and tetrazolium salts to indicate microbial growth (Eloff, 1998). Conventional antimicrobial
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Table 2.2: Summary of pathogens selected for investigation and their microbial characteristics 
Selected pathogen Microbial classification  
Skin associated 
condition(s) 
Growth medium References 
Brevibacterium agri 
ATCCᵃ 51663 
Gram-positive Foot odour 
Tryptone Soya 
broth/agar 
Abramson, (1983). 
Brevibacterium linens 
DSMᵇ 20425 
Gram-positive Foot odour 
 
Tryptone Soya 
broth/agar 
 
Abramson, (1983). 
 
Staphylococcus aureus 
ATCC 25923, 
Methicillin-resistant 
Staphylococcus aureus 
ATCC 43300 and 
Gentamycin-methicillin 
resistant Staphylococcus 
aureus 
ATCC  33592 
 
Gram-positives 
 
Abscesses, carbuncles, 
furunculosis, pyoderma, 
pustulosis, scalded scale 
syndrome, skin and soft 
tissue infections, skin 
necrosis, stye and 
sycosis barbae 
 
Tryptone Soya 
broth/agar 
Lim, (1998); Said-Salim 
et al.  (2003); Daum, 
(2007); Quave et al. 
(2008); Boucher et al., 
(2010); Peterson, (2010). 
Staphylococcus 
epidermidis 
ATCC 2223 
 
Gram-positive 
 
Minor abscesses 
Tryptone Soya 
broth/agar 
 
Lim, (1998). 
Propionibacterium 
acnes 
ATCC 11827 
 
Gram-positive 
 
Acne vulgaris 
 
Thioglycolate broth 
 
 
Lim, (1998); Weckesser 
et al. (2007). 
Escherichia coli 
ATCC 25922 
Gram-negative 
Cellulitis localized to 
lower and upper limbs, 
necrotizing fasciitis, 
surgical site infections 
and infection after burn 
injuries. 
 
Tryptone broth/agar 
Petkovsek et al. (2009); 
Masoud and Gouda, 
(2012). 
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Selected pathogen Microbial classification 
Skin associated 
condition(s) 
Growth medium References 
Pseudomonas 
aeruginosa 
ATCC 27853 
Gram-negative 
Pyoderma, cutaneous 
folliculitis, wound and 
burn infections 
Tryptone Soya 
broth/agar 
Agger and Mardan, 
(1995); Lim, (1998); 
Peterson, (2010). 
Candida albicans 
ATCC 10231 
 
Yeast 
Cutaneous candidiasis 
including intertrigo and 
perianal dermatitis. 
 
Tryptone broth/agar 
Lim, (1998); 
Weckesser et al. (2007). 
Microsporum canis 
ATCC 36299 
Dermatophyte Ringworm (tinea) 
Sabouraud’s Detrose 
broth/agar 
Beneke et al. (1984); 
Lim, (1998); Jamson et 
al. (2006). 
Trichophyton 
mentagrophytes 
ATCC 9533 
 
Dermatophyte 
 
Ringworm (tinea) 
Sabouraud’s Detrose 
broth/agar 
Beneke et al. (1984); 
Lim, (1998); Jamson et 
al. (2006). 
ᵃ American Type Culture Collection; ᵇ Deutsche Sammlung von Mikroorganismen.
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agents were used as positive controls, i.e. ciprofloxacin (Sigma Aldrich®) and amphotericin B 
(Sigma Aldrich®). The former (at a starting concentration of 0.01 mg/ml dissolved in sterile 
water), was used as a positive control for bacteria, while the latter (at a starting concentration 0.1 
mg/ml, initially dissolved in DSMO and thereafter diluted using sterile water), was used as a 
positive control for the yeast and dermatophytes. These controls were selected due to their 
known broad-spectrum activity against bacteria (ciprofloxacin) and fungi (amphotericin B), and 
were included in each assay to confirm the antimicrobial susceptibility of the test pathogens. 
Negative controls (solvent and growth medium) were also included. In this instance, acetone was 
diluted to a starting concentration of 32 mg/ml in sterile water as a solvent control and was 
included in all assays to determine if it posed any inhibitory effect on the growth of test 
pathogens. Growth medium was included as a culture control to confirm the presence of 
microbial growth in the absence of the antimicrobials.  
For the antimicrobial analysis, sterile 96-well microtitre plates were aseptically prepared under a 
laminar flow cabinet unit (Labcon) by adding 100 µl of TSB into each well (Figure 2.3). A 
volume of 100 µl of each plant extract (32 mg/ml) and the controls [antibiotic (0.01 mg/ml or 0.1 
mg/ml), acetone (32 mg/ml) and culture controls] respectively were transferred into the wells in 
the first row of the microtitre plates. Serial dilutions were performed longitudinally by 
transferring 100 µl of the well content and so diluting the extracts and controls with 50% each 
time. A 100 µl of the sub-culture (bacteria or yeast) was added to all the wells of each microtitre 
plate. Before use, the culture was first diluted in broth to a just-turbid consistency (0.5 
McFarland standard) and diluted 1:100 with broth to give a density of approximately 1×10
6 
colony forming units/ml (CFUs/ml). The final concentrations of the extracts thus ranged from 
8.00 mg/ml from the first row to 0.06 mg/ml in the last row. Each microtitre plate was sealed 
with a sterile adhesive seal to prevent evaporation of the extracts. The plates were then incubated 
at 37 ˚C for 24 hours and 48 hours for bacteria and yeast respectively. To confirm purity of the 
culture used, each diluted pathogen-broth mixture was also streaked onto TSA and incubated 
overnight (for bacteria) and 48 hours (for C. albicans). 
After incubation, 40 µl of 0.4 mg/ml of p-iodonitrotetrazolium (INT) dissolved in sterile water 
was added to all microtitre plate wells. INT was used as an indicator of microbial growth as it  
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changes from colourless to red in the presence of biological active micro-organisms (Eloff, 
1998). After the addition of INT, the plates were left at room temperature and assessed for the 
development of a red colour in the culture control columns which appeared after approximately 
1-6 hours depending on the test pathogen. For Candida albicans, the plates were left at room 
temperature and the results were read after 48 hours. The MIC was reported as the lowest 
concentration of the extract that resulted in inhibition of microbial growth, represented by a clear 
colour in the wells. In cases where the MIC of certain plant extracts was not detected (i.e. MIC < 
0.06 mg/ml), the extracts were diluted 10-fold to yield a starting concentration of 3.2 mg/ml and 
MIC assays repeated. Tests were performed in duplicate (or triplicate when inconsistent results 
were obtained) for each pathogen.   
When performing antimicrobial screening of plant extracts against fastidious pathogens 
(P. acnes, M. canis and T. mentagrophytes), slight modifications to the standard MIC methods 
were employed.  For P. acnes, the microtitre plates were incubated at 37 °C for seven days under 
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Figure 2.3: The microtitre plate dilution technique showing serial dilutions and corresponding 
concentration values of diluted plant extracts. 
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anaerobic conditions using a candle gas jar after which 50 µl of INT (growth indicator) was 
added. Since P. acnes does not grow readily on agar, the purity of the culture was determined by 
streaking the Thioglycolate broth culture onto a TSA plate which was then incubated under 
aerobic conditions. No growth could be observed on the TSA, indicating the absence of 
contaminants. For the dermatophytes (M. canis and T. mentagrophytes), after aseptically 
preparing the micro-titre plates, the plates were then transferred to the biohazard safety cabinet 
(Labcon) where 100 µl of culture was added. The culture was diluted to a ratio of 1:100 without 
first preparing a McFarland standard. The growth indicator (40 µl of INT) was added to the 
plates before incubation. The plates were then incubated at 35 °C for seven days under 100% 
relative humidity. For M. canis, the plates were incubated at 30 °C and the results were read 
when a red colour appeared in culture control columns, usually after four to seven days. 
 2.3 Results and discussion 
The antimicrobial properties of 82 (41 organic and 41 aqueous) extracts (some plants had 
different plant parts studied) derived from 37 plants against dermatological relevant pathogens 
(six Gram-positive bacteria, two Gram-negative bacteria, two dermatophytes and yeast) were 
determined. The MIC values (expressed in mg/ml) of the extracts for which no end point could 
be found were given a value of > 8.00 mg/ml. The antimicrobial results of both the aqueous and 
organic (dichloromethane: methanol) extracts are given in Table 2.3 and 2.4 respectively. 
Extracts with MIC < 1.00 mg/ml (written in bold) were considered noteworthy (Gibbons, 2004; 
Rios and Recio, 2005; Van Vuuren, 2008). The negative controls (acetone, water and growth 
media) did not affect the growth of all tested pathogens as they all returned MIC > 8.00 mg/ml. 
For positive controls (conventional antimicrobials), the activities varied (MIC values ranged 
0.01–1.25 µg/ml) depending on the susceptibility of the tested pathogens. 
2.3.1 Overall antimicrobial effect of plant extracts against the skin pathogens 
The overall antimicrobial profile of all the tested extracts (aqueous and organic) demonstrated 
that the organic extracts have higher inhibitory activity than the aqueous extracts (Figure 2.4). 
About 31.7% of the organic extracts displayed broad-spectrum antimicrobial effect while the rest 
(68.3 %) displayed noteworthy effects against one or more pathogens. The efficacy of the 
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aqueous extracts was mostly moderate with few (4.9 %) that displayed broad-spectrum activity 
while the majority (60.9 %) exhibited pathogen specific noteworthy effects (MIC<1.00 mg/ml). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trichophyton mentagrophytes was found to be the most susceptible pathogen with 98 % of the 
organic and 27 % of the aqueous extracts displaying noteworthy effects against this pathogen. 
These findings support the previous studies (Tadeg, 2004; Mabona et al., 2013) where T. 
mentagrophytes was also shown to be the most susceptible fungus towards plant extracts tested. 
Microsporum canis was further noted to be sensitive towards most (66 %) of the organic 
extracts. Amongst the Gram-positive bacteria, B. agri was the most susceptible, followed by S. 
epidermidis and P. acnes. Such findings were expected since the Gram-positive bacteria are
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Figure 2.4: Representation of the overall antimicrobial effect of aqueous and organic (D:M) 
extracts against skin pathogens. 
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known to have less complex cell wall structures which make them more susceptible for 
antimicrobial attack (Nostro et al., 2000). Conversely, S. aureus which is usually the most 
susceptible Gram-positive bacterium in many studies was found to be the most resistant 
pathogen towards both aqueous and organic extracts. In this instance, only 5 % of the organic 
extracts exhibited noteworthy activity against S. aureus, while none of the aqueous extracts 
displayed activity (Figure 2.5). 
 
 
 
 
 
 
 
 
 
 
 
 
While several studies report that the Gram-negative bacteria are more resistant to various 
antimicrobials, the present study showed P. aeruginosa to be the most susceptible amongst all 
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Figure 2.5: The percentage of aqueous and organic (D:M) extracts that displayed 
noteworthy activity (MIC<1.00 mg/ml) against each test pathogen in a group. 
 
 
 
42 
 
the bacterial strains. In this instance, 83 % of the organic extracts displayed noteworthy activity 
against P. aeruginosa. In general, Gram-negative bacteria are known to have complex cell wall 
structures composed of lipopolysaccharides. These lipopolysaccharides reportedly act as 
diffusion barrier which make cell walls impermeable and less susceptible to the antimicrobial 
agents (Nostro et al., 2000). In spite of this permeability barrier, the organic extracts in the 
present study proved to be effective against Gram-negative bacteria as 32 % of the extracts 
displayed noteworthy activity against E. coli (another Gram-negative strain). These findings may 
justify the potential of these organic extracts in combating multi-drug resistant pathogens. It was, 
however, found that none of the aqueous extracts displayed noteworthy activity against E. coli. 
2.3.2 Antimicrobial activity of the organic extracts  
Although the organic solvents (dichloromethane and methanol) were not the traditionally used 
solvents, the extracts prepared from these solvents were the most active, exhibiting noteworthy 
activity against at least three or more of the tested pathogens. Only A. vesicolor showed the 
weakest activity by only having noteworthy activity against T. mentagrophytes (Table 2.3). 
Furthermore, some plant species displayed broad-spectrum antimicrobial activity giving average 
MIC values of < 1.00 mg/ml against all the pathogens. Plants that displayed broad-spectrum 
activities include A. senegalensis, G. livingstonei, E. elephantina, K. africana, O. engleri, P. 
capensis subsp. capensis, S. brachypetala, S. birrea, S. cordatum, T. sericea and Z. capense. 
Annona senegalensis was reported to treat sores by the lay people of rural Maputaland (De Wet 
et al., 2013). Sores can be infected by various bacteria including S. aureus, GMRSA, MRSA, S. 
epidermidis, P. aeruginosa and sometimes be secondary infected by E. coli. This plant exhibited 
a broad-spectrum antimicrobial activity with an average MIC of 0.33 mg/ml. The plant was 
effective against MRSA (MIC value of 0.50 mg/ml), S. epidermidis (MIC value of 0.25 mg/ml), 
E. coli (MIC 0.50 mg/ml) and P. aeruginosa (MIC 0.25 mg/ml), the pathogens most likely to 
infect sores. Noteworthy antimicrobial properties were also observed against B. agri, B. linens, 
C. albicans, M.canis and T. mentagrophytes (MIC values between 0.06-0.50 mg/ml). From the 
literature, A. senegalensis have been reported to treat various skin diseases including leprosy
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Table 2.3: The average MIC values (mg/ml) of organic (dichloromethane: methanol) extracts against 12 dermatological relevant 
pathogens. 
Plant sample 
Pathogens Average 
MIC ± σ* B. agriᵃ B. lineᵇ GMRSAᶜ MRSAᵈ S. aureᵉ S. epidᶠ P. acneᵍ          P. aeruᶥ C. albiᶨ M. caniᵏ T. mentᶥ 
A. adianthifolia 
bark 
0.05 2.00 4.00 8.00    >8.00 1.00 1.50 1.50 1.00 1.00 0.13 0.06 1.84 ± 2.33 
A. burkei 
bark 
0.40 0.50 2.00 1.00 4.00 1.00 0.38 1.00 0.25 2.00 0.13 0.25 1.06 ± 1.12 
A. senegalensis 
roots 
0.13 0.13 1.00 0.50    >8.00 0.25 0.13 0.50 0.25 0.50 0.06 0.13 0.33 ± 0.28 
A. vesicolor 
bark 
1.00 >8.00 3.00 2.00 >8.00 1.00 8.00 1.00 1.00 >8.00 1.00 0.25 2.03  ± 2.37 
B. discolor 
twigs 
0.19 2.00 2.00 1.00 3.00 1.00 1.00 1.00 0.75 0.75 2.00 0.25 1.25  ± 0.82 
C. inerme 
twigs 
0.03 0.50 4.00 2.00 4.00 0.25 2.00 1.00 0.25 0.75 1.00 0.25 1.34 ± 1.23 
D. cinerea 
twigs 
1.00 1.00 2.00 2.00 4.00 0.19 1.00 0.75 0.25 2.00 0.25 0.50 1.25 ± 1.10 
D. obovata 
leaves 
0.19 0.50 2.00 2.00 4.00 1.00 2.00 1.00 0.50 0.75 1.00 0.34 1.27 ± 1.08 
D. schlechteri 
bark 
0.03 4.00 2.00 4.00 4.00 1.00 0.75 0.50 0.25 2.00 0.19 0.13 1.57 ± 1.62 
E. elephantina 
rhizome 
0.25 1.50 2.00 4.00 1.00 1.00 0.25 0.13 0.50 0.13 0.25 0.25 0.94 ± 1.14 
E. tirucalli 
Modified stems 
0.01 3.00 3.00 1.00 6.00 1.50 0.75 0.50 0.75 1.50 4.00 0.50 1.88 ± 1.81 
G. livingstonei 
bark 
0.02 0.06 0.50 0.25 1.00 0.06 0.25 0.13 0.50 0.25 0.13 0.13 0.27 ± 0.27 
H. hemerocallidea 
corms 
0.25 2.00 2.00 2.00    >8.00 2.00 1.50 1.00 2.00 1.00 1.00 0.13 1.35 ± 0.72 
H. malabarica 
leaves 
0.03 3.00 2.00 2.00 8.00 0.50 1.00 1.00 0.50 0.50 0.75 0.50 1.65 ± 2.17 
H. surratensis 
leaves 
0.75    >8.00 2.00 4.00 2.00 1.00 1.00 1.00 1.00 1.00 1.00 0.13 1.35 ± 1.02 
K. africana 
bark 
0.08 2.00 1.00 2.00   >8.00 0.01 0.31 2.00 0.25 0.38 0.34 0.06 0.77 ± 0.83 
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Plant sample 
Pathogens Average 
MIC ± σ* B. agriᵃ B. lineᵇ GMRSAᶜ MRSAᵈ S. aureᵉ S. epidᶠ P. acneᵍ          P. aeruᶥ C. albiᶨ M. caniᵏ T. mentᶥ 
K. africana 
fruits 
0.06 1.00 1.00 2.00   >8.00 0.13 0.31 2.00 0.25 0.38 0.38 0.06 0.68 ± 0.72 
L. javanica 
twigs 
0.02 0.50 2.00 4.00 4.00 0.19 0.50 0.50 0.25 0.25 0.13 0.13 1.04 ± 1.48 
M. balsamina 
leaves 
1.00 8.00 2.00 4.00 2.00 0.50 1.00 1.00 0.25 1.00 0.50 0.19 1.79 ± 2.22 
O. engleri 
bark 
0.02 0.13 1.00 1.00 0.75 0.05 0.13 0.19 0.38 0.25   >8.00 0.13 0.37 ± 0.37 
O. engleri 
leaves 
0.06 0.50 2.00 3.00 1.00 0.50 0.50 1.00 0.38 1.00 0.50 0.19 0.89 ± 0.84 
P. afra 
leaves 
3.00    >8.00 1.00 0.38 1.00 3.00 8.00 2.00 0.50 2.00 0.19 0.25 1.94 ± 2.26 
P. capensis 
roots 
0.06 0.50 0.50 2.00 2.00 0.03 0.19 1.00 0.25 0.25 0.38 0.06 0.60 ± 0.70 
R. multifidus 
whole plants 
0.10 8.00 2.00 4.00 2.00 0.25 1.00 1.00 1.00 0.75 0.25 0.13 1.71 ± 2.27 
S. birrea 
bark 
0.05 0.03 1.00 1.00 0.50 0.50 0.02 0.38 0.19 0.19 0.19 0.38 0.37 ± 0.33 
S. brachypetala 
bark 
0.13 0.13 1.00 1.00 1.00 0.50 0.25 0.50 0.25 0.50 2.00 0.50 0.65 ± 0.53 
S. cordatum 
bark 
0.25 0.06 2.00 2.00 2.00 1.00 0.31 0.75 0.25 0.38 0.50 >8.00 0.86 ± 0.77 
S. madagascariensis 
bark 
0.05 8.00 4.00 >8.00 >8.00 >8.00 8.00 1.00 0.75 1.00 0.13 0.38 2.59 ± 3.28 
S. madagascariensis 
leaves 
0.13 1.50 2.00 4.00 1.00 1.50 1.00 1.00 0.25 0.25 1.00 0.13 1.15 ± 1.08 
S. panduriforme 
fruits 
0.06 2.00 2.00 2.00 2.00 0.50   >8.00 2.00 1.00 1.00   >8.00 0.50 1.31 ± 0.77 
S. rigescens 
fruits 
0.06 1.00 2.00 2.00 4.00 0.15 2.00 1.00 0.50 0.13 0.19 0.13 1.20 ± 1.21 
S. serratuloides 
leaves 
0.50 3.00 4.00 1.50 4.00 1.00 1.50 2.00 1.50 1.50 1.00 0.38 1.82 ± 1.26 
S. spinosa 
fruits 
0.04 1.50 4.00 2.00 4.00 0.25 2.00 1.00 0.50 0.50 0.50 0.25 1.38 ± 1.39 
T. elegans 
fruits 
0.06 2.00 2.00 4.00    >8.00 0.03 1.50 1.00 0.50 0.13 1.00 0.19 1.13 ± 1.21 
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Plant sample 
Pathogens Average 
MIC ± σ* B. agriᵃ B. lineᵇ GMRSAᶜ MRSAᵈ S. aureᵉ S. epidᶠ P. acneᵍ          P. aeruᶥ C. albiᶨ M. caniᵏ T. mentᶥ 
T. elegans 
leaves 
0.38 3.00 2.00 4.00 4.00 1.00 6.00 2.00 0.38 0.75 0.13 0.13 1.98 ± 1.90 
T. sericea 
leaves 
0.19 2.00     >8.00   >8.00 1.00 1.00 0.25 0.50 0.75 0.50 0.25 0.34 0.68 ± 0.55 
W. indica 
roots 
0.31 0.50 4.00 3.00 2.00 1.00 0.75 1.00 0.25 1.00   >8.00 0.25 1.28 ± 1.23 
W. somnifera 
roots 
0.31 1.00 2.00 4.00 2.00 1.00 1.50 1.00 0.38 2.00 0.50 0.25 1.33 ± 1.07 
X. caffra 
twigs 
1.00 0.50 2.00 4.00 8.00 0.50 0.50 0.25 0.25 0.50 0.75 0.13 1.45 ± 2.31 
Z. capense 
roots 
0.19 0.06 2.00 4.00    >8.00 1.00 1.00 1.00 0.50 0.13 0.50 0.13 0.96 ± 1.32 
Z. mucronata 
leaves 
0.01 3.00 2.00 4.00 8.00 1.00 1.00 1.00 0.50 0.13 0.50 0.13 1.77 ± 2.31 
Positive control 
(Ciprofloxacin/ 
Amphotericin B 
µg/ml) 
0.18 0.13 0.63 0.31 0.63 0.34 1.25 0.16 0.16 0.01 0.13 0.01 0.33 ± 0.24 
Negative control 
(acetone) 
>8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00±>8.00 
Culture control 
(growth medium) 
>8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00±>8.00 
ᵃBrevibacterium agri ATCC 51663; ᵇBrevibacterium linens DSM 20425; ᶜGentamycin-methicillin resistant Staphylococcus aureus ATCC 33592; ᵈMethicillin-
resistant Staphylococcus aureus ATCC 43300; ᵉStaphylococcus aureus ATCC 25923; ᶠStaphylococcus epidermidis ATCC 2223;  ᵍPropionibacterium acnes 
ATCC 11827;  Escherichia coli ATCC 25922;  Pseudomonas aeruginosa ATCC 27853; ᶨCandida albicans ATCC 10231; ᵏMicrosporum  canis ATCC 36299; 
ᶥTrichophyton mentagrophytes ATCC 9533; *MIC values >8.00 were not considered when calculating the average MIC and the standard deviation (σ) since no 
end point for MIC determination was obtained. 
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which is usually caused by Mycobacterium leprae (Abbiw, 1990), wounds (Hutchings et al., 
1996), dermatitis and other unspecified skin infections (Kisangau et al, 2007). However, no 
studies have investigated the antimicrobial activity of this plant. Thus, the present study is the 
first to document the antimicrobial efficacy of A. senegalensis against skin pathogens. 
Elephantorrhiza elephantina is well documented for its use against skin diseases. This plant is 
used as an astringent to new wounds (Pooley, 1998), and to treat acne (Pujol, 1990; Van Wyk et 
al., 2009) as well as dermatitis (Maphosa et al., 2012). The antimicrobial properties of 
E. elephantina have been reported by Mabona et al. (2013) where the organic extracts of the 
roots and rhizome showed noteworthy activity against 70% of the tested dermatological relevant 
pathogens giving MIC values of 0.50 mg/ml with notable activity observed against P. acnes 
(MIC 0.05 mg/ml). In the present study, E. elephantina rhizome was validated for its use against 
sores (De Wet et al., 2013). This plant exhibited broad-spectrum activity (average MIC of 
0.94 mg/ml), which is congruent with the activity obtained by Mabona et al. (2013). However, 
the antimicrobial activity was more prominent against the Gram-negative E. coli (MIC 0.13 
mg/ml) and P. aeruginosa (MIC 0.50 mg/ml) as well as fungal strains C. albicans (MIC 0.13 
mg/ml), M. canis (0.25 mg/ml) and T. mentagrophytes (MIC 0.25 mg/ml) while in Mabona et al. 
(2013), the Gram-positive strains S. aureus (MIC 0.50 mg/ml), MRSA (MIC 0.50 mg/ml) and 
GMRSA (MIC 0.50 mg/ml) seemed most susceptible.  
 Garcinia livingstonei demonstrated the best broad-spectrum activity (average MIC of 0.27 
mg/ml) when compared to the other organic extracts studied, with noteworthy activity against 11 
of the 12 tested pathogens (MIC range from 0.02-0.50 mg/ml). Although, G. livingstonei was 
only reported to treat burns (De Wet et al., 2013), which are usually subjected to secondary 
infection by E. coli and P. aeruginosa (Lim, 1998), the broad-spectrum antimicrobial activity 
obtained may imply that the plant could be effective in treating both primary, secondary as well 
fungal skin infections. The current findings also correlate with those reported by Van Vuuren et 
al. (2015) where the dichloromethane: methanol bark extract of G. livingstonei displayed 
noteworthy activity against all tested diarrheal pathogens (MIC values range 0.12-0.75 mg/ml). 
Some compounds (amentoflavone and 4’monomethoxy amentoflavone) isolated from G. 
livingstonei acetone leaf extract also displayed noteworthy antimicrobial activity against E. coli, 
S. aureus, and P. aeruginosa with MIC values ranging from 8-100 µg/ml (Kaikabo et al., 2009). 
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These findings from literature and those documented in the current study demonstrate the 
potential of G. livingstonei in combating infectious diseases, especially skin infections. 
The bark of K. africana was reported to treat incisions and ringworm while the fruits were 
reported to treat ringworm (De Wet et al., 2013). In addition to being effective against the 
dermatophytes M. canis (MIC 0.34 mg/ml) and T. mentagrophytes (MIC 0.06 mg/ml), the bark 
and fruit extracts were also effective against other pathogens (B. agri, S. epidermidis, P. acnes, 
P. aeruginosa, and C. albicans) displaying almost similar MIC values ranging from 0.01-0.38 
mg/ml. These findings may imply the presence of similar compounds in both bark and fruits of 
K. africana. Chemical studies indicated the presence of an iridiod, vermonoside, which is 
commonly found in both bark and fruit of this plant species (Goudaa et al., 2003; Gabriel and 
Olubunmi, 2009; Van Wyk et al., 2009). Mabona et al. (2013) also investigated the 
dichloromethane: methanol fruit extracts of K. africana against the same skin pathogens 
investigated in the present study, but found it to exhibit low antimicrobial activity (MIC >1.00 
mg/ml). This may be due to the phytochemical variation within the species due to different 
seasons (summer and winter) in which the plant material was collected. It is known that, the 
phytochemical concentration and composition of plants of the same species may vary with 
seasonal variation which may also influence the biological activity. Similarly, Naidoo et al. 
(2013) also reported the low antimicrobial activity of the aqueous and organic leaf extracts of K. 
africana against pathogens associated with sexually transmitted infections (STIs). In this 
instance, a possible explanation of such contradiction could be that different plant parts were 
used. In the current study fruits and bark were used while Naidoo et al. (2013) used leaves. 
The antimicrobial properties of O. engleri against pathogens associated with STIs have also been 
reported by Naidoo et al. (2013). However, no previous studies were found related to the 
antimicrobial activity of O. engleri against pathogens associated with skin ailments. In the 
current study, O. engleri was validated for its use against sores (De Wet et al., 2013). Both bark 
and leaf extracts exerted broad-spectrum activity giving average MIC values of 0.37 and 0.89 
mg/ml respectively. For the bark extract, notable antimicrobial effects were observed against B. 
agri (MIC 0.02 mg/ml) and S. epidermidis (MIC 0.05 mg/ml) while the leaf extract exerted an 
MIC of 0.06 mg/ml against B. agri. The more pronounced activity of the bark extract could be 
due to high concentrations of active ingredients found in bark (Van Wyk et al., 2009). In this 
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instance, the leaves could easily be substituted for the bark in traditional preparations as a 
precaution to prevent unsustainable harvesting of the bark.   
Parinari capensis subsp. capensis was also reported to treat sores (De Wet et al., 2013). This 
plant species was found to give a broad-spectrum activity with average MIC of 0.60 mg/ml. 
Although there are no studies that have evaluated the antimicrobial properties of P. capensis 
against skin pathogens, a few studies reported the activity of this plant against other pathogens 
such as fungi. In this instance, the antifungal activity of P. capensis was tested against a plant 
pathogen, Cladosporium cucumerinum, where noteworthy activity (MIC 0.10 mg/ml) was 
reported (Garo et al., 1997). Uys et al. (2002) found the dichloromethane: methanol extract of P. 
capensis to be a promising antimalarial agent. York et al. (2012) studied its effect on respiratory 
tract pathogens, and reported that both the dichloromethane: methanol and aqueous extracts of P. 
capensis exhibited noteworthy activity against S. aureus with MIC values of 0.25 and 
0.50 mg/ml respectively. 
Even though the bark of S. brachypetala was reported to be effective against sores when used in 
combination with S. birrea (De Wet et al., 2013), the organic bark extract of S. brachypetala 
demonstrated noteworthy activities against eight pathogens independently with an average MIC 
of 0.65 mg/ml. Hutchings et al. (1996), documented S. brachypetala as a treatment for acne. To 
the best of our knowledge, no antimicrobial studies have been conducted in this regard. Its 
effects on diarrhoeal pathogens have, however been studied by Mathabe et al. (2006), where it 
was found that the methanol, ethanol, acetone and aqueous extracts of S. brachypetala were 
effective against 12 diarrhoeal pathogens tested (MIC values range 0.31-0.63 mg/ml). 
Interestingly, contradictory results have been reported in other studies where low activities 
against diarrheal pathogens were noted for the plant. For instance, Van Vuuren et al. (2015) 
found the dichloromethane: methanol extract of S. brachypetala to be only effective against 
Shigella flexneri and Enterococcus faecalis (MIC of 0.58 mg/ml and 0.63 mg/ml respectively) 
amongst five tested pathogens. Even compounds purified from the extract gave poor activity 
when tested against Bacillus subtilis, E. coli, Klebsiella pneumoniae and S. aureus, i.e. linoleic 
acid was least active (MIC values all >1 mg/ml) and methyl-5,11,14,17-eicosatetraenoate 
demonstrated weak activity against B. subtilis and S. aureus (MIC values of 0.78 mg/ml).    
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The antimicrobial properties of S. birrea have been studied and the bark extracts have been 
found to possess antibacterial activity against S. aureus (MIC 0.15 mg/ml) and P. aeruginosa 
(MIC 0.37 mg/ml) (Eloff, 2001). The antimicrobial activities of S. birrea bark have been further 
supported in recent studies (York et al., 2012, Naidoo et al., 2013, Van Vuuren et al., 2015). In 
the study by York et al. (2012) on respiratory tract pathogens, aqueous and dichloromethane: 
methanol bark extracts displayed broad-spectrum activity (average MIC value of 0.64 mg/ml). 
Naidoo et al. (2013) also found S. birrea bark extract to have broad-spectrum activity against 
pathogens associated with STIs including Trichomonas vaginalis, Candida albicans, Oligella 
ureolytica and Ureaplsma urealyticum, displaying an average MIC of 0.89 mg/ml. The same 
activity was also obtained by Van Vuuren et al. (2015) where dichloromethane: methanol extract 
of S. birrea exhibited notable activity against the diarrhoeal pathogens such as Bacillus cereus, 
Enterococcus faecalis, Escherichia coli, Proteus vulgaris, Salmonella typhimurium, Shigella 
flexneri and Staphylococcus aureus (MIC range 0.20-0.95 mg/ml). In the present study, S. birrea 
bark was investigated against skin pathogens as the plant was reported to treat burns, boils and 
sores independently as well as in combination with other plants (De Wet et al., 2013). In this 
instance, the organic extract of the bark displayed noteworthy activity against 10 of the 12 tested 
pathogens (mean MIC 0.37 mg/ml). In our study, the best activities were noted against B. agri, 
B. linens and P. acnes with MIC values as low as 0.05, 0.03 and 0.02 mg/ml respectively. This 
validates the use of S. birrea as a potential effective antimicrobial agent against a large variety of 
pathogens all related to the various diseases the plant was reported to treat. However, the least 
antimicrobial activity observed against GMRSA and MRSA (1.00 mg/ml) indicates that S. birrea 
might not be an effective antimicrobial against resistant strains.  
Syzygium cordatum was reported to treat sores and burns (De Wet et al., 2010) and was found to 
exhibit a broad-spectrum activity with the average MIC of 0.86 mg/ml in this study. Steenkamp 
et al. (2007) demonstrated that S. cordatum also possesses antifungal properties, where the 
methanolic bark extract  displayed activity against two strains of Candida albicans (MIC value 
of 0.83 mg/ml). In the present study, MIC value obtained from the dichloromethane: methanol 
bark extract against C. albicans was even lower at 0.38 mg/ml. Other previous studies have 
further shown that S. cordatum bark is effective against diarrhoeal pathogens (Sibandze et al., 
2010; Mulaudzi et al., 2011; Van Vuuren et al., 2015), respiratory tract pathogens (York et al., 
2012) and pathogens associated with  STIs (Van Vuuren and Naidoo, 2010; Naidoo et al., 2013). 
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Although dermatological uses for S. cordatum have been documented including the treatment of 
wounds (Hutchings et al., 1996), mouth sores and skin rashes (Corrigan et al., 2011), only its 
effect on S. aureus has been studied by York et al. (2012) where the organic and aqueous 
extracts exerted noteworthy activity with MIC values of 0.38 and 0.25 mg/ml respectively.  
A previous antimicrobial study showed Terminalia sericea to exhibit broad-spectrum activity 
against dermatological relevant pathogens similar to the pathogens investigated in the present 
study, with noteworthy MIC values ranging between 0.03-0.80 mg/ml (Mabona et al. 2013). Our 
results show comparable findings in which T. sericea exhibited an average MIC value of 0.68 
mg/ml against the test pathogens. This plant has also been found to possess broad-spectrum 
activity (average MIC<1.00 mg/ml) against diarrheal pathogens (Van Vuuren et al., 2015). The 
least activity for this species was however reported by Eloff (1999) against S. aureus, E. coli and 
P. aeruginosa (MIC range 1.00-6.00 mg/ml). Similar findings were also observed by Steenkamp 
et al. (2007) where T. sericea extract showed poor activity against S. aureus (MIC 5.00 mg/ml) 
and S. epidermidis (MIC 2.50 mg/ml). Such discrepancies could be attributed to the different 
solvents used. The present study and that of Mabona et al. (2013) employed dichloromethane and 
methanol while Eloff (1999) and Steenkamp et al. (2007) used methanol only. Consequently the 
active components may thus not be polar enough to completely dissolve in methanol. 
Zanthoxylum capense was found to exhibit broad-spectrum antimicrobial activity with the 
average MIC of 0.96 mg/ml. The roots of this plant were reported to treat boils in an 
ethnobotanical study by De Wet et al. (2013). The poor antimicrobial activity was, however, 
observed against the Gram-positive bacteria GMRSA (MIC 2.00 mg/ml) MRSA (MIC 4.00 
mg/ml), S. aureus (MIC >8.00 mg/ml) and S. epidermidis (MIC 1.00 mg/ml) which are most 
likely to be associated with boils. These findings contradict those obtained by Ndhlala et al. 
(2011) where the dichloromethane: methanol extracts of Z. capense roots exhibited noteworthy 
activity against S. aureus (MIC 0.19 mg/ml). The same study also demonstrated the activity of Z. 
capense against E. coli (MIC 0.78 mg/ml) which was found to be least susceptible in the present 
study giving a MIC value of 1.00 mg/ml. Such contradictions could be due to different localities 
where plants were sourced. 
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Even though the plant species with the most pronounced broad-spectrum activities have been 
highlighted, the other plant extracts also displayed a correlation between antimicrobial efficacy 
and their respective traditional uses. For instance, M. balsamina, specifically reported to treat 
ringworm, was found to be highly effective against the dermatophytes (MIC values of 0.50 and 
0.19 mg/ml against M. canis and T. mentagrophytes respectively). Similarly, T. elegans leaves, 
reported to treat ringworm and wounds, also exhibited noteworthy against the dermatophytes 
(MIC of 0.13 mg/ml against both M. canis and T. mentagrophytes). Furthermore, the latter 
species was also found effective against P. aeruginosa (MIC value of 0.38 mg/ml) which is most 
likely to cause secondary wound infections.  
Lippia javanica did not display broad-spectrum activity (mean MIC>1.00 mg/ml), however, this 
plant exhibited notable antimicrobial activity against nine of the 12 tested pathogens. The best 
activity was observed against B. agri, S. epidermidis, M. canis and T. mentagrophytes with MIC 
values as low as 0.02, 0.19, 0.13 mg/ml respectively. Previous studies on L. javanica have 
focused on investigating the antimicrobial activity of the plant against respiratory tract pathogens 
since the plant is rich in volatile compounds that are known to be effective in treatment of 
various chest ailments (Manenzhe et al., 2004; Viljoen et al., 2005; York et al., 2012). Very little 
research has been done on the antimicrobial efficacy of L. javanica against skin associated 
pathogens. Shikanga et al. (2010) provided some antimicrobial data of this species against 
S. aureus, E. coli and P. aeruginosa where the plant was found to give noteworthy activities 
(MIC values range 0.13-0.42 mg/ml). In the present study, L. javanica was validated for its use 
to treat sores (De Wet et al., 2013), where the findings obtained evidenced the effectiveness of L. 
javanica against skin infections in addition to its well known effect against respiratory tract 
infections. 
Ximenia caffra also did not display broad-spectrum activity. However, the plant was found to 
possess noteworthy activities against eight of the pathogens tested with an MIC ranging from 
0.13-0.75 mg/ml. This plant has been evaluated against pathogens associated with STIs where it 
was also found to possess antigonococcal, antifungal and antibacterial activities (Mulaudzi et al., 
2011; Naidoo et al., 2013). In the present study X. caffra was validated for its use in treatment of 
sores (De Wet et al., 2013). It was found to be less effective against Gram-positive GMRSA, 
MRSA and S. aureus, but more effective against the Gram-negative strains (E. coli and P. 
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aeruginosa) displaying MIC values of 0.25 mg/ml in both instances. Notable activity was also 
obtained against the dermatophyte, T. mentagrophytes (MIC value 0.13 mg/ml).  
The findings presented in this study not only validate the tradition uses of these selected plant 
species, but also highlights the need to incorporate skin pathogens other than the commonly 
included pathogens such as S. aureus. 
2.3.3 Antimicrobial activity of aqueous extracts 
Even though water was the solvent used traditionally for the majority of the plants, the aqueous 
extracts exhibited moderate to poor activity (Table 2.4). While several studies reported water as a 
poor extractor of antimicrobial compounds from plant material, other studies have found the 
water extracts to be antimicrobially active displaying activities which are comparable or even 
superior to those from organically derived extracts. For example, in a study by Kumar et al. 
(2007), water extracts were found to be effective when investigated against B. cereus, E. coli, 
Micrococcus luteus, P. aeruginosa and S. aureus. Olajuyigbe and Afolayan, (2011) also found 
aqueous extracts to be antimicrobially active against pathogens associated with STIs with MIC 
values ranging between 0.16 and 0.63 mg/ml, the activities comparable to those exhibited by the 
ethanol extracts also investigated. Similar findings were further obtained by Naidoo et al, (2013), 
where the activities of the aqueous extracts were found to be equal and in some cases superior to 
the activities of the organic extracts against STI pathogens.  
In the present study, 27 of the 41 aqueous extracts investigated were found to be active, 
exhibiting MIC values below 1.00 mg/ml for at least one or more of the pathogen(s) tested. 
Interestingly it was found that, although A. vesicolor, K. africana and S. birrea were not reported 
to treat acne, the aqueous extracts of these plants displayed notable activity against P. acnes with 
MIC values of 0.13, 0.19 and 0.13 mg/ml respectively.  P. capensis and T. elegans displayed the 
best activity amongst the aqueous extracts against T. mentagrophytes (MIC 0.13 and 0.19 mg/ml 
respectively). 
 Certain plant species exhibited relevant activity (MIC values<1.00 mg/ml) against the pathogens 
most likely to cause the skin infections they were reported to treat. In this instance, A. burkei was 
reported to treat ringworm (De Wet et al., 2013) and the aqueous extract showed noteworthy 
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Table 2.4: The average MIC values (mg/ml) of aqueous extracts against 12 dermatological relevant pathogens. 
Plant sample 
Pathogens Average  
MIC ± σ* B. agriᵃ B. lineᵇ GMRSAᶜ MRSAᵈ S. aureᵉ S. epidᶠ P. acneᵍ          P. aeruᶥ C. albiᶨ M. caniᵏ T. mentᶥ 
A. adianthifolia 
bark 
>8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00±>8.00 
A. burkei 
bark 
0.50 1.50 >8.00 2.00 3.00 2.00 0.50 >8.00 >8.00 >8.00 4.00 0.50 1.75 ± 1.28 
A. senegalensis 
roots 
3.00 1.00 4.00 2.00 >8.00 4.00 1.00 2.00 >8.00 0.50 0.50 0.50 1.85 ± 1.39 
A. vesicolor 
bark 
>8.00 >8.00 >8.00 8.00 >8.00 >8.00 0.13 >8.00 2.00 >8.00 4.00 0.25 2.88 ± 3.28 
B. discolor 
twigs 
>8.00 >8.00 >8.00 0.25 6.00 >8.00 >8.00 >8.00 0.50 >8.00 4.00 1.00 2.35 ± 2.53 
C. inerme 
twigs 
>8.00 8.00 >8.00 >8.00 8.00 >8.00 8.00 8.00 >8.00 >8.00 4.00 0.75 6.13 ± 3.08 
D. cinerea 
twigs 
>8.00 >8.00 >8.00 >8.00 >8.00 >8.00 4.00 >8.00 >8.00 >8.00 >8.00 >8.00 4.00 ± 0.00 
D. obovata 
leaves 
>8.00 4.00 3.00 >8.00 >8.00 1.00 >8.00 4.00 >8.00 >8.00 >8.00 >8.00 3.00 ± 1.41 
D. schlechteri 
bark 
>8.00 2.00 4.00 3.00 4.00 8.00 1.50 3.00 4.00 4.00 0.75 4.00 3.48 ± 1.33 
E. elephantina 
rhizome 
2.00 >8.00 4.00 4.00 6.00 4.00 2.00 1.00 2.00 2.00 0.50 2.00 2.68 ± 1.62 
E. tirucalli 
modified stems 
>8.00 >8.00 0.50 0.25 >8.00 1.00 1.00 >8.00 >8.00 >8.00 >8.00 >8.00 0.69 ± 0.37 
G. livingstonei 
bark 
0.75 8.00 2.00 1.50 2.00 4.00 >8.00 >8.00 >8.00 4.00 0.50 6.00 3.19 ± 2.53 
H. hemerocallidea 
corms 
>8.00 >8.00 >8.00 1.00 2.00 0.25 2.00 2.00 4.00 >8.00 8.00 4.00 2.91 ± 2.44 
H. malabarica 
leaves 
>8.00 >8.00 >8.00 >8.00 8.00 >8.00 >8.00 >8.00 >8.00 >8.00 0.50 8.00 5.50 ± 5.59 
H. surratensis 
leaves 
>8.00 >8.00 2.00 4.00 >8.00 >8.00 8.00 >8.00 >8.00 8.00 4.00 4.00 5.00 ± 2.45 
K. africana 
bark 
8.00 >8.00 4.00 4.00 8.00 4.00 6.00 4.00 >8.00 8.00 >8.00 >8.00 5.75 ± 1.98 
K. africana 
fruits 
0.25 8.00 2.00 >8.00 >8.00 0.25 0.19 2.00 >8.00 4.00 2.00 1.00 2.19 ± 2.50 
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Plant sample 
Pathogens Average 
MIC ± σ* B. agriᵃ B. lineᵇ GMRSAᶜ MRSAᵈ S. aureᵉ S. epidᶠ P. acneᵍ          P. aeruᶥ C. albiᶨ M. caniᵏ T. mentᶥ 
L. javanica 
twigs 
>8.00 >8.00 2.00 8.00 4.00 3.00 6.00 4.00 4.00 >8.00 6.00 8.00 5.00 ± 2.12 
M. balsamina 
leaves 
0.50 >8.00 1.00 1.00 >8.00 >8.00 8.00 >8.00 1.00 2.00 6.00 >8.00 2.79 ± 3.34 
O. engleri 
bark 
0.50 0.25 1.00 1.00 2.00 2.00 0.38 1.00 1.00 8.00 4.00 0.25 1.78 ± 2.22 
O. engleri 
leaves 
4.00 >8.00 8.00 4.00 4.00 2.00 0.25 1.00 1.00 8.00 4.00 2.00 3.45 ± 2.63 
P. afra 
leaves 
>8.00 >8.00 4.00 0.50 >8.00 >8.00 >8.00 2.00 >8.00 >8.00 8.00 0.50 3.00 ± 3.14 
P. capensis 
roots 
4.00 >8.00 8.00 1.00 >8.00 >8.00 >8.00 3.00 >8.00 >8.00 4.00 0.13 3.36 ± 2.77 
R. multifidus 
whole plants 
>8.00 >8.00 >8.00 >8.00 >8.00 >8.00 0.58 >8.00 >8.00 >8.00 >8.00 4.00 2.29 ± 3.34 
S. birrea 
bark 
2.00 0.50 2.00 2.00 2.00 2.00 0.13 3.00 2.00 1.00 2.50 2.00 1.76 ± 0.82 
S. brachypetala 
bark 
0.50 1.00 1.00 1.00 >8.00 2.00 0.50 8.00 >8.00 0.50 4.00 0.50 1.90 ± 2.40 
S. cordatum 
bark 
1.00 >8.00 2.00 2.00 2.00 4.00 8.00 1.00 4.00 2.00 4.00 >8.00 3.00 ± 2.37 
S. madagascariensis 
bark 
0.75 8.00 >8.00 2.00 >8.00 >8.00 8.00 >8.00 >8.00 >8.00 >8.00 8.00 5.35 ± 3.66 
S. madagascariensis 
leaves 
>8.00 >8.00 1.00 >8.00 >8.00 2.00 >8.00 >8.00 0.50 >8.00 6.00 8.00 3.50 ± 3.15 
S. panduriforme 
fruits 
>8.00 1.00 >8.00 8.00 4.00 >8.00 >8.00 >8.00 >8.00 0.25 8.00 0.38 3.61 ± 3.67 
S. rigescens 
fruits 
>8.00 4.00 >8.00 3.00 >8.00 0.50 8.00 >8.00 >8.00 >8.00 1.00 >8.00 3.30 ± 2.99 
S. serratuloides 
leaves 
>8.00 >8.00 8.00 >8.00 4.00 >8.00 8.00 8.00 >8.00 >8.00 8.00 1.00 6.17 ± 2.99 
S. spinosa 
fruits 
>8.00 >8.00 1.00 8.00 8.00 >8.00 >8.00 >8.00 >8.00 0.50 8.00 >8.00 5.10 ± 3.97 
T. elegans 
fruits 
8.00 4.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 1.00 0.19 3.30 ± 3.54 
T. elegans 
leaves 
>8.00 8.00 >8.00 >8.00 >8.00 2.00 1.00 >8.00 >8.00 8.00 4.00 >8.00 4.60 ± 3.29 
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Plant sample 
Pathogens Average 
MIC ± σ* B. agriᵃ B. lineᵇ GMRSAᶜ MRSAᵈ S. aureᵉ S. epidᶠ P. acneᵍ          P. aeruᶥ C. albiᶨ M. caniᵏ T. mentᶥ 
T. sericea 
leaves 
>8.00 >8.00 >8.00 >8.00 4.00 >8.00 >8.00 2.00 >8.00 >8.00 6.00 >8.00 4.00 ± 2.00 
W. indica 
roots 
>8.00 >8.00 >8.00 2.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 1.00 1.00 1.33 ± 0.58 
W. somnifera 
roots 
>8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 0.31 0.50 0.41 ± 0.13 
X. caffra 
twigs 
2.00 1.00 4.00 4.00 2.00 4.00 1.00 1.00 4.00 0.25 2.00 8.00 2.77 ± 2.18 
Z. capense 
roots 
>8.00 6.00 4.00 2.00 8.00 >8.00 >8.00 >8.00 8.00 8.00 8.00 1.00 5.38 ± 2.94 
Z. mucronata 
leaves 
8.00 8.00 >8.00 4.00 4.00 3.00 8.00 8.00 >8.00 >8.00 >8.00 >8.00 6.14 ± 2.17 
Positive control 
(Ciprofloxacin/ 
Amphotericin B 
µg/ml) 
0.18 0.13 0.63 0.31 0.63 0.34 1.25 0.16 0.16 0.01 0.13 0.01 0.33 ± 0.24 
Negative control 
(water) 
>8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00±>8.00 
Culture control 
(growth medium) 
>8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00 >8.00±>8.00 
ᵃBrevibacterium agri ATCC 51663; ᵇBrevibacterium linens DSM 20425; ᶜGentamycin-methicillin resistant Staphylococcus aureus ATCC 33592; ᵈMethicillin-
resistant Staphylococcus aureus ATCC 43300; ᵉStaphylococcus aureus ATCC 25923; ᶠStaphylococcus epidermidis ATCC 2223;  ᵍPropionibacterium acnes 
ATCC 11827;  Escherichia coli ATCC 25922;  Pseudomonas aeruginosa ATCC 27853; ᶨCandida albicans ATCC 10231; ᵏMicrosporum  canis ATCC 36299; 
ᶥTrichophyton mentagrophytes ATCC 9533; *MIC values >8.00 were not considered when calculating the average MIC and the standard deviation (σ)  since no 
end point for MIC determination was obtained. 
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activity against T. mentagrophytes (MIC 0.50 mg/ml), i.e. a pathogen responsible for ringworm 
infections, thus validating its traditional use. The aqueous extract of E. tirucalli was reported to 
treat sores, and exhibited noteworthy activity against GMRSA and MRSA (MIC values of 0.50 
and 0.25 mg/ml respectively), i.e. pathogens mostly associated with sores as well as skin and soft 
tissue infections. On the other hand, A. senegalensis which was also reported to treat sores, gave 
poor activity against the bacterial pathogens (MIC values>1.00 mg/ml) but exhibited noteworthy 
activity against all fungal pathogens, C. albicans, M. canis and T. mentagrophytes with MIC 
values of 0.50 mg/ml. These findings may favour the plant as a potential antimicrobial against 
ringworm infections. 
2.4 Antimicrobial activity and traditional use 
Eight plants species (A. burkei, B. discolor, D. delagoensis, O. engleri, P. capensis subsp. 
capensis, P. afra, S. rigescens and S. pseudocordifolia) were documented for the first time in the 
literature as a treatment of skin diseases (De Wet et al., 2013). With the exception of D. 
delagoensis and S. pseudocordifolia, six of these plants (A. burkei, B. discolor, O. engleri, 
P. capensis subsp. capensis, P. afra and S. rigescens) which were investigated in this study did 
show a correlation in antimicrobial efficacy and traditional use. For instance, A. burkei was 
reported to treat ringworm, and both aqueous and organic extracts of the plant were found to be 
active against the causative agents of ringworm, i.e. M. canis (MIC 0.13 mg/ml for the organic 
extract) and T. mentagrophytes (MIC values of 0.25 and 0.50 mg/ml for organic and water 
extracts respectively). Ozoroa engleri, also documented for the first time as a medicinal plant to 
treat sores by De Wet et al. (2013), displayed broad-spectrum activity with average MIC values 
of 0.37 and 0.89 mg/ml for the organic extracts of bark and leaves respectively. Noteworthy 
activity from O. engleri was observed with the organic bark extract against S. aureus (MIC 0.75 
mg/ml), S.epidermidis (MIC 0.05 mg/ml), E. coli (MIC 0.19 mg/ml) and P. aeruginosa (MIC 
0.38 mg/ml). These are all pathogens associated with sore infections. Parinari capensis subsp. 
capensis, also reported to treat sores, was among the plants that displayed a broad-spectrum 
antimicrobial activity against the tested pathogens with an average MIC of 0.60 mg/ml. For P. 
afra and S. rigescens, the antimicrobial activity was mostly moderate, displaying pathogen 
specific noteworthy activity against at least two or more test pathogens. 
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Even though some plant species (A. senegalensis, G. livingstonei, P. capensis, S. brachypetala, 
T. sericea and Z. capense) were rarely used by the lay people of rural Maputaland, their organic 
extracts were found to exhibit broad-spectrum antimicrobial activity. Other plant species which 
are most frequently used have, however, only exhibited moderate to poor activities. In this 
instance, S. serratuloides was the most cited plant (cited 17 times) by the interviewees as a 
treatment of skin diseases (De Wet et al., 2013). This plant is also well documented for its use in 
the treatment of various skin diseases including abscesses, boils (Van Wyk and Gericke, 2000), 
burns, cuts (Pooley, 2003), skin eruptions due to syphilis (Taylor et al., 2003) and STI sores (De 
Wet et al., 2012). The plant, however, displayed mostly poor antimicrobial activity when tested 
against the pathogens related to these skin ailments. This may imply that this plant could act by 
inducing other healing properties in a dermatological condition, i.e. it may act as an anti-
inflammatory or for pain relief which would substantiate its traditional uses even though it is not 
necessarily an antimicrobial agent. Furthermore, it is known that in vitro studies may not always 
corroborate in vivo studies. It may thus be a case where S. serratuloides exhibits in vivo 
noteworthy activity even though its in vitro activity is questionable. The anti-inflammatory 
activity of S. serratuloides had been reported by Fawole et al. (2010), where the petroleum ether 
leaf extract exhibited good cyclooxygenase-1 (COX-1) enzyme inhibition (62%) while the 
methanol extract showed 71.6% COX-2 enzyme inhibition. Gould, 2014 also reported the in vivo 
wound healing properties of S. serratuloides, where the plant was found to be effective in 
treating deep partial thickness wounds in a porcine. Thus, future studies should investigate the 
inflammatory and other pharmacological properties of S. serratuloides apart from its 
antimicrobial effects. A similar incidence has been found by Naidoo et al. (2013) who also 
obtained the poor activity for the same plant against STI pathogens. Similarly, York et al., (2012) 
reported the poor antimicrobial activity of L. javanica which was frequently mentioned by the 
interviewees as a treatment of respiratory tract infections. York et al., (2012) concluded that, the 
frequency of a certain plant use does not necessarily correlate with high antimicrobial efficacy. 
Other plants that were frequently mentioned in the survey by De Wet et al. (2013) were T. 
elegans and S. madagascariensis, which again displayed moderate antimicrobial activity. 
Sclerocarya birrea which was also frequently mentioned did show good antimicrobial activity 
with broad-spectrum activity obtained from the organic extract (mean MIC 0.37 mg/ml). 
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2.5 Summary 
 Organic extracts had better antimicrobial activity with more than 80% displaying correlation 
between antimicrobial efficacy and the pathogens most likely to be responsible for the 
specific skin infections they were reported to treat. 
 The most antimicrobially active organic extract was G. livingstonei (mean MIC of 0.27 
mg/ml), displaying noteworthy activity against 11 of the 12 tested pathogens with MIC 
values ranging from 0.02 to 0.50 mg/ml. 
 For the aqueous extracts, the antimicrobial efficacy was mostly moderate with 24 extracts 
displaying pathogen specific noteworthy antimicrobial effects. 
 T. mentagrophytes was the most susceptible pathogen with the majority (98%) of the organic 
extracts investigated exhibiting noteworthy activity (MIC values <1.00 mg/ml). 
Susceptibility was also pronounced against a Gram-negative, P. aeruginosa (83%) and a 
Gram-positive B. agri (88%) bacteria. 
 For the resistant Staphylococcal strains, noteworthy effects were mostly observed. Activities 
between 0.25 - 0.50 mg/ml were observed for the plant species A. senegalensis, G. 
livingstonei, P. afra. and E. tirucalli. 
 Six of the eight plant species (A. burkei, B. discolor, O. engleri, P. capensis, P. afra, and S. 
rigescens) documented for the first time in Maputaland as a treatment for skin inflictions, 
demonstrated susceptible antimicrobial effects. 
 O. engleri, documented for the first time as a treatment for skin diseases demonstrated 
noteworthy activity against nine of the 12 tested pathogens displaying the mean MIC values 
of 0.37 and 0.89 mg/ml for the organic extracts of bark and leaves respectively.  
 Organic and aqueous extracts of A. burkei (also documented for the first time to treat 
ringworm), exhibited noteworthy activity against the causative pathogen T. mentagrophytes 
with MIC values of 0.25 and 0.50 mg/ml respectively which validates its use as a treatment 
of ringworm.  
 Similarly, P. capensis subsp. capensis reported to treat sores displayed a broad-spectrum 
activity (mean MIC 0.60 mg/ml) with noteworthy activity observed against MRSA, P. 
aeruginosa and S. epidermidis (activities between 0.25 – 0.50 mg/ml) which are the 
pathogens that are most likely to infect sores.  
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Chapter three: Interactive profiles of plants used in combinations to 
treat skin diseases 
 
3.1 Introduction 
The rationale of combining plants in a medication is the desire to produce a combination with 
improved therapeutic effect. The most desirable outcome in combination therapy is usually the 
additive or synergistic interaction. The former occurs when the effect of the combined plants 
equals the effect of each plant brought into combination. The latter occurs when the combined 
effect exceeds the effects of the individual plants simply added together (Che et al., 2013). 
Combination therapy is not only confined to traditional medicine. Even in clinical practice, 
critical diseases such as HIV/AIDS and cancer are treated more effectively with pharmaceutical 
combinations than they can be with single drugs (Wagner and Ulrich-Merzenich, 2009). In 
combination therapy, small quantities of medicines have to be used in order to obtain a specific 
outcome. Furthermore, when one of the plants used in a combination has toxic effects, the non-
toxic plant is capable of reducing toxicity. However, this is not always the case as in some cases, 
Herb-herb interaction may result in increased toxicity even though the combination may give 
another pharmacologically desired synergistic effect. Such toxicity is not limited only to herbal 
preparations, even pharmaceutical drug-drug interactions are sometimes associated with toxic 
effects. Thus, caution should be adhered to when considering combination therapy. Even though 
synergism or an additive interaction is the desired outcome in combination therapy, however, 
non-interactive and even antagonistic interactions may also occur. The latter is when the 
inhibitory effect of the combination is decreased compared to the inhibitory effects of individual 
plants incorporated into a combination. This usually suggests that the plants forming part of the 
combination have opposing effects.  
About 28 of the 47 plants documented in an ethnobotanical survey in northern Maputaland were 
combined to form 14 different combinations. Eight combinations (Table 3.1) were considered for 
investigation based on the availability of the plant material during the time of collection. While 
the independent antimicrobial efficacy of the plants used in combinations was determined in 
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Chapter 2, this Chapter first reports on the evaluation of the possible antimicrobial interactions of 
these plants when combined in equal ratios. In doing so, possible synergistic or antagonistic 
interactions against dermatological relevant pathogens were identified. The combinations were 
further analyzed in various ratios to determine the suitable ratios in which these remedies could 
be combined for better efficacy. 
Table 3.1: Plant combinations considered for antimicrobial analysis adapted from De Wet et al. 
(2013). 
Plant species in the combination Part(s) used 
Mode of 
administration 
Medical condition 
Acacia burkei and Kigelia africana Bark 
Decoction taken 
orally 
Ringworm 
Acacia burkei, Ozoroa engleri, 
Sclerocarya birrea, Syzygium 
cordatum, Tabernaemontana 
elegans  and Lippia javanica 
Bark and leaves 
Decoction used 
as enema 
Sores 
Brachylaena discolor, Euphorbia 
tirucalli, Hypoxis hemerocallidea, 
Ozoroa engleri, Senecio 
serratuloides 
Twigs, modified 
stems and corms 
Decoction taken 
orally 
Sores 
Canthium inerme and Dichrostachys 
cinerea 
Twigs 
Decoction used 
for steaming 
Acne 
Hypoxis hemerocallidea and 
Solanum rigescens 
Corms and fruits 
Decoction taken 
orally 
Boils 
Schotia brachypetala and 
Sclerocarya birrea 
 
Bark 
Decoction used 
as enema 
Sores 
Sclerocarya birrea and Syzygium 
cordatum 
Bark 
Powder applied 
topically 
Burns 
Strychnos madagascariensis and 
Strychnos spinosa 
Leaves and fruits 
Paste applied 
topically 
Sores 
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3.2 Materials and methods 
3.2.1 Selection and preparation of microbial cultures 
Three commonly tested pathogens associated with skin infections, i.e. two Gram-positive (S. 
aureus ATCC 25923 and S. epidermidis ATCC 2223) and a Gram-negative (P. aeruginosa 
ATCC 27853) strains, were selected to test the efficacy of all plant combinations. However, for 
some combinations, other additional pathogens were selected based on their relation to the 
traditional use for the particular combination. For instance, a combination reported to treat 
ringworm were evaluated against M. canis ATCC 36299 and T. mentagrophytes ATCC 9533 in 
addition to S. aureus, S. epidermidis and P. aeruginosa. Furthermore, the combination reported 
to treat acne was investigated against P. acnes ATCC 11827 in addition to the commonly tested 
pathogens. The selected pathogens were then prepared according to specifications detailed in 
Chapter 2, Section 2.2.3.2. 
3.2.2 Combination studies  
3.2.2.1 Determination of the sum of Fractional Inhibitory Concentration (ΣFIC) 
Microtitre plates were aseptically prepared by adding 100 µl of the growth medium in all wells. 
For combinations of two plants, 50 µl from each plant extract at a starting concentration of 32 
mg/ml were combined adding up 100 µl in the first row of the microtitre plate to make a 1:1 
combination. Where five or six plants were combined, 20 or 16.6 µl from each extract 
respectively, were combined to make up a volume of 100 µl in each well in a 1:1:1:1:1 or 
1:1:1:1:1:1 combination. Serial dilutions were performed on the extracts as detailed in Chapter 2, 
Section 2.2.3.3. Tests were undertaken in duplicates and triplicates with positive (conventional 
antimicrobials) and negative (acetone, water and sterile medium) controls included in each assay. 
The MIC values were determined for the plant combinations and the Fractional Inhibitory 
Concentration (FIC) was calculated for each combination. The FIC was calculated by dividing 
the MIC value of the combination by the MIC value of a particular plant extract placed in a 
combination (Equation 3.1). The ΣFIC was then calculated by adding together the FIC values. 
Equation 3.1:  FICₐ=  
 
MIC (a) in combination with (b) 
MIC (a) independently 
FICb= 
MIC (b) in combination with (a) 
MIC (b) independently 
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(a) and (b) in the equation represent different plants in the combination. Where five or six plants 
were combined, the equation also brought into account the number of plant species forming part 
of each combination. The value of the ΣFIC (also called the FIC index) was used to determine if 
the plants in a combination are synergistic, additive, non-interactive or antagonistic. The plants 
were regarded as synergistic if their ΣFIC value is equal or less than 0.50 mg/ml. The additive 
effect was observed when the ΣFIC was greater than 0.50 but less than or equal to 1.00 mg/ml. 
For the non-interactive interaction, the ΣFIC was greater than 1.00 but less than or equal to 4.00 
mg/ml while antagonism occurred when the ΣFIC was greater than 4.00 mg/ml (Van Vuuren and 
Viljoen, 2011).   
 3.2.2.2 Varied ratio studies: Isobologram construction   
Since the ΣFIC method is based on assumption that each extract in a combination gives half the 
antimicrobial effect of which is not always the case, the combinations were further studied using 
the isobole method. This method takes into account that the antimicrobial interaction may vary 
depending on the ratio in which the two plants are combined (Van Vuuren and Viljoen, 2011). 
Three combinations with two plants per combination were then combined in nine ratios i.e. 
90:10, 80:20, 70:30, 60:40, 50:50, 40:60, 30:70, 20:80 and 10:90, with each ratio constituting the 
100 µl in the first row of the microtitre plate. The MIC was determined for all combinations 
using the MIC method detailed in Chapter 2, Section 2.2.3.3. Positive and negative controls were 
included in each assay and all assays were undertaken at least in duplicate. The mean MIC 
values of plant combinations were then plotted against independent plant MIC values on an 
isobologram as a ratio using a GraphPad Prism® version 5 software. This expressed the 
interactions of various ratio combinations on an isobole graph. The isobole graph was interpreted 
by examining the data points of the ratios falling within various quadrants or on either three of 
the adjoining lines (the 0.5:0.5 line, the 1.0:1.0 line and the 4.0:4.0 line) of the two axes (Figure 
3.1). Synergistic activity was noted for points falling below or on the 0.5:0.5 line of the 
isobologram. An additive effect was expressed when ratio points fell between the 0.5:0.5 and 
1.0:1.0 line or on the 1.0:1.0 line. Points falling between the 1.0:1.0 and 4.0:4.0 line expressed 
the non-interactive interaction while antagonism was noted for points falling above the 4.0:4.0 
line (Van Vuuren and Viljoen, 2011). 
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Figure 3.1: Isobologram interpretation showing synergy, additive, non-interactive and 
antagonistic interactions when two plants are combined in various ratios, where a is one plant 
and b is another (adapted from Van Vuuren and Viljoen, 2011). 
3.3 Results and discussion 
3.3.1 ΣFICs for plants combined in equal ratios 
Eight plant combinations (with two to six plants per combination) were analyzed for their 
efficacy against S. aureus, S. epidermidis and P. aeruginosa. The mean MIC and the ΣFIC 
values for aqueous and organic (dichloromethane: methanol) extract combinations are depicted 
in Table 3.2. In cases where no end point for MIC determination was found either for a 
combination or individual plant(s) in a combination, the ΣFIC could not be calculated. In these 
cases, tentative interpretations (synergism, additive, non-interactive or antagonistic effect) were 
given based on the increase or decrease in MIC value of a combination when compared with the 
MIC values of the individual plants making up the combination. 
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Table 3.2: The mean MICs and ΣFICs of aqueous and organic plant extracts used in 
combinations to treat skin diseases. 
Plant species and combinations 
S. aureus 
ATCC 25923 
S. epidermidis 
ATCC 2223 
P. aeruginosa 
ATCC 27853 
D:M H₂O D:M H₂O D:M H₂O 
A. burkei MIC values 
(mg/ml) 
4.00 3.00 1.00 2.00 0.25 >8.00 
K. africana >8.00 8.00 0.01 4.00 0.25 >8.00 
A. burkei and K. africana 
MIC value 0.50 >8.00 0.50 1.50 0.50 >8.00 
ΣFIC value ND ND 0.75 0.56 2.00 ND 
                                     ΣFIC interpretation SYN ANT ADD ADD NON ANT 
A. burkei 
MIC values 
(mg/ml) 
4.00 3.00 1.00 2.00 0.25 >8.00 
O. engleri 0.75 2.00 0.05 2.00 0.38 1.00 
S. birrea 0.50 2.00 0.50 2.00 0.19 2.00 
S. cordatum 2.00 2.00 1.00 4.00 0.25 4.00 
T.  elegans 4.00 >8.00 1.00 2.00 0.38 >8.00 
L. javanica 4.00 4.00 0.19 3.00 0.25 4.00 
A. burkei, O. engleri,  
S. birrea, S. cordatum,  
T.  elegans and L. javanica 
MIC value 0.75 6.00 0.50 1.00 0.50 1.00 
ΣFIC value 0.57 2.15 2.43    0.57 1.80 ND 
                                  ΣFIC interpretation ADD NON NON   ADD NON ADD 
B.  discolor 
MIC values 
(mg/ml) 
3.00 6.00 1.00 >8.00 0.75 0.50 
E. tirucalli 6.00 >8.00 1.50 1.00 0.75 >8.00 
H. hemerocallidea >8.00 2.00 2.00 0.25 2.00 4.00 
O. engleri 1.00 4.00 0.50 2.00 0.38 1.00 
S. serratuloides 4.00 4.00 1.00 >8.00 1.50 >8.00 
B.  discolor,  E. tirucalli,  
H. hemerocallidea, O. 
engleri and S. serratuloides 
MIC value 0.50 0.38 0.50 1.00 0.50 1.00 
ΣFIC value ND ND 0.52 ND 0.92 ND 
                                 ΣFIC interpretation SYN SYN ADD ADD ADD ADD 
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Plant species and combinations 
S. aureus 
ATCC 25923 
S. epidermidis 
ATCC 2223 
P. aeruginosa 
ATCC 27853 
D:M H₂O D:M H₂O D:M H₂O 
C. inerme MIC values 
(mg/ml) 
4.00 8.00 0.25 >8.00 0.25 >8.00 
D. cinerea 4.00 >8.00 0.19 >8.00 0.25 >8.00 
C. inerme and D. cinerea 
MIC value 0.50 >8.00 0.50 >8.00 0.75 >8.00 
ΣFIC value 0.19 ND 2.32 ND 3.00 ND 
                                     ΣFIC interpretation SYN ANT NON ANT NON ANT 
H. hemerocallidea MIC values 
(mg/ml) 
>8.00 2.00 2.00 0.25 2.00 4.00 
S. rigescens 4.00 >8.00 0.15 0.50 0.50 >8.00 
H. hemerocallidea and 
S. rigescens 
MIC value 0.50 0.63 0.01 0.50 1.00 1.00 
ΣFIC value ND ND 0.04 0.56 2.00 ND 
                                     ΣFIC interpretation SYN ADD SYN ADD NON ADD 
S. brachypetala MIC values 
(mg/ml) 
1.00 >8.00 0.50 2.00 0.25 >8.00 
S. birrea 0.50 2.00 0.50 2.00 0.19 2.00 
S. brachypetala and  
S. birrea 
MIC 0.50 2.00 0.25 2.00 0.25 0.25 
       ΣFIC 0.75 2.15 0.34 1.00 1.16 ND 
                                     ΣFIC interpretation ADD NON SYN ADD NON SYN 
S. birrea MIC values 
(mg/ml) 
0.50 2.00 0.50 2.00 0.19 2.00 
S. cordatum 2.00 2.00 1.00 4.00 0.25 4.00 
S. birrea and S. cordatum 
MIC value 0.50 0.25 0.25 4.00 0.25 0.50 
ΣFIC value 0.63 0.13 0.34 1.50 1.16 0.19 
                                    ΣFIC interpretation ADD SYN SYN NON NON SYN 
S. madagascariensis MIC values 
(mg/ml) 
1.00 >8.00 1.50 2.00 0.25 0.50 
S. spinosa 4.00 8.00 0.25 >8.00 0.50 >8.00 
S. madagascariensis and 
S. spinosa 
MIC value 0.50 >8.00 0.13 >8.00 0.50 >8.00 
ΣFIC value 0.38 ND 0.29 ND 1.50 ND 
                                     ΣFIC interpretation SYN ANT SYN ANT NON ANT 
D:M= dichloromethane: methanol (1:1) extracts, H₂O = aqueous extracts, ND = Not determined as no end point for 
MIC determination was obtained; SYN = Synergism (ΣFIC<0.50); ADD = Additive (ΣFIC>0.50-1.00); NON = 
Non-interactive (ΣFIC1.00->4.00); ANT = Antagonism (ΣFIC>4.00); Shaded = summary of results obtained in 
Chapter two; Bold = noteworthy and synergistic activity. 
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The combinations analyzed in equal ratios displayed synergistic (27%), additive (31%), non-
interactive (25%) as well as antagonistic (17%) interactions against the tested pathogens. The 
majority of the combinations displayed synergistic interactions against S. aureus (44%), 
followed by S. epidermidis (25%) and then P. aeruginosa (12%).  Additive effects of the 
combinations were more prominent against S. epidermidis (44%) while non-interactive 
interactions mostly occurred against P. aeruginosa (44 %) (Figure 3.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The combination of A. burkei and K. africana was reported as a combined treatment for 
ringworm (De Wet et al., 2013). Mostly, additive interactions were observed when the 
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  Figure 3.2: Antimicrobial interactions of plant combinations against the three tested pathogens.   
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combination was investigated against S. aureus, S. epidermidis and P. aeruginosa. Synergistic 
effect was only observed from the organic extract combination against S. aureus (based on 
tentative interpretation). When tested against M. canis and T. mentagrophytes (the causative 
agents of ringworm), both aqueous and organic extracts of the combination displayed non-
interactive interaction against M. canis (Table 3.3). This was not expected especially for the 
organic extracts as they displayed noteworthy activity when investigated independently against 
M. canis with MIC values of 0.13 and 0.34 mg/ml for A. burkei and K. africana respectively 
(Chapter 2, Table 2.3). These findings may imply that the combination is not effective against M. 
canis or perhaps the plants may be combined for some other pharmacological purposes. Despite 
the non-interactive effect observed against M. canis, the aqueous and organic extracts of A. 
burkei and K. africana did exhibit synergistic effect against T. mentagrophytes with the highest 
display of synergism (ΣFIC value 0.17) noted for the aqueous extracts. The observed synergistic 
effect, especially from an aqueous extract combination, lends credibility to the use of this 
combination against ringworm. 
Table 3.3: The mean MICs and ΣFICs of A. burkei in combination with K. africana investigated 
further in relation to its traditional uses.  
Plants in a combination 
Test pathogen 
M. canis 
ATCC 36299 
T. mentagrophytes 
ATCC 9533 
A. burkei 
MIC value 
(mg/ml) 
0.13 4.00 0.25 0.50 
K. africana 0.50 4.00 0.06 1.00 
A. burkei and K. africana 
MIC value 0.38 8.00 0.13 0.16 
ΣFIC value 1.90 2.00 0.48 0.17 
ΣFIC interpretation NON NON SYN SYN 
D:M= dichloromethane: methanol (1:1) extracts, H₂O = aqueous extracts, ND = Not determined as no end point for 
MIC determination was obtained; SYN = Synergism (ΣFIC<0.50); ADD = Additive (ΣFIC>0.50-1.00); NON = 
Non-interactive (ΣFIC1.00->4.00); ANT = Antagonism (ΣFIC>4.00); Shaded = summary of results obtained in 
Chapter two; Bold = noteworthy and synergistic activity. 
 
The aqueous and organic extracts of another poly-herbal combination (A. burkei, O. engleri, S. 
birrea, S. cordatum, T. elegans and L. javanica) also reported as a combined treatment of sores, 
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displayed mostly non-interactive interactions against the three test pathogens. The better 
interaction was an additive effect (ΣFIC 0.57) observed from the organic extracts combination 
against S. aureus. However, it was worth noting that the aqueous extracts of the combination 
interacted synergistically against P. aeruginosa (based on tentatitive interpretation). When 
considering the MIC data of the plants brought into this combination (Chapter 2, Table 2.3), the 
antimicrobial activity was mostly moderate (MIC values ranging 1.00 - >8.00 mg/ml). Thus, the 
synergistic effects observed indicated that the activity was enhanced when the plants were 
combined which supports the use of this combination for the treatment of sores caused by P. 
aeruginosa infections. 
A combination with five plants (B. discolor, E. tirucalli, H. hemerocallidea, O. engleri and S. 
serratuloides) which was reported to treat sores showed synergistic or additive effects against the 
three pathogens (S. aureus, S. epidermidis and P. aeruginosa). Synergistic interactions were 
observed against S. aureus based on tentative interpretation since the organic extract of H. 
hemerocallidea had an average MIC value of >8.00 mg/ml. Therefore, the ΣFIC could not be 
calculated for the combination having H. hemerocallidea. However, the efficacy of the combined 
aqueous extracts was improved (showed by the tentative synergistic and additive effects) 
especially when considering the low activity obtained when the aqueous extracts of the 
combined plants were investigated individually. This was a promising result for the lay people as 
they use water as a solvent for medicinal preparations. 
When C. inerme and D. cinerea were combined, mostly additive and non-interactive interactions 
were observed. Synergistic activity was only evident against S. aureus (ΣFIC 0.19 for the organic 
extract combination). Since the combined use of the plants was reported to treat acne (De Wet et 
al., 2013), the 1:1 combination was further investigated against P. acnes (the causative agent of 
acne) in which non-interactive (organic extracts and aqueous extracts) interactions were 
observed (Table 3.4). From the MIC data (Chapter 2, Table 2.2 and 2.3), the combined plants 
also displayed poor activity when investigated independently against P. acnes. Thus, these 
findings do not support the use of this combination for the treatment of P. acnes, but infections 
caused by S. aureus such as boils, carbuncles, pyoderma etc. may be treated successfully with 
this combination. Furthermore, the individual plants could have a potential in the treatment of 
other skin infections as they showed noteworthy activity against pathogens such as B. agri (MIC 
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value 0.03 mg/ml for C. inerme), B. linens (MIC value 0.50 mg/ml for C. inerme), S. epidermidis 
(MIC values 0.25 and 0.19 mg/ml for C. inerme and D. cinerea respectively), P. aeruginosa 
(MIC values 0.25 mg/ml for both C. inerme and D. cinerea) and T. mentagrophytes (MIC values 
0.25 and 0.50 mg/ml for C. inerme and D. cinerea respectively).  
Table 3.4: The mean MICs and ΣFICs of aqueous and organic extract combinations investigated 
further in relation to their traditional uses.  
Plants in a combination 
Test pathogen 
P. acnes 
ATCC 11827 
D:M H₂O 
C. inerme MIC values 
(mg/ml) 
2.00 8.00 
D. cinerea 1.00 4.00 
C. inerme and D. cinerea 
MIC value 1.50 8.00 
ΣFIC value 1.13 1.50 
                                              ΣFIC interpretation NON NON 
H. hemerocallidea MIC values 
(mg/ml) 
1.50 2.00 
S. rigescens 2.00 8.00 
H. hemerocallidea and S. rigescens MIC value 0.09 8.00 
ΣFIC value 0.05 16.50 
                                                         ΣFIC interpretation SYN ANT 
D:M= dichloromethane: methanol (1:1) extracts, H₂O = aqueous extracts, ND = Not determined as no end point for 
MIC determination was obtained; SYN = Synergism (ΣFIC<0.50); ADD = Additive (ΣFIC>0.50-1.00); NON = 
Non-interactive (ΣFIC1.00->4.00); ANT = Antagonism (ΣFIC>4.00); Shaded = summary of results obtained in 
Chapter two; Bold = noteworthy and synergistic activity. 
 
A strong synergistic activity (ΣFIC value 0.04) was evident from an organic combination of 
H. hemerocallidea and S. rigescens against S. epidermidis. When investigated independently, the 
organic extract of H. hemerocallidea showed moderate activity (2.00 mg/ml) against 
S. epidermidis while S. rigescens displayed noteworthy activity (0.15 mg/ml). This shows that S. 
rigescens contributed strongly to the enhanced activity of the combination. The aqueous extracts 
of this combination was also promising as it displayed additive effects against the three tested 
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pathogens (S. aureus, S. epidermidis and P. aeruginosa). Due to the observed positive results, 
this combination was investigated further using the isobole method. When further tested against 
P. acnes (Table 3.4), this combination displayed a strong synergistic effect with the ΣFIC value 
of 0.05 for the organic extract combination as opposed to a strong antagonistic effect of ΣFIC 
value of 16.50 by the aqueous extract combination. Such contradicting effects can be attributed 
to the different solvents used (water vs. dichloromethane: methanol) extracting different classes 
of active compounds (York et al., 2012). 
The combined antimicrobial effect of S. brachypetala and S. birrea showed a synergistic 
interaction against S. epidermidis (organic extract combinations - ΣFIC 0.34) and P. aeruginosa 
(aqueous extract combination – tentative interpretation). An additive effect was observed from 
the organic extract combination against S. aureus (ΣFIC value 0.75) as well as with the aqueous 
extract combination against S. epidermidis (ΣFIC 1.00). When investigated independently, the 
organic extracts of S. birrea and S. brachypetala displayed noteworthy antimicrobial activity 
against P. aeruginosa with MIC values of 0.19 and 0.25 mg/ml respectively. However, when 
combined, the activity was not enhanced (ΣFIC value 1.16) as one would expect. The enhanced 
efficacy was only observed against S. epidermidis with synergistic effect (ΣFIC 0.34) from 
combined organic extracts and an additive effect (ΣFIC 1.00) from aqueous extracts. 
Traditionally, S. birrea is combined with S. cordatum to treat sores (De Wet et al., 2013). When 
this combination was investigated against the pathogens S. aureus, S. epidermidis and P. 
aeruginosa, mostly synergistic interactions were evident with the ΣFIC values of 0.13 (aqueous 
extract combination), 0.34 (organic extract combination) and 0.19 (aqueous extract combination) 
respectively. Additive interaction (ΣFIC 0.63) from organic extracts against S. aureus and non-
interactive effects (ΣFIC 1.50 and 1.16) against S. epidermidis and P. aeruginosa were also 
observed. This is the first report for the evaluation of this combination against skin pathogens. 
An evaluation against pathogens associated with sexually transmitted infections did, however, 
exhibit noteworthy interaction (aqueous extract combination) with the ΣFIC value of 0.42 against 
of the pathogen Oligella ureolytica (Naidoo et al., 2013). These findings support the use of this 
combination in treatment of infectious diseases including skin infections, as claimed by the lay 
people of northern Maputaland. 
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When the combination of S. madagascariensis and S. spinosa was investigated against S. aureus, 
S. epidermidis and P. aeruginosa, the interaction was mostly non-interactive. The synergistic 
interaction was only observed for the organic extracts against S. aureus (ΣFIC 0.38) and S. 
epidermidis (ΣFIC 0.29). These synergistic interactions indicated an enhanced efficacy when the 
plants were combined compared with the low efficacy obtained when the plants were 
investigated independently. However, with P. aeruginosa, the combined efficacy of the organic 
extracts was reduced (ΣFIC 1.50) while the inhibitory effects of the independent extracts against 
this micro-organism (MIC values of 0.25 and 0.50 mg/ml for S. madagascariensis and S. spinosa 
respectively) were more noteworthy than those of the combined extracts.     
3.3.2 Isobolograms for plants combined in various ratios 
Some of the plant extract combinations showed promising synergistic interactions in a 1:1 ratio 
and were consequently selected for further analysis by means of the varied ratio method. 
However, the combinations that displayed synergistic interactions in a 1:1 ratio combination but 
contained more than two plants per combination were not investigated further in varied ratio 
studies. Each of the selected combination was investigated against the pathogen(s) in which 
synergistic activity was observed from the 1:1 combination (ΣFICs). Both aqueous and organic 
extracts of the selected combinations were assayed and the following plant combinations were 
examined: 
(a) Acacia burkei in combination with Kigelia africana, investigated against S. aureus. 
(b) Canthium inerme in combination with Dichrostachys cinerea, investigated against S.       
aureus. 
(c) Hypoxis hemerocallidea in combination with Solanum rigescens, investigated against S. 
aureus and S. epidermidis. 
(d) Schotia brachypetala in combination with Sclerocarya birrea, investigated against P. 
aeruginosa and S. aureus. 
(e) Sclerocarya birrea in combination with Syzygium cordatum, investigated against P. 
aeruginosa, S. aureus and S. epidermidis.  
(f) Strychnos madagascariensis in combination with Strychnos spinosa, investigated against 
S. aureus and S. epidermidis. 
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The isobolograms for all combinations [with each combination investigated against the relevant 
pathogen(s)] are shown in Figures 3.3-3.9 and are discussed in order of efficacy. 
3.3.2.1 Hypoxis hemerocallidea in combination with Solanum rigescens 
From the isobologram interactions of the aqueous and organic extract combinations of H. 
hemerocallidea and S. rigescens against S. aureus and S. epidermidis (Figure 3.3), the greatest 
synergistic interaction was observed from the organic extract combination against S. epidermidis, 
the interaction that was also observed from the 1:1 combination. The isobologram displayed a 
synergistic profile (all ratio points fell below the 0.5 line) irrespective of the ratio at which the 
two plants were combined. When investigated independently, the organic extract of H. 
hemerocallidea showed moderate activity (2.00 mg/ml) against S. epidermidis while S. rigescens 
displayed noteworthy activity (0.15 mg/ml). Thus, S. rigescens contributed strongly to the 
enhanced activity of the combination.  
Even though S. rigescens and H. hemerocallidea have not been investigated as a combination 
against skin associated pathogens, H. hemerocallidea is well documented for its use against skin 
diseases (Hutchings et al., 1996; Elgorashi et al., 2003; Taylor et al., 2003; Van Wyk and Wink 
2004; Van Wyk et al., 2009; Drewes et al., 2008; De Wet et al., 2012) while our earlier study 
(De Wet et al., 2013) documented S. rigescens for the first time as treatment of skin diseases. 
This brings into consideration the importance of validating the newly discovered plants. The 
aqueous extract combination however, displayed an additive effect from a 1:1 combination. The 
same pattern was also observed from the isobologram with all ratio points occurring in the 
additive region with exception of the 9:1 ratio point (where H. hemerocallidea was higher) 
returning a non-interactive result against S. epidermidis. Thus, it could be deduced that when the 
concentration of H. hemerocallidea increases, the efficacy of the aqueous combination decreases 
against S. epidermidis.  
Where the activity against S. aureus is concerned, a synergistic interaction was exhibited from 
the organic extract combination, with eight ratio points (8:2, 7:3, 6:4, 5:5, 4:6, 3:7, 2:8 and 1:9) 
occurring on the 0.50:0.50 line. All the ratio points where the concentration of H. hemerocallidea 
was higher in relation to S. rigescens fell in the synergy region. Only one ratio point (9:1) 
occurred in the additive range where the concentration of S. rigescens was higher. On the other 
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hand, the aqueous extract combinations all exhibited an additive effect with three ratio points 
(9:1; 8:2 and 7:3) where the concentration of H. hemerocallidea was higher lying closer to the 
synergy line. From these results, it could be deduced that H. hemerocallidea contributed more to 
the observed synergistic effect against S. aureus.  
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3.3.2.2 Schotia brachypetala in combination with Sclerocarya birrea 
When examining the interactive profiles of the aqueous and organic extracts of S. brachypetala 
combined with S. birrea (Figure 3.4), it was noted that the combinations mainly exhibited 
additive patterns against the tested pathogens. Some ratio points, however, did exhibit synergism, 
as in P. aeruginosa isobologram for aqueous extracts combinations. Even though the synergistic 
interaction was based on tentative interpretation in a 1:1 combination (ΣFIC), the majority of the 
ratio points where S. brachypetala was higher (9:1, 8:2, 7:3, and 6:4) did exhibit a synergistic 
effect. Thus, the observed synergy gave some support to the traditional use of this combination 
0.00 0.25 0.50 0.75 1.00 1.25 1.50
0.00
0.25
0.50
0.75
1.00
1.25
1.50 S. epidermidis
ATCC 2223
MIC H. hemerocallidea in
combination/MIC
H. hemerocallidea independently
M
I
C
S
. 
ri
g
e
sc
e
n
s 
in
 c
o
m
b
in
a
ti
o
n
/M
IC
S
. 
ri
g
e
sc
e
n
s
in
d
e
p
e
n
d
e
n
tl
y
 
Figure 3.3: Isobologram representation of H. hemerocallidea in combination with S. rigescens 
against S. aureus and S. epidermidis. Where: the squares (□) = organic extract combinations, 
the triangles (∆) = aqueous extract combinations, ■  = 1:1 combination, ■  = combinations 
containing more H. hemerocallidea, ■  = combinations containing more S. rigescens. 
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and higher concentrations of S. brachypetala should be incorporated in order to obtain greatest 
effect against P. aeruginosa.  For the organic extract combination, only one ratio point (9:1) with 
the majority of S. brachypetala fell in synergistic region. Thus, for the combined organic extracts 
to be effective against P. aeruginosa, they should be incorporated into a ratio of 9:1 (S. 
brachypetala: S. birrea). In S. epidermidis isobologram, two ratio points (6:4 and 5:5) of the 
organic extracts combination fell in the synergy region while the aqueous extracts ratio points 
occur in the additive region as was also observed from the ΣFICs. Even though S. birrea and S. 
brachypetala have been investigated for their independent antimicrobial properties against 
various other pathogens (as mentioned in Chapter 2, Section 2.3.2), no previous studies have 
investigated the interactive properties of this combination against dermatological relevant 
pathogens. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Isobologram representation of S. brachypetala in combination with S. birrea against 
P. aeruginosa and S. epidermidis. Where: the squares (□) = organic extract combinations, the 
triangles (∆) = aqueous extract combinations, ■  = 1:1 combination, ■  = combinations 
containing more S. brachypetala, ■  = combinations containing more S. birrea. 
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3.3.2.3 Sclerocarya birrea in combination with Syzygium cordatum 
The aqueous extract combination of S. birrea and S. cordatum exhibited synergistic effect in a 
1:1 combination (ΣFIC 0.13) investigated against S. aureus. When analyzed in various ratios 
(Figure 3.5), the ΣFIC evaluation of synergy was supported with five ratio points (2:8; 7:3; 6:4; 
5:5 and 4:6, S. birrea: S. cordatum) occurring at the synergy region of the isobologram. Only one 
ratio point (where S. cordatum was in higher concentration) fell on a 0.5:0.5 line while the 9:1 
point returned a non-interactive interaction. The majority of the organic extract ratio points, 
particularly where S. birrea was in majority displayed an additive effect, the effect that was also 
observed from the ΣFIC analysis. For S. epidermidis, the organic extract combination ratios did 
not display a specific pattern. Synergy (one point), additive (four points) and non- interactive 
interactions were observed for the organic extract. All the interactions occur where the 
concentrations of both plants were equal and it was worth noting that the 1:1 (50:50 µl) ratio 
point fell in a synergy region, thus corresponding with the synergistic effect observed from the 
ΣFIC (0.34).  
In a P. aeruginosa isobologram, the majority of ratio points for both aqueous and organic extract 
combinations displayed an additive pattern. Only two ratio points (1:1 and 2:8, S. birrea: S. 
cordatum) from the aqueous combination fell in the synergy region. The synergistic effect 
observed from the 1:1 (50:50) ratio point supported the ΣFIC evaluation (ΣFIC 0.19). One point 
(4:6 S. birrea: S. cordatum) from organic combination fell in the synergy region while a 1:1 
point gave a non-interactive interaction which corresponded with the non-interactive interaction 
observed from the 1:1 combination (ΣFIC 1.16). The synergistic interaction observed from some 
ratio points of this combination particularly the aqueous combination, indicated that the 
antimicrobial efficacy was enhanced when comparing to their independent antimicrobial effects 
(Table 3.2). York et al. (2012) investigated the antimicrobial efficacy of these plants in a 1:1 
combination against the respiratory tract pathogens where no synergy was depicted. However, 
when investigated against the pathogens associated with STIs, this combination exerted a 
synergistic effect in varied ratio studies (Naidoo et al., 2013). 
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Figure 3.5: Isobologram representation of S. birrea in combination with S. cordatum against 
S. aureus, S. epidermidis and P. aeruginosa. Where: the squares (□) = organic extract 
combinations, the triangles (∆) = aqueous extract combinations, ■  = 1:1 combination, ■  
= combinations containing more S. birrea, ■  = combinations containing more S. cordatum. 
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3.3.2.4 Strychnos madagascariensis in combination with Strychnos spinosa 
When varying concentrations of the organic extracts of these plants were combined (Figure 3.6), 
the ΣFIC evaluation of synergy (0.38) was supported against S. aureus with most of the ratio 
points (eight) occurring in a synergy region of the isobologram. Only one ratio point (6:4) where 
S. spinosa was in majority in relation to S. madagascariensis returned an additive interaction. 
Since all the ratio points where the concentration of S. madagascariensis was higher fell in a 
synergy region, it can be deduced that this plant greatly contributed to the observed synergistic 
effect.  The ratio points of the aqueous extracts of the same combination against the same 
pathogen (S. aureus), mostly displayed an additive effect. Even though the effect of the 
combination was tentatively interpreted as non-interactive in the ΣFIC evaluation, only two ratio 
points (9:1 and 8:2 S. spinosa: S. madagascariensis) gave a non-interactive interaction. This 
indicates that, the efficacy of the combined plants may rely on the specific ratios in which the 
two plants are combined. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6: Isobologram representation of S. spinosa in combination with S. madagascariensis 
against S. aureus and S. epidermidis. Where: the squares (□) = organic extract combinations, the 
triangles (∆) = aqueous extract combinations, ■  = 1:1 combination, ■  = combinations 
containing more S. madagascariensis, ■  = combinations containing more S. spinosa. 
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When investigated against S. epidermidis, some ratio points from the organic extracts displayed a 
synergistic effect. Three ratio points (1:9; 3:7 and 4:6) where S. spinosa was higher gave a 
synergistic effect while only one point (9:1) where S. madagascariensis was higher gave a 
synergistic effect. The aqueous combination supported the ΣFIC evaluation with most of the 
ratio points occurring at the non-interactive region. Only one point (1:9) where S. 
madagascariensis was in majority gave an additive interaction.  S. spinosa has been found to 
have poor activity when investigated individually against C. albicans, E. coli, S. aureus and P. 
aeruginosa (Kubmarawa et al., 2007). S. madagascariensis has only been documented for its use 
against inflammation and wounds (Norscia and Borgognini-Tarli, 2006) and has only been 
evaluated against S. aureus and E. coli in a diarrheal study by Van Vuuren et al. (2015), studies 
that have evaluated its antimicrobial efficacy in combination with S. spinosa against skin 
associated pathogens are limited. 
3.3.2.5 Canthium inerme in combination with Dichrostachys cinerea  
In varied ratio analysis of C. inerme and D. cinerea (Figure 3.7), two ratio points (5:5 and 4:6 C. 
inerme: D. cinerea) of organic extracts combination occurred at the synergy region of the 
isobologram while other points fell in the additive (1:9; 3:7 and 4:6) and the non-interactive 
region (9:1; 8: 2 and 7:3 D. cinerea: C. inerme). D. cinerea proved to contribute less effect since 
the majority of the ratio points containing D. cinerea in majority displayed a non-interactive 
interaction. The combination of the aqueous extract contributed equal effects as all ratio points 
occurred in an additive line. When investigated individually, D. cinerea ethanol extract gave 
poor activity against C. albicans, E. coli, S. aureus and P. aeruginosa (Kubmarawa et al., 2007). 
No antimicrobial study could be found for C. inerme against skin pathogens, this plant is only 
documented for its use in treatment of small pox lesions and body sores (Watt and Brandwijk, 
1962). In the present study it was found that, a 5:5 and 4:6 organic combination of C. inerme in 
relation to D. cinerea can be a promising anti-staphylococcal.  
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3.3.2.6 Acacia burkei in combination with Kigelia africana 
When combined in varying ratios, the aqueous and organic extracts of A. burkei in combination 
with K. africana exhibited both synergy, additive and non-interactive interactions (Figure 3.8). A 
1:1 ratio point of the organic combination occurred in a synergy region of the isobologram, thus 
supporting the ΣFIC evaluation of synergy. Another ratio point (1:9, A. burkei: K. africana) also 
displayed a synergistic interaction. Furthermore, two ratio points (1:9 and 2:8, A. burkei: K. 
africana) from the aqueous combination displayed a synergistic interaction. The ratio points for 
both aqueous and organic extract combinations having K. africana in majority proved to be less 
effective giving only the additive and non-interactive interactions. Thus, for this combination to 
be effective against S. aureus, more A. burkei in relation to K. africana should be incorporated in 
1:9 ratio for the organic combination and in 1:9; 2:8 ratios for the aqueous combination. The 
antimicrobial efficacy of K. africana against skin associated pathogens has been reported 
(Mabona et al., 2013) while A. burkei has only been investigated against S. aureus and E. coli in 
a previous study by Van Vuuren et al. (2015).  No antimicrobial study has reported the efficacy 
of the combination of these two plants against skin associated pathogens. 
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Figure 3.7: Isobologram representation of C. inerme in combination with D. cinerea against S. 
aureus. Where: the squares (□) = organic extract combinations, the triangles (∆) = aqueous 
extract combinations, ■  = 1:1 combination, ■  = combinations containing more D. 
cinerea, ■  = combinations containing more C. inerme. 
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3.4 Summary 
 The overall ΣFIC analysis of the plant combinations indicated that some plants possess 
promising interactions when combined as 27% of the combinations were synergistic, 31% 
were additive, 25% were non-interactive and only 17% were antagonistic. 
 Staphylococcus aureus proved to be the most susceptible pathogen with 44% of the 
combinations in 1:1 FIC combinations displaying synergistic effects against this micro-
organism. 
 The 1:1 organic extract combination of H. hemerocallidea and S. rigescens exhibited the best 
synergistic interaction (ΣFIC value 0.04) against S. epidermidis. 
 The combination (1:1) of A. burkei and K. africana which was reported to treat ringworm by 
the lay people of northern Maputaland displayed a promising activity (synergism) against T. 
mentagrophytes which supports the traditional use of this combination. 
0.00 0.25 0.50 0.75 1.00 1.25 1.50
0.00
0.25
0.50
0.75
1.00
1.25
1.50
MIC K. africana in
 combination/MIC
K. africana independently
    S. aureus
ATCC 25923
M
I
C
A
. 
b
u
rk
e
i 
in
 c
o
m
b
in
a
ti
o
n
/M
IC
A
. 
b
u
rk
e
i
in
d
e
p
e
n
d
e
n
tl
y
 
Figure 3.8: Isobologram representation of A. burkei in combination with K. africana against 
S. aureus Where: the squares (□) = organic extract combinations, the triangles (∆) = 
aqueous extract combinations, ■  = 1:1 combination, ■  = combinations containing more 
K. africana, ■  = combinations containing more K. africana. 
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 It was worth noting that the multi-plant combination of B. discolor,  E. tirucalli,  
H. hemerocallidea, O. engleri and S. serratuloides displayed synergistic and additive effects 
(mostly based on tentative interpretation) against S. aureus, S. epidermidis and P. aeruginosa 
although the combination could not be investigated further in isobole method due to the 
number of plants combined. 
 The isobologram method supported the findings from the 1:1 ΣFIC analysis where it was 
found that the majority of the combinations in various ratios displayed additive patterns. 
 The various ratio combinations of the organic extracts of H. hemerocallidea and S. rigescens 
again exhibited the best synergistic effect against S. epidermidis with all ratio points plotted 
within the synergistic quadrant.  
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Chapter Four: In vitro diffusion characteristics of the 
antimicrobially active plant extracts across porcine skin 
 
4.1 Introduction 
The skin is a site of interest for application of drugs intended for local (on diseased skin) and 
systemic therapeutic effect (Sharma et al., 2011). However, the stratum corneum forms a barrier 
which determines the penetration or impermeability of a drug to or through the skin (Valenta and 
Auner, 2004). This layer is usually 10-20 µm thick depending on the body region being thicker 
on palmar and plantar regions (Mehta, 2004). It is composed of dead keratinized cells which 
form the outermost part of the avascularised epidermis (Figure 4.1). Beneath the stratum 
corneum are other layers of the viable epidermis namely, stratum lucidum, stratum granulosum, 
stratum spinosum and stratum basale. The layer below the epidermis is a vascularised dermis in 
which epidermal appendages such as hair follicles, sebaceous and sweat glands originate. After 
penetrating the stratum corneum (a limiting barrier), a drug can diffuse relatively easy through 
the viable epidermis to the dermis for systemic absorption (Kwatra et al., 2013). Occurring 
beneath the epidermis is the subcutaneous tissue or hypodermis which is not necessarily involved 
in drug absorption as it occurs beneath the vascular system (Reddy et al., 2014).  
The ability of a drug to penetrate the multilayered skin largely depends on its physicochemical 
properties such as lipophilicity, solubility, molecular weight or size, melting point and pH of the 
solution (Latheeshjlal et al., 2011; Gaikwad, 2013). Since the stratum corneum is lipophilic 
(composed of 40% of fats) drug molecules have to be lipophilic in order to partition within the 
lipid lamellae of the stratum corneum cells (corneocytes). However, if a drug is too lipophilic, it 
will be unable to diffuse through the aqueous dermis beneath and remain in the stratum corneum. 
Thus, a good drug candidate must have a low melting point in order to be adequately soluble in 
both fats and water. Drugs containing larger molecules cannot permeate the skin while those 
with a molecular weight of less than 500 Daltons are sufficiently mobile and permeate quickly. A 
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saturated drug formulation with a pH between five and nine also penetrates easily through the 
skin (Naik et al., 2000). 
 
 
 
 
 
 
 
 
 
Figure 4.1: Schematic representation of the human skin (Trommer and Neubert, 2006). 
Generally, drug molecules penetrate the skin by passive diffusion (Mehta, 2004). The molecules 
pass though the stratum corneum via appendigeal, intercellular or intracellular routes as depicted 
in Figure 4.2. Skin appendages provide a direct channel for drugs with larger molecules to 
penetrate the skin bypassing the stratum corneum. However, skin appendages occupy 0.1% of 
the skin surface which limits the area available for a drug to directly contact the skin. 
Consequently, skin appendages are not necessarily considered as routes of drug absorption 
(Kwatra et al., 2013). The intercellular and transcellular routes of drug diffusion across the 
stratum corneum depend on the physicochemical properties and partition coefficient of drug 
molecules. Small hydrophilic molecules diffuse passively (paracellular or intercellular) across 
the stratum corneum while lipophilic drugs follow the intracellular route of penetration. Most 
molecules diffuse through the lipid matrix between the corneocytes to the site of action 
(Gaikwad, 2013). 
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Figure 4.2: Routes of penetration through the stratum corneum of the skin (Rahimpour and 
Hamishehkar, 2012). 
 
 Plant preparations also possess a complex mixture of chemical compounds that when applied 
topically, exert local or systemic effects to a dermatological condition (Nidhal et al., 2005). 
Evaluating percutaneous absorption of these compounds is of prime importance in understanding 
their permeation behavior through the skin. Various in vitro and in vivo models are used in 
determining the permeation and mechanism of action of drugs in the skin. While the in vivo 
models give more reliable results, they are, however, expensive and require exposure of the 
animal or human being to a drug or compound. In vitro models are reproducible, easy to control 
and may provide preliminary observations needed for further in vivo observations (Sahaya et al., 
2012), although the results may not always correlate with the in vivo state (Gonzalez, 2006). In 
most in vitro models, porcine skin is widely used as a model for the cutaneous barrier as it has 
been reported to give comparable results to human skin (Godin and Touitou, 2007). The 
technique involves topical application of a drug on one side of the excised skin placed between a 
donor and a receptor chamber as presented in Figure 4.3. Diffused compounds are collected in a 
Follicular transport 
Intercellular transport Transcellular transport 
Stratum 
corneum 
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receptor chamber at various time points and assayed with, for example High Performance Liquid 
Chromatography. 
 
Figure 4.3: A flow-through diffusion cell system showing how the transdermal penetration of 
drug molecules is assessed in vitro (Silva et al., 2012). 
 
Considering the lack of scientific information on the percutaneous absorption of compounds 
present in the topically applied plants studied in the present study, this chapter focuses on 
obtaining the chemical profiles and determining permeability properties of the chemical 
compounds from the most antimicrobially active plant extracts. Four independent plant extracts 
and one combination that were reported to be used topically by De Wet et al. (2013) were 
selected for in vitro diffusion studies based on the preliminary antimicrobial analysis. 
Dichloromethane: Methanol (D:M) extracts were used as a guide on selecting the extracts with 
broad spectrum antimicrobial activity (mean MIC<1.00 mg/ml). Aqueous extracts of the same 
selected D:M extracts were also included so as to compare the permeation behavior of 
compounds present within these extracts.  Selected plants (most antimicrobially active topically 
applied plants) as well as their mean MIC values are depicted in Table 4.1 (independent plants 
Donor compartment 
(formulations) 
Pig ear skin 
Circulating water 
system (37 °C) 
    Collect samples 
ports 
Receiving compartment (solutions that ensure 
sink conditions) 
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adapted from Chapter 2, Table 2.3 and 2.4) and Table 4.2 (combination adapted from Chapter 3, 
Table 3.2). 
Table 4.1: The most antimicrobially active topically applied plants selected for further analysis. 
Botanical name Part used Disease(s) treated 
*Average MIC values 
(mg/ml) 
D:M Aqueous 
Garcinia livingstonei  Bark Burns ˟0.27 ˟3.19 
Kigelia africana  Fruits Ringworm 0.68 2.19 
Sclerocarya birrea  Bark 
Burns, boils and 
sores 
0.37 1.76 
Syzygium cordatum  Bark Burns and sores ˟0.86 ˟3.00 
*Mean MIC values were calculated as the sum of MIC values of all tested pathogens divided by the total number of 
pathogens investigated against each plant extract. ˟There are MIC values that were not considered (MIC>8.00 
mg/ml) since no end point was obtained for MIC determination. 
 
Table 4.2:  Most antimicrobially active topically applied plant combination. 
Combination 
ΣFIC values of test micro-organisms 
S. aureus  
ATCC 25923 
S. epidermidis  
ATCC 2223 
P. aeruginosa  
ATCC 27853 
D:M Aqueous D:M Aqueous D:M Aqueous 
Sclerocarya birrea and 
Syzygium cordatum 
0.63 0.13 0.34 1.50 1.16 0.19 
ΣFIC interpretation Additive Synergism Synergism 
Non-
interactive 
Non-
interactive 
Synergism 
Highlighted in bold are synergistic interactions. 
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4.2 Materials and methods 
4.2.1 Chemicals and reagents 
All chemicals used were obtained from ACE (Associated Chemical Enterprises) Southdale 
Johannesburg, Sigma-Aldrich Pty (ltd) (St. Louis, MO, USA) and RC (Rochelle Chemicals) 
South Africa. Methanol and formic acid were of HPLC grade while all the other laboratory 
chemicals used were of analytical reagent grade and included the following: aluminum chloride,  
ammonium solution, benzene, bismuth (III) subnitrate, ferric chloride, 32% hydrochloric acid, L 
(+) – tartaric acid, Meyer’s reagent, petroleum ether, potassium hydroxide, potassium iodide, 
sodium azide  and sulphuric acid. Other reagents or solutions were prepared using analytical 
grade chemicals and double distilled Millipore water. They included: Dragendorff’s reagent and 
phosphate buffered saline solution (PBS). Dragendorff’s reagent was prepared by mixing 1:1:1 
ratio (v/v) of bismuth nitrate, tartaric acid and potassium iodide solutions (Bibi et al., 2012). PBS 
was prepared by mixing Sodium chloride (8 g), Potassium chloride (0.3 g), Potassium phosphate 
monobasic (0.2 g) and di- Sodium hydrogen orthophosphate 2-hydrate (0.73 g) in a liter of 
double distilled Millipore water and adjusting the pH to 7.4.  
4.2.2 Equipment and apparatus 
For UV/Vis spectra, a Ultra-Violet Visible Spectrophotometer (Thermo Scientific Multiskan 
GO) was used. Chemical profiling of extracts was performed using reverse-phase High 
Performance Liquid Chromatography (RP-HPLC). The analyses were performed utilizing a 
Flexar Perkin Elmer HPLC system containing a Perkin Elmer binary pump, a Flexar LC 
autosampler and a Flexar LC UV/Vis detector.  The column used was a Brownlee Spheri-5 RP-
C18, 5μ, 100 x 4.6 mm. For the in vitro diffusion assay, an ILC07 automated system consisting 
of 7 in-line flow cells from PermeGear INC (Hellertown, PA, USA) was used. The system 
consisted of an ISCO Retriever IV fraction collector, an Ismatec IPC peristaltic pump and a 
Thermoscientic Haake SC100 water bath. Each flow cell of the system contained an orifice area 
of 0.039 cm².  
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4.2.3 Preliminary qualitative phytochemical screening 
Various chemical tests were performed in order to determine the possible group of chemical 
compounds present in each of the selected plant extracts. The chemical tests were conducted 
using standard qualitative methods with slight modifications as described by Ahumuza and 
Kirimuhuzya, (2011) and Bibi et al. (2012) as follows: 
Test for alkaloids: Each of the aqueous and organic powdered plant extracts (0.1 g) was added 
to 2 ml of Hydrochloric acid. The mixtures were warmed, filtered with Whatman filter paper and 
the filtrates were divided into 1 ml and 1 ml of each reagent (Dragendoff’s and Meyer’s reagent) 
was added. Turbidity or precipitation indicated the presence of alkaloids.   
Test for anthraquinones: The extract (0.1 g) was mixed with 1% (v/v) hydrochloric acid in 
water and boiled. The boiled mixture was cooled, filtered with Whatman filter paper and the 
filtrate was shaken with 3 ml of benzene. The benzene layer was removed and 10% (v/v) 
ammonium solution was added. The appearance of a pink, violet or red colour in the lower phase 
of the ammonium solution indicated the presence of anthraquinones. 
Test for coumarins: The plant extract (0.1 g), moistened with 1N sodium hydroxide was placed 
in a test tube and covered with a filter paper also moistened with the same solvent. The test tube 
was then placed in boiling water for a few minutes. The filter paper was removed and examined 
under UV light for yellow florescence which indicated the presence of coumarins.  
Test for flavonoids: The extract (0.1 g) was shaken with 5 ml of petroleum ether. The fatty 
petroleum ether layer was then removed and the defatted residue was dissolved in 5 ml of 80% 
(v/v) ethanol in water. The solution was filtered using Whatman filter paper and the filtrate was 
divided into 2 ml which were then reacted separately with 1% (w/v) aluminum chloride solution 
and 1% (w/v) potassium hydroxide solution in methanol. Formation of a yellow colour in the 
filtrate that reacted with the aluminum chloride solution indicated the presence of flavones. In 
the filtrate that was reacted with potassium hydroxide solution, formation of a dark yellow colour 
indicated the presence of flavonoids. 
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Test for saponins: A small amount of plant (approximately 0.05 g) extract was dissolved in 
boiling water in a test tube. The mixture was allowed to cool and shaken thoroughly. Persistent 
frothing indicated the presence of saponins. 
Test for tannins: Plant extract (0.1 g) was boiled with 2 ml of distilled water. The boiled 
mixture was cooled, filtered using a Whatman filter paper and the filtrate was added into 0.1% 
(w/v) iron chloride. Formation of a brown green or blue black colour indicated the presence of 
tannins. 
Test for sterols: A small amount of plant extract was added into 2 ml of 92% (v/v) sulphuric 
acid in a test tube. A purple ring formed at the upper surface indicated the presence of sterols.  
4.2.4 Ultraviolet-Visible spectrum analysis 
The crude extracts (D: M and aqueous) were further subjected to ultraviolet-visible (UV-Vis) 
spectrum analysis in order to determine the absorption maxima of the compounds detected in the 
phytochemical screening investigation. The extracts were first dissolved in a Phosphate buffered 
saline (PBS) to a standard concentration of 32 mg/ml. Phosphate buffered solution was preserved 
with 0.1% (w/v) sodium azide for long-term use. It was maintained at a physiological pH of 7.4 
to ensure that it does not interfere with the chemical composition of the extracts, for instance 
through ionization. Extracts were diluted further into 1:100 using PBS prior to obtaining the 
spectra in the range of 200 - 800 nm.  PBS was used as the solvent blank. 
4.2.5 Chemical profiling of extracts prior to the in vitro permeation assay 
Chemical profiling of each extract was performed using the previously described HPLC system 
(Chapter 4, Section 4.2.2) prior to and after in vitro permeation assays. The column temperature 
of the HPLC was held constant at 25 °C. Plant extracts (32 mg/ml in PBS) were initially filtered 
through a syringe filter (0.45 µm) before chemical analysis. An aliquot (10 µl of the extract) was 
injected into the chromatographic system and the resultant chromatograms were used to indicate 
the peak spectrum of chemical compounds. PBS was used as a control.   
The run time for all samples prior to and after in vitro permeability assays was 45 minutes at 1 
ml/min. Different mobile phases were investigated in order to optimize the resulting 
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chromatogram peaks which included a gradient elution with a mixture of HPLC grade methanol 
(A): water (B) as well as HPLC grade methanol (A): water with 0.1% (v/v) formic acid (B). 
Better peak separation was obtained when using a mixture of methanol: water with formic acid 
(acidic aqueous solution) which was then selected as a mobile phase for the rest of the 
experiments. The chromatograms obtained when using methanol: water and methanol: water 
with formic acid are shown in appendix H1-H2. Double distilled Millipore water was first 
filtered through a 0.45 µm pore filter before being used. Chromatographic separation was 
performed by a gradient elution as seen in Table 4.3. The extracts were first monitored at 
different wavelengths including 210, 260, 280 and 360 nm based on absorption maxima 
wavelengths obtained under the UV-Vis spectrum analysis. A wavelength of 260 nm was then 
selected as a monitoring wavelength since there were no differences in chromatograms obtained 
under all the wavelengths investigated. Thus, only the chromatograms obtained at 260 and 360 
nm were included in the appendices (appendix H1-H3).   
Table 4.3: Elution gradient for 45 min runs at a flow rate of 1 ml/min. 
Step time (min) % A (Methanol) % B (Water + 0.1% (v/v) 
formic acid) 
0.5 1.0 99.0 
10.0 5.0 95.0 
5.0 15.0 85.0 
5.0 20.0 80.0 
20.0 60.0 40.0 
5.0 1.0 99.0 
10.0 1.0 99.0 
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4.2.6 In-vitro permeation assay  
4.2.6.1 Collection and storage conditions of porcine skin tissue samples 
An ethics waiver for the approval of the use of porcine skin tissue samples was obtained from the 
University of the Witwatersrand School of animal, plant and environmental sciences as well as 
the Human Research Ethics Committee (Appendix I). The excised porcine skin tissue samples 
were then harvested from animals (porcine) euthanized for other purposes at the central animal 
service unit at the University of the Witwatersrand Medical School. After collection, the skin 
were immediately placed in a PBS (pH 7.4) solution and transported to the laboratory within an 
hour. Excess fat and connective tissue were removed and the specimens were cut into 1x4 cm 
strips. The tissue strips were then placed in cryovials, snap frozen at -196 °C and stored in liquid 
nitrogen until further use.   
 4.2.6.2 In vitro permeability experiment 
The permeability characteristics of the number of chemical compounds present in the plant 
extracts were determined using a 7 in-line (flow-through) diffusion system. A diagrammatic 
representation of the steps undertaken during each permeability experiment is depicted in Figure 
4.4. Prior to each experiment, liquid nitrogen frozen skin tissue strips were thawed in PBS for 5 
min at room temperature. The thawed skin tissue strips were cut into seven 1x1 cm diameter 
sections. The skin sections were mounted into the donor compartments of a flow-through 
diffusion system with the stratum corneum facing up in the direction of the donor compartments. 
Each compartment was then held together with a clamp wedging the skin between the donor and 
receptor compartments. The exposed surface area of the skin for diffusion in each flow cell was 
0.039 cm². All air bubbles under the skin were removed and 500 µl of the plant extract with a 
concentration of 32 mg/ml was topically applied on the exposed skin surface in the donor 
compartment. The donor compartments were then covered with parafilm to prevent any 
evaporation and to keep a constant temperature within the chambers throughout the experiment. 
The temperature of the system was kept at 37 °C in a water bath. Each experiment was run for a 
total period of two hours at flow rate of 1.5 ml/h with liquid (containing the diffused compounds 
from the extracts) collected every 10 min in the fraction collector. Phosphate Buffered Saline 
(pH 7.4) was used as elution medium. All experiments were performed in sextuple for each  
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Figure 4.4: Diagrammatic representation of how the permeability experiment was conducted. 
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extract with PBS used as a control. The liquid collected every 10 min was analyzed with RP-
HPLC to determine whether the compounds present in the crude extracts were capable of 
diffusing from the extract across the skin. 
4.3 Results and discussion 
4.3.1 Preliminary qualitative phytochemical screening 
Preliminary qualitative phytochemical screening (Table 4.4) revealed the predominant presence 
of flavonoids, saponins, tannins and anthraquinones in all tested extracts of the selected plants. 
Flavonoids are usually the main active ingredients used in medical preparations for the treatment 
of human ailments (Saravanakumar et al., 2009). As a result, flavonoids are the subject of anti-
infective research because of their antibacterial, antifungal and antiviral properties. This class of 
phytochemical contains various compounds that may differ in their modes of action when 
targeting the microbial cell. For instance, some flavonoid compounds may interfere with nucleic 
acid while others may inhibit cytoplasmic membrane function and energy metabolism of the 
microbial cell (Cushnie and Lamb, 2005).   
On the other hand, saponins are known to protect plants from microbial attack. Saponins usually 
act by disrupting the cell membrane resulting in irreversible damage of the lipid bilayer which 
account for their antimicrobial activity. This class of phytochemical also exhibit anti- 
inflammatory properties where they inhibit vascular permeability, the first stage of inflammation 
(Sparg et al., 2004). Anthraquinones isolated from plants also poses antibacterial and antifungal 
properties (De Barros et al., 2011). Tannin containing plants usually possess anti-inflammatory, 
anti-ulcer and antiparasitic properties. Tannins are also known to inhibit microbial growth by 
precipitating digestive proteins and thus hindering the availability of nutrients (Prasad et al., 
2008). These compounds act in the same manner when exposed to burn wounds. They precipitate 
proteins of the exposed tissue in burn wounds and form granulation tissue.  
These four classes of compounds (flavonoids, saponins, tannins and anthraquinones) were all 
present in the tested extracts and may account for their broad-spectrum antimicrobial activity, as 
observed in Chapter 2, Section 2.3.2, Table 2.3. In addition to the four common classes of 
compounds found above, G. livingstonei also indicated the presence of alkaloids and flavones,  
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Table 4.4: Preliminary qualitative phytochemical screening results. 
Phytochemicals 
tested 
Plants analysed 
G. livingstonei 
Bark 
K. africana 
Fruits 
S. birrea 
Bark 
S. cordatum 
Bark 
D:M H₂O D:M H₂O D:M H₂O D:M H₂O 
Alkaloids +++ + - - - - + + 
Anthraquinones +++ +++ + + +++ +++ +++ +++ 
Coumarins - - ++ +++ - - - - 
Flavones ++ ++ + + - - - - 
Flavonoids +++ +++ +++ +++ +++ +++ +++ +++ 
Saponins +++ +++ +++ ++ +++ +++ +++ +++ 
Sterols - - ++ + ++ ++ - - 
Tannins +++ + ++ + ++ ++ ++ ++ 
D:M: Dichloromethane: methanol extract; H₂O: aqueous extract; +++ : resent in large amount; ++: moderately 
present; + : present in small amount; -: not detected. 
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while K. africana indicated the presence of coumarins, flavones and sterols.  S. birrea indicated 
the presence of sterols while S. cordatum indicated the additional presence of alkaloids.  The 
results obtained in the present study correspond mostly with previous studies performed on 
similar plant extracts.  Previous studies indicated the presence of alkaloids, saponins, flavonoids, 
steroids and tannins in K. africana leaves and fruits (Priya et al., 2012; Agyare et al., 2013; Priya 
et al., 2013; Arkhipov et al., 2014; Solomon et al., 2014).  Steroids, flavonoids, coumarins, 
tannins, alkaloids and saponins were also found to be present in the bark, leaf and fruit extracts 
of S. cordatum (Pallant and Steenkamp, 2008; Wanyama et al., 2011; Cordier et al., 2013; 
Deliwe and Amabeoku, 2013; Sidney et al., 2015).  Leaf and bark extracts of S. birrea similarly 
indicated the presence of alkaloids, anthraquinones, flavonoids, saponins, steroids and tannins 
(Ojewole et al., 2010; Dabai et al., 2013; Baba et al., 2014), while steroids and flavonoids were 
mainly detected in G. livingstonei root and stem extracts (Magadula and Suleimani, 2010; 
Magadula and Tewtrakul, 2010).  
4.3.2 UV-Vis spectrometry   
The UV-Vis spectra of the selected plant extracts were performed at wavelengths ranging 
between 200-800 nm and their profiles displayed different absorption maxima between 210 and 
330 nm (Figure 4.5). Three absorption peaks were recorded for G. livingstonei extracts (organic 
and aqueous). For the organic extract, the absorption peaks occurred at wavelengths of 218, 268 
and 292 nm. With the aqueous extract, the first absorption peak (212 nm) was much lower than 
that observed from the organic extract which may imply the presence of more compounds in the 
organic extract than the aqueous extract at the absorption wavelength of 210 nm. The second 
peak (262 nm) displayed maximum absorption similar to that of the organic extract.  All the 
other extracts (K. africana, S. birrea and S. cordatum) displayed two main peaks. Kigelia 
africana extracts had a major absorption peak at 216 nm accompanied by a weak shoulder at 254 
nm. The first major peak of both S. birrea and S. cordatum were recorded at the same 
wavelength (224 nm) for both organic and aqueous extracts. The second peak for S. birrea 
occurred at 284 nm while that of S. cordatum was recorded at 260 nm. 
From all the extracts, the first major peaks were detected at around 212, 216 and 218 nm which 
can be characteristic of saponins that are usually absorbed at a lower wavelength of nearly 210  
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Figure 4.5: The UV/Vis spectra of the selected plant extracts analyzed at 200-800 nm. 
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nm (Oleszek, 2002). Saponins were present in all the extracts during phytochemical screening 
analysis. Furthermore, the second peaks from all extracts were detected at around 250-268 nm 
which may also confirm the presence of flavonoids (also detected in all extracts in 
phytochemical screening) since all flavonoids with aromatic chromophores are usually absorbed 
at a wavelength of 250 nm of the UV spectra. However, other flavonoids with carbonyl 
chromophores may also be slightly absorbed at the 300 nm regions (Sisa et al., 2010).  
Garcinia livingstonei extracts exhibited peaks at 310 nm (aqueous extract) and 330 nm (organic 
extract). These peaks may indicate the presence of an anthraquinone moiety which usually gives 
maximum absorption at a wavelength between 257-341 nm (Osman et al., 2010) and 
anthraquinones were detected in G. livingstonei extracts. No other studies have analysed the UV-
Vis spectra of these four plants investigated. 
4.3.3 In vitro permeation of compounds from the most active plant extracts 
Plant extracts are topically applied for the treatment of various skin diseases e.g. dermatitis, 
psoriasis, burns, inflammation and infections.  The skin in these diseased states usually contains 
a compromised barrier function resulting in water loss and altered permeation of topically 
applied agents (Tsai et al., 2001).  The active compounds in topically applied dermatological 
drugs may aim to act on the skin surface for superficial skin infections. They may also act on the 
dermal layer where they may penetrate the skin without systemic absorption for ailments 
affecting epidermal and dermal layers (Baert et al., 2007). Even though the topical administration 
of drugs is usually the most convenient since it is non-invasive and has a better compliance with 
patients, active compounds are, however, usually affected by the permeability of the stratum 
corneum (Baskar et al., 2012; Andrews et al., 2013). Thus, in most in vitro studies, the use of 
biological membrane systems which represent the stratum corneum are employed to study the 
diffusion profile of the active compounds from topical formulations. This allows the objective 
comparison of the mode of action of newly developed topical products whether they serve to act 
locally, dermally or transdermally on the skin. The same in vitro model (biological membrane 
system model) was used in this study to evaluate the diffusion of compounds present within the 
most antimicrobially active extracts through intact skin to provide a preliminary indication of the 
movement of these compounds through an intact skin barrier. Thawed intact porcine skin was 
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used as it is not always feasible to use freshly excised skin when conducting the diffusion 
experiments. Furthermore, the diffusion of compounds from the topically applied drugs usually 
occurs in the non-viable cells of the stratum corneum (Bartosova and Bajgar, 2012). It has also 
previously been found by Van der Bijl et al. (2001) that snap freezing tissues in liquid nitrogen 
within one hour of tissue removal only minimally affect diffusion of compounds across the tissue 
when compared to a freshly excised tissue. 
Previous in vitro studies have investigated the permeation behavior of some known compounds 
present in topical formulations after certain time intervals with the mean flux values plotted as 
the standard curves (Heard et al., 2006; Boonen et al., 2010; Park et al., 2012).  In the present 
study, all the groups of compounds present in each crude extract (chemical fingerprint) were 
evaluated for their permeation properties across the intact skin after 120 min of exposure and 
sampled after every 10 min interval. Thus, the results obtained were expressed as the HPLC 
chromatogram profile (chemical fingerprint) of each extract before and after the in vitro 
permeation assay. The results after the in vitro permeation assay were presented as 
chromatogram peaks (chemical fingerprint) after different time intervals which is 10, 60 and 120 
min. PBS which was used as a control gave a single peak in all experiments and its RP-HPLC 
chromatogram peak and a retention time (1.02 min) and can be seen in Figure 4.6. The RP-
HPLC chromatogram peaks of all the investigated extracts (before and after the in vitro 
permeability experiment) are depicted in Figures 4.7-4.16 with retention times of the major 
peaks detected shown in Tables 4.5-4.14. The retention times for some peaks before and after the 
permeability experiment, however, differed because the compounds may have co-eluted before 
the permeability experiment and separated after diffusion through the skin. Furthermore, some 
compounds present within the crude extracts (before the permeability experiment) giving 
retention times within 5 min could hardly be detected because of the low concentrations of these 
chemical compounds.  
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From all the extracts, K. africana possessed more compounds capable of permeating the skin. 
Approximately 19 peaks were detected in the crude organic extract (Figure 4.7A) while 14 were 
detected in the aqueous extract (Figure 4.8A) before the permeability assay. Agyare et al. (2013) 
detected eight and nine groups of chemical compounds from K. africana methanol bark and leaf 
extracts respectively. Such discrepancies in the number of groups of compounds detected may be 
due to the different plant parts analyzed and the extraction solvents used. In both aqueous and 
organic extracts analyzed in the present study, the compounds permeated in greater quantities 
after 10 min of exposure of the skin then decreased as the duration of exposure increased to 120 
min as seen in Figures 4.7B-D and 4.8B-D and corresponding retention times in Tables 4.5-4.6. 
About nine peaks permeated the skin from the organic extract after 10 min. The number of peaks 
then decreased from 60 to 120 min (five peaks detected). For the aqueous extract, some of the 
compounds also rapidly diffused across the skin with four peaks detected after 10 min.  
However, the peaks became smaller in size from 60 to 120 min. The permeation behavior of such 
compounds in K. africana aqueous and organic extracts may indicate that the compounds may be 
small and slightly lipophilic and were able to diffuse rapidly through the stratum corneum.  K. 
africana was reported to treat ringworm (De Wet et al., 2013) which is a superficial skin 
infection that does not require penetration of active compounds through the skin.  
 
Figure 4.6: HPLC chromatogram for PBS (control) analyzed at a wavelength of 260 nm. 
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Figure 4.7: Chromatograms of K. africana organic extract prior (A) and after (B-D) the 
permeability assay at different time intervals (10, 60 and 120 min) of exposure to the skin at 260 
nm. 
prior and after the permeability assay at different time intervals (10, 60 and 120 min) of exposure 
to the skin at the wavelength 260 nm. 
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Figure 4.8: Chromatograms of K. africana aqueous extract prior (A) and after (B-D) the 
permeability assay at different time intervals (10, 60 and 120 min) of exposure to the skin at 260 
nm. 
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Table 4.5: Major peaks detected in K. africana organic extract (a) prior and (b) after the 
permeability assay with peak 1-9 detected after 10 min while only peak 1-3, 4 and 6 remained 
after 60 to 120 min. 
Peak number Retention time 
1 0.98 
2 1.15 
3 1.54 
4 2.02 
5 2.28 
6 3.37 
7 3.72 
8 4.07 
9 4.48 
10 5.53 
11 6.09 
12 9.02 
13 12.23 
14 12.69 
15 21.47 
16 22.77 
17 30.99 
18 31.16 
19 35.63 
 
Table 4.6: Major peaks detected in K. africana aqueous extract (a) prior and (b) after the 
permeability assay with peak 1, 2, 4 and 7 detected after 10 min while peak 1, 2 and 7 remained 
up to 60 min and only peak 2 were detected at 120 min. 
 
Peak number Retention time 
1 0.98 
2 1.19 
3 1.46 
4 1.94 
5 2.28 
6 2.89 
Peak number Retention time 
1 0.99 
2 1.16 
3 1.53 
4 1.96 
5 2.23 
6 3.20 
7 3.58 
8 3.85 
9 4.21 
 
(a) 
(b) 
Peak number Retention time 
1 0.96 
2 1.20 
4 1.96 
7 3.34 
 
(a) (b) 
103 
 
Peak number Retention time 
7 3.22 
8 3.88 
9 4.39 
10 5.62 
11 6.01 
12 11.12 
13 20.40 
14 35.16 
Shaded are the retention times of the group of compounds detected prior to and after the in vitro permeability assay. 
The numbers given to the peaks after the permeability experiment correspond to the peak numbers before the 
permeability experiment.  
 
Thus, it can be concluded that the plant may be effective in treatment of both deep and 
superficial skin infections since some compounds were capable of permeating the skin while 
others may have accumulated within the skin as they could not go through because of their 
bigger size. 
S. cordatum organic extract also possessed some compounds capable of diffusing across the skin.  
About 22 peaks were detected from the organic extract with 10 peaks detected after 10 min of 
the permeation assay (Figure 4.9A). The number of peaks detected decreased from 60 to 120 min 
with only four peaks detected (Figure 4.9B-D). For the aqueous extract (Figure 4.10A), 15 peaks 
were detected from the crude extract with three (10 min), five (60 min) and one peak (120 min) 
detected after the in vitro permeation assay (Figure 4.10B-D). The diffusion of compounds was 
rapid from the organic extract being high after 10 min and then decreased as the duration of skin 
exposure to the extract increased to 120 min. A similar trend was observed for the aqueous 
extract, with fewer peaks detected after the permeability experiment. Cock and Van Vuuren, 
(2015) detected approximately nine and 12 chromatogram peaks from the crude methanol and 
aqueous extracts of S. cordatum bark respectively, although the detected compounds were not 
investigated for their permeability across the skin. In the present study, the diffusion of 
compounds from S. cordatum extracts were analyzed as the plant was reported to treat burns and 
sores (De Wet et al., 2013). The causes of sores can be numerous and some may result in deep 
infections affecting the underlying skin layers such as cellulitis or leg ulcers. In such cases, the 
permeation of active compounds from a drug to the target site is of utmost importance. Thus, the 
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Figure 4.9: Chromatograms of S. cordatum organic extract prior (A) and after (B-D) the 
permeability assay at different time intervals (10, 60 and 120 min) of exposure to the skin at 260 
nm. 
prior and after the permeability assay at different time intervals (10, 60 and 120 min) of exposure 
to the skin at the wavelength 260 nm. 
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Figure 4.10: Chromatograms of S. cordatum aqueous extract prior (A) and after (B-D) the 
permeability assay at different time intervals (10, 60 and 120 min) of exposure to the skin at 260 
nm. 
prior and after the permeability assay at different time intervals (10, 60 and 120 min) of exposure to 
the skin at the wavelength 260 nm. 
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Table 4.7: Major peaks detected in S. cordatum organic extract (a) prior and (b) after the 
permeability assay min) detected after the in vitro permeation assay with peak 2-10 detected after 
10 min while only peak 2-6 remained after 60 to 120 min. 
 
Peak number Retention time 
1 0.06 
2 0.97 
3 1.15 
4 1.22 
5 1.38 
6 1.54 
7 2.07 
8 2.31 
9 3.34 
10 3.78 
11 5.79 
12 6.28 
13 17.86 
14 18.34 
15 20.94 
16 21.34 
17 29.38 
18 31.24 
19 35.16 
20 37.41 
21 38.57 
22 41.12 
 
Table 4.8: Major peaks detected in S. cordatum aqueous extract (a) prior and (b) after the 
permeability assay with peak 1, 2 and 4 detected after 10 min while peak 1-5 were detected at 60 
min and only peak 2 was detected at 120 min. 
 
Peak number Retention time 
1 0.98 
2 1.18 
Peak number Retention time 
2 0.98 
3 1.16 
4 1.22 
6 1.52 
7 2.05 
8 2.23 
9 3.22 
10 3.83 
 
(a) (b) 
Peak number Retention time 
1 1.02 
2 1.21 
3 1.99 
4 3.15 
5 3.67 
 
(a) (b) 
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Peak number Retention time 
3 2.18 
4 3.35 
5 3.67 
6 5.51 
7 6.14 
8 7.70 
9 12.30 
10 15.62 
11 20.55 
12 20.86 
13 31.36 
14 34.99 
15 36.90 
Shaded are the retention times of the group of compounds detected prior and after the in vitro permeability assay. 
The numbers given to the peaks after the permeability experiment correspond to the peak numbers before the 
permeability experiment. 
 
permeation profile of the compounds from S. cordatum organic extract was in congruent with 
one of its traditional uses (the treatment of sores).  
For G. livingstonei organic (Figure 4.11A) and aqueous (Figure 4.12A) extracts, few compounds 
diffused across the skin even though the organic extract of the plant was found to have broad-
spectrum antimicrobial activity 0.27 mg/ml when compared to the other extracts. More groups of 
compounds were also detected from G. livingstonei organic extract under phytochemical 
screening compared to the other extracts. Only four groups of compounds (after 10, 60 and 120 
min) from the 34 compounds detected from the crude organic extract permeated the skin. In the 
aqueous extract, six (10 min), three (60 min) and two (120 min) compounds from the 28 
compounds detected in crude extract permeated across the skin. The diffusion of such 
compounds, however, might correlate with the traditional use of G. livingstonei since the plant 
was reported to treat burns. In most cases, burn wounds usually affect the top epidermal layers of 
the skin. Third degree burns that affect all layers of the skin are usually rare. G. livingstonei was 
reported to treat superficial burn wounds and associated secondary bacterial infections. In such 
cases the accumulation of chemical compounds within the skin will be necessary. 
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Figure 4.11: Chromatograms of G. livingstonei organic extract prior (A) and after (B-D) the 
permeability assay at different time intervals (10, 60 and 120 min) of exposure to the skin at 260 
nm. 
prior and after the permeability assay at different time intervals (10, 60 and 120 min) of exposure to 
the skin at the wavelength 260 nm. 
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Figure 4.12: Chromatograms of G. livingstonei aqueous extract prior (A) and after (B-D) the 
permeability assay at different time intervals (10, 60 and 120 min) of exposure to the skin at 260 nm. 
prior and after the permeability assay at different time intervals (10, 60 and 120 min) of exposure to 
the skin at the wavelength 260 nm. 
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Table 4.9: Major peaks detected in G. livingstonei organic extract (a) prior and (b) after the 
permeability assay with peak 1,2,4,5 and 10 detected at 10 up to 120 min. 
 
Peak number Retention time 
1 0.97 
2 1.09 
3 1.23 
4 1.55 
5 1.84 
6 2.00 
7 2.22 
8 2.37 
9 3.08 
10 3.34 
11 3.97 
12 4.28 
13 4.70 
14 5.06 
15 5.50 
16 8.92 
17 11.75 
18 12.75 
19 16.64 
20 17.28 
21 17.78 
22 18.26 
23 22.27 
24 23.75 
25 24.31 
26 25.28 
27 25.82 
28 26.63 
29 29.64 
30 30.72 
31 33.05 
32 35.30 
(a) (b) 
Peak number Retention time 
1 0.98 
3 1.17 
4 1.49 
5 1.87 
10 3.36 
 
111 
 
Peak number Retention time 
33 37.09 
34 39.79 
 
Table 4.10: Major peaks detected in G. livingstonei aqueous extract (a) prior and (b) after the 
permeability assay with peaks 2,4,7 and 8 detected after 10 min while peaks 2,4 and 8 remained 
at 60 min and only peaks 2 and was detected at 120 min. 
 
Peak number Retention time 
1 0.93 
2 1.06 
3 1.20 
4 1.63 
5 1.95 
6 2.46 
7 2.60 
8 3.24 
9 3.75 
10 10.20 
11 11.23 
12 15.68 
13 17.22 
14 17.60 
15 20.38 
16 20.69 
17 21.46 
18 22.38 
19 22.96 
20 24.56 
21 25.28 
22 29.67 
23 30.16 
24 31.36 
25 32.85 
26 34.99 
Peak number Retention time 
2 1.05 
4 1.57 
7 2.60 
8 3.15 
 
(a) (b) 
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Peak number Retention time 
27 36.57 
28 39.21 
Shaded are the retention times of the group of compounds detected prior and after the in vitro permeability assay. The 
numbers given to the peaks after the permeability experiment correspond to the peak numbers before the permeability 
experiment. 
 
S. birrea was expected to have more compounds capable of permeating the skin because it was 
reported to treat deep skin infections (boils and sores) (De Wet et al., 2013). The penetration of 
compounds across the skin is important so as to reach the target site and exert their effects. For 
the organic extract, 22 groups of compounds were observed in the crude extract, however, only 
six and five were detected after 10 and 60 to 120 min of the permeability assay (Figure 4.13A-
D). In the aqueous extract (Figure 4.14A-D) where 19 compounds were observed before the 
permeability experiment only four compounds were detected after 10 to 60 min which then 
decreased (three peaks) as the duration increased to 120 min. The permeation behavior of 
compounds from S. birrea extracts may indicate that the permeated compounds were relatively 
small and permeated across the skin easily compared to the larger compounds detected prior the 
permeation assay. The larger compounds that did not diffuse through the skin (not detected) 
might accumulate within the skin thus exerting their effect locally within the skin.  
Some compounds also permeated rapidly across the skin within 10 min from organic and 
aqueous extracts of a combination of S. birrea and S. cordatum (Figure 4.15-4.16). About nine 
peaks were detected after 10 min from approximately 21 peaks observed from the crude organic 
extract before the permeation assay (Figure 4.15A-B). The peaks then decreased at 60 min (eight 
peaks) and increased at 120 min (nine peaks) (Figure 4.15C-D).  For the aqueous extract, six 
peaks diffused across the skin after 10 min [which then decreased at 60 (five peaks) and 120 min 
(four peaks)] from approximately 17 peaks detected from the crude extract (Figure 4.16A-D). 
The permeation behavior of the compounds from the combined extracts particularly the 
combined organic extracts resembled that of S. cordatum organic extract. Thus, it might be 
concluded that S. cordatum compounds are capable of permeating to a greater extent across the 
skin compared to S. birrea compounds.  
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Figure 4.13: Chromatograms of S. birrea organic extract prior (A) and after (B-D) the permeability 
assay at different time intervals (10, 60 and 120 min) of exposure to the skin at 260 nm. 
prior and after the permeability assay at different time intervals (10, 60 and 120 min) of exposure to 
the skin at the wavelength 260 nm. 
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Figure 4.14: Chromatograms of S. birrea aqueous extract prior (A) and after (B-D) the 
permeability assay at different time intervals (10, 60 and 120 min) of exposure to the skin at 260 
nm. 
prior and after the permeability assay at different time intervals (10, 60 and 120 min) of exposure 
to the skin at the wavelength 260 nm. 
 
S. birrea aqueous 
 
10 min 
 
60 min 
 
120 min 
 
  1-5 
6 
7 
8 
9 
 10 
11 12 
13 14 
15 16 
17 
18 
19 
1 
2 3 
6 
2 
1 
3 
1 
2 3 
0 
250 
 
500 
 
2.50 
 
2.50 
 
0 
 2.50 
 
0 
 
45 
 Time (min) 
125 
 
375 
 
1.25 
 
0 
 
1.25 
 
1.25 
 
0 
 
5 
 
10 
 
15 
 
20 
 
25 
 
30 
 
35 
 
40 
 
A
b
so
rb
a
n
ce
 (
m
A
U
) 
 
A
b
so
rb
a
n
ce
 (
m
A
U
) 
 
A
b
so
rb
a
n
ce
 (
m
A
U
) 
 
A
b
so
rb
a
n
ce
 (
m
A
U
) 
 
A 
B
A 
C
A 
D
A 
115 
 
Table 4.11: Major peaks detected in S. birrea organic extract (a) prior and (b) after the 
permeability assay with peak 1,2,4,5,7 and 8 detected at 10 up to 120 min. 
 
Peak number Retention time 
1 0.96 
2 1.13 
3 1.31 
4 1.52 
5 2.13 
6 2.49 
7 3.04 
8 3.39 
9 5.41 
10 5.88 
11 8.33 
12 8.87 
13 10.47 
14 11.07 
15 11.65 
16 17.44 
17 18.48 
18 19.25 
19 19.54 
20 21.17 
21 22.17 
22 23.07 
 
 
 
 
 
 
Peak number Retention time 
1 0.99 
2 1.17 
4 1.52 
5 1.95 
7 3.22 
8 3.63 
 
(a) (b) 
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Table 4.12: Major peaks detected in S. birrea aqueous extract (a) prior and (b) after the 
permeability assay with peaks 1-3 and 6 detected after 10 min while peaks 1-3 remained after 60 
to 120 min. 
 
Peak number Retention time 
1 0.97 
2 1.17 
3 1.61 
4 1.89 
5 2.37 
6 3.13 
7 3.62 
8 5.33 
9 5.99 
10 8.62 
11 9.99 
12 10.83 
13 11.99 
14 14.25 
15 17.52 
16 18.45 
17 19.79 
18 21.08 
19 22.13 
Shaded are the retention times of the group of compounds detected prior and after the in vitro permeability assay. 
The numbers given to the peaks after the permeability experiment correspond to the peak numbers before the 
permeability experiment. 
 
 
 
 
 
 
Peak number Retention time 
1 1.02 
2 1.20 
3 1.56 
6 3.11 
 
(a) (b) 
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Figure 4.15: Chromatograms of S. birrea in combination with S. cordatum organic extracts prior 
(A) and after (B-D) the permeability assay at different time intervals (10, 60 and 120 min) of 
exposure to the skin at 260 nm. 
prior and after the permeability assay at different time intervals (10, 60 and 120 min) of exposure 
to the skin at the wavelength 260 nm. 
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Figure 4.16 Chromatograms of S. birrea in combination with S. cordatum aqueous extracts 
prior (A) and after (B-D) the permeability assay at different time intervals (10, 60 and 120 min) 
of exposure to the skin at 260 nm. 
prior and after the permeability assay at different time intervals (10, 60 and 120 min) of 
exposure to the skin at the wavelength 260 nm. 
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Table 4.13: Major peaks detected in S. birrea in combination with S. cordatum organic extract 
(a) prior and (b) after the permeability assay with peaks 1-9 detected at 10 min, peaks 1-7 
detected at 60 min while peaks 1-9 were detected at 120 min. 
 
Peak number Retention time 
1 0.97 
2 1.16 
3 1.27 
4 1.39 
5 1.79 
6 2.35 
7 2.54 
8 3.55 
9 4.00 
10 5.68 
11 6.25 
12 9.11 
13 10.43 
14 12.79 
15 16.42 
16 17.89 
17 20.29 
18 20.91 
19 22.84 
20 23.78 
21 34.86 
22 36.71 
 
 
 
 
Peak number Retention time 
1 0.98 
2 1.18 
3 1.30 
4 1.50 
5 1.92 
6 2.22 
7 2.76 
8 3.51 
9 3.76 
 
(a) (b) 
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Table 4.14: Major peaks detected in S. birrea in combination with S. cordatum aqueous extract 
(a) prior and (b) after the permeability assay with peaks 1-3,4 and 6-7 detected after 10 min 
while peaks 1-3,4 and 7 remained at 60  min and only peaks 1-3 were detected at 120 min. 
 
Peak number Retention time 
1 0.98 
2 1.18 
3 1.37 
4 1.69 
5 2.05 
6 2.83 
7 3.34 
8 3.79 
9 5.53 
10 6.14 
11 8.92 
12 10.20 
13 10.97 
14 12.29 
15 17.64 
16 22.37 
17 35.24 
Shaded are the retention times of the group of compounds detected prior and after the in vitro permeability assay. The 
numbers given to the peaks after the permeability experiment correspond to the peak numbers before the permeability 
experiment. 
 
All the investigated plant extracts and the combined extracts of S. birrea and S. cordatum 
displayed a similar pattern in their permeation behavior through the skin. The chemical 
fingerprints of all the extracts prior to the permeability experiments were very complex. 
However, only relatively hydrophilic compounds eluting within 5 min from the RP-HPLC 
column were detected after a 10 min exposure time of the intact porcine skin to the various 
extracts.  The permeation behaviour of the compounds from all the extracts indicated that they 
were most probably small, have a balance between hydrophilicity and lipophilicity and were able 
to diffuse rapidly through the intact stratum corneum. The predominantly lipophilic compounds 
Peak number Retention time 
1 1.06 
2 1.20 
3 1.57 
5 1.97 
6 2.75 
7 3.19 
 
(a) (b) 
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observed within the crude extracts most probably accumulated within the intact skin due to their 
size as well as their affinity for the lipophilic stratum corneum. Usually, lipophilicity is among 
the physicochemical properties that determine the diffusion rate of drug molecules through the 
skin. As stated in Section 4.1, the stratum corneum is lipophilic, and drug molecules have to be 
lipophilic to be able to partition within the lipid lamellae of the corneocytes (Naik et al., 2000). 
Permeation through the intact skin will depend on a balance between the hydrophilicity and the 
lipophilicity of the compound diffusing through the skin to give maximum skin penetration.  The 
rate of diffusion of compounds through intact skin also decreases with increasing molecular 
weight or size (Jakasa et al., 2007).  
In intact skin, the stratum corneum is the main barrier to hydrophilic compounds and facilitates 
the movement of lipophilic compounds.  Because these crude extracts are used under conditions 
where a compromised skin barrier is present e.g. dermatitis, psoriasis, burns, infections and 
inflammation, permeation behaviour of compounds will be altered (Davies et al., 2015).  
Previous studies have indicated that diffusion of hydrophilic and amphipathic compounds 
increases through a compromised barrier of the skin, for example where there are abnormalities 
in the lipids of the stratum corneum, as is the case with psoriasis, dermatitis and UV irradiation 
(Tsai et al., 2001).  The epidermal and dermal layers of the skin are hydrophilic and it was shown 
by a previous study that the viable epidermis also provides a rate limiting step to the diffusion of 
compounds in the event that the stratum corneum becomes diseased, damaged or absent, as is the 
case with burn wounds (Andrews et al., 2013). When the barrier function of the skin is 
compromised, the rate of diffusion of most molecules will increase, including compounds of 
larger molecular size, however, depending on their physicochemical properties such as their 
lipophilicity.  In the case of a compromised barrier function, it can thus be assumed that the 
compounds that were found diffusing through the intact skin within 10 min from these extracts 
would diffuse at a much faster rate. The larger and presumably quite lipophilic compounds 
present in these extracts that did not diffuse through intact skin even after 120 min, would be 
expected to penetrate the compromised skin to a far larger extent. However, the intact skin 
surrounding the areas where the skin barrier function is compromised such as burn wounds, 
could possibly act as a reservoir where active compounds may accumulate after topical 
application to the area, thus extending and enhancing the pharmacological effect such as the 
antimicrobial effect at the compromised site.  
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From the preliminary phytochemical analyses, flavonoids, saponins, anthraquinones and tannins 
were predominantly present in all the extracts analysed. Thus, the in vitro diffusion of these 
groups of compounds across the intact skin would largely depend on their physicochemical 
properties. Flavonoids possess numerous hydroxyl groups which render the molecule hydrophilic 
with low stability and solubility in lipophilic media (Danihelova et al., 2012). In addition, the 
hydroxyl groups in flavonoids are highly ionizable (Herrero-Martinez et al., 2005). The 
ionization state of a drug molecule also determines its permeation rate through the skin with non-
ionized compounds permeating faster than the ionized compounds. In the current study, the 
permeability experiments were conducted at a physiological pH of 7.4. Flavonoids are weak 
acids and their pKa values usually vary between 7.3 and 12.5 since they possess phenyl hydroxyl 
groups (Liang et al., 1997). It has been reported that, flavonoids with a vicinal-trihydroxyl 
functional group are unstable at pH 7.4 (Yao et al., 2013) while the 3,4,-hydroxyflavonoids are 
negatively charged at pH 7 (Jovanoic et al., 1994). Furthermore, the presence of keratin in the 
stratum corneum presents both negatively and positively charged groups that provide an effective 
barrier against charged molecules (Bartosova and Bajgar, 2012). Thus, it might be concluded that 
the flavonoids were not amongst the major groups of compounds that permeated rapidly through 
the skin. Other studies also found flavonoids to permeate the skin at a very low rate with their 
permeability usually improved using penetration enhancers (Bonina et al., 1996; Saija et al., 
1998; Artc et al., 2002; Vicentini et al., 2008). Dvorakova et al. (1999) found a flavonoid, 
epigallocatechin gallate (EGCG) impermeable across the human skin in vitro with low 
penetration observed in mouse skin. Dal Belo et al. (2009) also found EGCG to accumulate in 
the stratum corneum of the human skin and quercetin (another flavonoid) to permeate the stratum 
corneum but remain in the viable epidermis. When the skin barrier function however becomes 
compromised, the penetration of flavonoids is expected to be much greater and at a faster rate 
because the stratum corneum, which is the main barrier to compounds in intact skin, in some 
cases may be absent (such as in burn wounds).  In the case of skin infection being present, these 
agents could act on the microorganisms much more rapidly resulting in an antimicrobial effect. 
Saponins contain both lipophilic (sapogenin) and hydrophilic (sugar) properties (Shi et al., 
2004). It has been reported that a good candidate drug for topical application must possess both 
lipophilic and hydrophilic properties to be adequately soluble in both lipophilic (stratum 
corneum) and hydrophilic (dermis) layers of the skin. Because of their ampipathic nature, it can 
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possibly be speculated that saponins might have been among the major compounds that 
permeated the skin as they were also found to be predominant in all the extracts. Pino et al. 
(2012) investigated the transdermal permeation of the macromolecules avicins which belong to 
the family of saponins where high permeability was observed. It was then concluded that, both 
the hydrophilic and hydrophobic portions act synergistically in facilitating the penetration of 
saponins molecules across the skin lipids. In the case of a compromised skin barrier, these agents 
are expected to diffuse at a higher rate into the diseased skin tissue exerting a much more rapid 
pharmacological effect. 
The basic chemical structure of all anthraquinones is the merger of three benzene rings (Gessler 
et al., 2013). Drugs with benzene rings in their structures are usually lipophilic and diffuse easily 
through the stratum corneum of the skin. Thus, anthraquinones were also assumed to be present 
in the major compounds that were capable of permeating more rapidly across the skin. The 
anthraquinones derivatives, danthron and dianthrone were also found to be capable of 
permeating the skin in vitro, even though the permeation rate was higher in a diseased skin than 
in a normal skin (Wang et al., 1987). 
Tannins are polyphenolic compounds with a molecular mass extending from 300 – 3000 
(Khanbabaee and Van Ree, 2001; Ashok and Upadhyaya, 2012).  These molecules contain a 
large number of hydroxyl groups rendering them water soluble. Tannins have astringent 
properties, thus dehydrate the skin, bind and precipitate proteins (Ashok and Upadhyaya, 2012).  
These compounds are known to form a protective layer over compromised skin and thus as such 
are not expected to penetrate through intact skin, but rather to accumulate within the skin layers 
(Ashok and Upadhyaya, 2012). It would thus be assumed that tannins will penetrate further 
within compromised skin tissue. However, due to the astringent properties and the ability to bind 
proteins, tannins would have a strong local effect due to the accumulation within compromised 
skin layers. These agents are then assumed to exert a local effect due to the formation of a 
reservoir within the skin.  
The presence of alkaloids, coumarins, flavones and sterols was also indicated in some of the 
crude extracts.  Alkaloids are a diverse group of chemicals found in plants classified as organic 
nitrogenous bases (Fester, 2010) of which many show good skin penetration (Chan, 2012).  
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Alkaloids present in some of the tested extracts are thus also assumed to have diffused rapidly 
through intact skin. Coumarin is a fragrant compound that occurs naturally in some plants and 
can be used as an anti-inflammatory or anticancer agent.  It penetrates the skin well and is thus 
also expected to be one of the compounds that penetrated rapidly across intact skin (Beckley-
Kartey et al., 1997). Plant sterols are similar to cholesterol in structure and when consumed 
orally can eventually transfer to the skin where they form part of the surface lipids.  These 
compounds are thus not expected to permeate across the skin but rather to accumulate within the 
skin layers, hydrating the skin and causing anti-inflammatory effects (Gustav Parmentier GmbH, 
2014).  The plant sterols are thus not expected to have diffused across the skin after the exposure 
of the intact skin to the organic extracts in which they were originally detected. Flavones form 
part of the flavonoids which were described above. As mentioned before, all of these compounds 
would also have penetrated much more rapidly through compromised skin resulting in a more 
rapid therapeutic effect. 
4.4 Summary 
 The preliminary phytochemical screening results revealed the predominant presence of 
flavonoids, saponins, anthraqunones and saponins from all the tested plant extracts. 
 All the extracts gave the first maximum absorption peaks between 212-218 nm under the 
UV-Vis spectrometry. The second absorption maxima occurred between 250-268 nm from 
all the extracts. G. livingstonei extracts gave another absorption peak at 310 nm for the 
aqueous extract and at 330 nm for the organic extract. The third absorption maximum peak 
was also observed from the organic extract of S. birrea at 362 nm. 
 All the extracts displayed a similar pattern in their permeation behavior across the intact 
porcine skin with major peaks being eluted within a retention time of 5 min from the HPLC 
column and other compounds being eluted in small amounts after 15 min retention time. The 
number of peaks detected in the organic extracts was greater than in the aqueous extracts.  
 The extracts of K. africana and S. cordatum proved to have more compounds capable of 
permeating the skin compared to than other extracts. The results demonstrated that 
lipophilicity, molecular weight and particle size largely influence the permeability rate of 
compounds across the skin. 
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Chapter five: General conclusions and further recommendations 
 
5.1 Thesis summary 
Medicinal plants are abundant in northern Maputaland and are frequently used by the rural 
inhabitants for the treatment of various ailments. The special focus of this study was to validate 
the traditional use of plants by the lay people of Maputaland to treat skin diseases. Thirty six 
plants documented in an ethnobotanical study conducted in four rural communities of 
Maputaland were considered for investigation in order to support their ethnobotanical claims. 
The 36 plants extracted with water and dichloromethane: methanol were first investigated for 
their antimicrobial activity against dermatological relevant pathogens. The individual plants were 
then combined into eight combinations as used by the lay people of northern Maputaland for the 
treatment of skin ailments. Six combinations were further investigated for their interactions when 
combined in various ratios. Four of the most antimicrobial active plants and a combination of S. 
birrea and S. cordatum which were reported to be used topically were further investigated for 
their chemical profiles and the group of chemical compounds that are capable of permeating the 
skin. 
5.1.1 Antimicrobial validation of individual plants 
When testing the antimicrobial activity of individual plants, it was found that the 
dichloromethane: methanol extracts have higher inhibitory effect with 31.7% of the extracts 
showing broad-spectrum antimicrobial activity (mean MIC<1.00 mg/ml). Plants that 
demonstrated broad-spectrum activity included A. senegalensis, E. elephantina, G. livingstonei, 
K. africana, O. engleri, P. capensis subsp. capensis, S. brachypetala, S. birrea, S. cordatum T. 
sericea, and Z. capense. The aqueous extracts displayed less activity when compared to the 
organic extracts. Only 4.9% displayed broad-spectrum activity with a few (25) displaying 
pathogen specific activity. When analyzing the efficacy of the frequently used plant species, it 
was concluded that the commonly used plants do not necessarily give higher antimicrobial 
efficacy. For instance, S. serratuloides which was the most mentioned plant by the lay people of 
Maputaland was least active in terms of antimicrobial activity. However, more than 80% of the 
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organic extracts displayed a correlation between antimicrobial efficacy and their traditional use 
which indicates that some of the plants have a potential in the management of skin infections, as 
claimed by rural inhabitants of northern Maputaland. 
5.1.2 Antimicrobial interactions of combined plants 
The aqueous and organic extracts of the eight plant combinations mostly displayed additive 
interactions when investigated against S. aureus, S. epidermidis and P. aeruginosa. Notable 
synergistic interaction from the combination of A. burkei with K. africana (aqueous and organic 
extracts) against T. mentagrophytes gave some validation to the reported traditional use of this 
combination against ringworm infections. When combined further into various ratios, the effect 
of the three selected combinations predominantly displayed additive interactions with some of 
the ratio points giving synergistic interactions. This indicated that the interaction between these 
plants vary depending on the ratio in which they were mixed. However, the organic combination 
of H. hemerocallidea and S. rigescens displayed noteworthy synergistic interactions against S. 
epidermidis irrespective of the ratio in which the two plants were combined.  
5.1.3 Chemical and permeability profiles of the most active topically used plants 
Results observed from the preliminary phytochemical screening indicated that all the four plants 
(G. livingstonei, K. africana, S. birrea and S. cordatum) tested possess anthraquinones, 
flavonoids, tannins and saponins.  Even though the detected compounds may differ in their 
modes of action when targeting microbial cells, they all possess antimicrobial activity which may 
account for the broad-spectrum antimicrobial activity observed from the organic extracts of the 
tested plants. Based on the UV-Vis spectrometry, all the extracts indicated absorption peaks 
between 212 and 294 nm. The obtained absorption peaks for the plant extracts were 
characteristic of the phytochemicals determined in the preliminary phytochemical screening as 
they possess specific structures and functional groups that absorb at specific regions under UV-
Vis spectrometry. The HPLC profiles of the extracts prior to the permeability experiments were 
very complex indicating the presence of a large number of chemical compounds in the extracts. 
The permeability pattern of some of the group of compounds across the skin provided some 
basic scientific insight on the pharmacokinetics (diffusion across porcine skin) of compounds 
present in medicinal plants intended for topical application.  
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5.2 Future recommendations   
Even though the traditionally used plants are perceived to have less side effects when compared 
to the conventional drugs (Saikia et al., 2006), some studies have reported toxic effects 
associated with many plants used as traditional medicine (Fennell et al., 2004). Plants used to 
treat skin diseases have been associated with allergic reactions, dermatitis and photosensitization 
to mention a few (Mabona and Van Vuuren, 2013). Even some of the plant species investigated 
in the current study have been reported to possess cytotoxicity, mutagenic, irritation and even 
lethal effects (Table 5.1). Of concern is that these plant species are used on regular basis by the 
rural inhabitants of northern Maputaland and the current study has only provided the in vitro 
evidence of the antimicrobial properties of the documented plants. Thus, toxicity studies should 
be carried out on plants with unknown toxicity information and those with reported toxicity 
properties should be used with caution. Furthermore, for combination studies, the plants with 
toxic effects should be incorporated with non-toxic plants to determine if toxicity will be reduced 
to a more safe level.  
Some of the investigated plants such as S. panduriforme, S. spinosa and R. multifidus were 
reported to treat warts and shingles by the lay people of Maputaland. These plant species 
displayed poor activity when investigated against the selected pathogens. Warts and shingles are 
caused by the human papillomavirus and varicella-zoster virus respectively. These viruses 
usually affect the immune-compromised individually due to HIV infection. The KwaZulu-Natal 
province has a high rate of HIV infection and the lay people of Maputaland believe that warts 
and shingles can only be treated with traditional medicine (De Wet et al., 2013). Thus, a future 
recommendation is to examine these plants against the associated viral pathogens. 
Even though the therapeutic effect of medicinal plants can be identified in vitro, it is necessary to 
further investigate these plants in vivo to validate their in vitro efficacy. It should be considered 
that the in vitro results may not always correlate with the in vivo activity. Thus, both the active 
and least active plant extracts should be taken to the in vivo model as it might happen that the 
extract which demonstrated weak activity in vitro may become active when subjected to an 
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Table 5.1: Toxicity reports of plants used to treat skin diseases in northern Maputaland. 
Plant species Toxicity reports References 
A. adianthifolia 
The aqueous and organic extracts were found to be non-toxic when tested in 
the MTT (3-[4, 5-dimethyl-2-thiazol-yl]-2, 5-diphenyl-2H-tetrazolium 
bromide) cellular viability assay. 
Naidoo et al., 2013. 
A. burkei No evidence found.  
A. senegalensis 
Varying degrees of depression, weakness, droopiness, intestine lesions and 
death were observed from aqueous stem bark extracts after parenteral 
administration to chicks. 
Nwosu et al., 2011. 
The root bark extracts were found to be safe when orally administered to 
mice at lower doses; however, caution is warranted when taken at higher 
doses. 
Okoye et al., 2012. 
A. vesicolor 
Pods tested toxic when investigated in guinea pigs. Gummow and Erasmus, 1990. 
Severe nervous toxicity effects were observed from the sheep after being 
drenched with pod-material. 
Gummow et al., 1992. 
Clinical signs such as hyperaesthesia, wild running, nystagmus, rapid 
blinking and death occurred in sheep and goats after ingestion of ripe dry 
pods. 
 
Soldan et al., 1996.   
B. discolor 
Non-toxic or had low toxicity with marine C2C12 myoblasts, preadipocytes 
and human liver cells. 
Van de Venter et al., 2008. 
 
C. inerme No evidence found.  
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Plant species Toxicity reports References 
D. cinerea 
Tested non-toxic in Wistar albino mice. Jayakumari et al., 2011. 
Tested non-toxic in brine shrimp lethality assay, human myelogeneous 
leukaemia cells and Salmonella Mutagenecity assay. 
Hurinanthan, 2009. 
Tested non-toxic in brine shrimp lethality assay. Nguta and Mbaria, 2013. 
Aqueous root extracts tested toxic against Artemia salina larvae, the brine 
shrimp larvae. 
Nguta et al., 2012. 
D. obovata No evidence found.  
D. schlechteri No evidence found.  
E. elephantina 
Histopathological effects were observed in kidneys, lungs, liver and spleen 
when given in high doses to rats.  
Maphosa et a., 2012. 
E. tirucalli 
Has been found to possess irritant and tumour promoting compounds. Chhabra et al., 1990. 
Has been found to be lethal after consumption by humans. Neuwinger, 1996. 
No toxic effects were observed when boipolymeric fractions were 
consumed by Wistar rats. 
Bani et al., 2007. 
The latex was found to be non-toxic when tested on Wistar rats.  Silva et al., 2007. 
The aqueous extract of E. tirucalli latex was found to have high piscicidal 
activity when tested on the fresh water fish, Heteropneustes fossilis.  
Kumar et al., 2010. 
G. livingstonei 
The compounds, amentoflavone and 4-methoxy amentoflavone isolated 
from G. livingstonei leaves displayed low toxicity against Vero monkey 
kidney cells in MTT assay. 
 
Kaikabo et al., 2009.  
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Plant species Toxicity reports References 
H. hemerocallidea 
Aqueous corm extracts caused brief hypertension and bradychardia in 
guinea-pigs and rats. Impairment in kidney function was also observed in 
rats. 
Owira and Ojewole, 2009. 
The corm extract showed minimal toxicity when tested by the MTT cellular 
viability assay. 
Morobe et al., 2012. 
H. malabarica No evidence found.  
H. surratensis No evidence found.  
K. africana 
Aqueous and organic leaf extracts have been found to be toxic when tested 
against kidney epithelial cells in MTT cellular viability assay. 
Naidoo et al., 2013. 
L. javanica 
The leaf extracts were found to cause detrimental effects when administered 
at high doses in BALB/c mice. 
Madzimure et al., 2011. 
Has been found to possess mutagenic effects. Elogarashi et al., 2003. 
M. balsamina 
Reported to be toxic at very high doses on tissues and organs of rats. Geidam et al., 2007. 
Isolated compounds (tritepenoids and balsaminol) showed weak toxicity 
towards human breast cancer (Mcf-7) cell line. 
Ramalhete et al., 2010. 
Aqueous extracts tested safe in the Salmonella Mutagenecity assay. Ndhlala et al., 2011. 
A compound, balsaminoside tested toxic at high doses against human 
hepatoma (Huh-7) cell line. 
Ramalhete et al., 2014. 
O. engleri 
Dichloromethane extracts exhibited high cytotoxicity effects in monkey 
kidney cell test. 
Prozesky et al., 2001. 
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Plant species Toxicity reports References 
O. engleri 
The aqueous and organic extracts were found to be non-toxic when 
investigated against kidney epithelial cell line in MTT assay. 
Naidoo et al., 2013. 
P. afra No evidence found.  
P. capensis Compounds isolated from stem extracts were reported to be toxic in vivo. Uys et al., 2002. 
R. multifidus 
The aqueous and organic extracts were found to be non-toxic when 
investigated against kidney epithelial cell line in MTT assay. 
Naidoo et al., 2013. 
S. birrea 
No toxic effects were observed from the Ames and VITOTOX toxicity 
tests. 
Elogarashi et al., 2003. 
Genotoxicity was observed from the micronucleus test. Fenell et al., 2004. 
No toxic effects were observed in brine shrimp toxicity assay. McGaw et al., 2007. 
Cytotoxicity was observed from the dichloromethane: methanol extracts on 
Chang liver, 3T3-L1 adipose and C2C12 muscle cells.  
Van de Venter et al., 2008. 
Aqueous and methanol extracts of the stem bark were found to be non-toxic 
on mice. 
Ojewole et al., 2010. 
The aqueous and organic extracts were found to be non-toxic when 
investigated against kidney epithelial cell line in MTT assay. 
Naidoo et al., 2013. 
S. brachypetala Tested positive on the brine shrimp toxicity assay. McGaw et al., 2007. 
S. cordatum 
Showed non-toxic effects on the Ames and VITOTOX toxicity tests. Elogarashi et al., 2003. 
Bark and leaf extracts were found to be non-toxic when tested on cultures of 
Vero cells. 
Samie et al., 2008. 
S. madagascariensis No evidence found.  
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Plant species Toxicity reports References 
S. panduriforme No evidence found  
S. rigescens No evidence found.  
S. serratuloides 
The aqueous and organic extracts were found to be non-toxic when 
investigated against kidney epithelial cell line in MTT assay. 
Naidoo et al., 2013. 
S. spinosa 
Tested non-toxic against J774 mammalian cell lines but toxic on L6 cells. Hoet et al., 2004. 
Tested non-toxic on L-6 and MRC-5 mammalian cell lines.  Zirihi et al., 2005. 
Aqueous extracts exhibited tonic muscle spasms and high mortality rate 
(83%) when evaluated in BALB/c mice. 
Nyahangare et al., 2012. 
Displyed low toxicity in the MTT assay. Isa et al., 2014. 
 
T. elegans 
Tested toxic against resting and PHA- stimulated human lymphocytes. Pallant and Steenkamp, 2008. 
Tested non-toxic in the MTT assay. Naidoo et al., 2013. 
T. sericea 
Showed cytotoxicity effects on the velvet monkey kidney cells with ID 
value of 24 mg/ml. 
Tshikalange et al., 2005. 
No mutagenic effects were observed. Eldeen et al., 2006. 
Acetone extracts of T. sericea were found to non-toxic when investigated in 
brine shrimp assay. 
Eloff et al., 2008. 
W. indica 
The roots, stem, leaves and aerial parts of W. indica have been reported to 
be toxic when investigated on mice. Leaf extract showed minimum toxicity 
against a miracidia of Shistosoma mansoni. An alkaloid, adouetin isolated 
from W. indica exhibited a minimal lethal dose of 75 mg/mL in mice. 
Zongo et al., 2013. 
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Plant species Toxicity reports References 
W. somnifera 
The root extract was found to be non-toxic when orally administered to 
Wistar rats.  
Prabu et al., 2012. 
X. caffra 
The aqueous and organic extracts were found to be non-toxic when 
investigated against kidney epithelial cell line in MTT assay. 
Naidoo et al., 2013. 
Z. capense Aqueous extracts tested safe in the Salmonella Mutagenecity assay. Ndhlala et al., 2011. 
Z. mucronata 
The plant extract has been reported to be highly toxic by causing DNA 
damage and chromosomal aberrations. 
Fenell et al., 2004. 
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animal model, and vice versa (York et al. 2012). In addition, some of the plant species were 
reported to treat wounds and burns (De Wet et al., 2013) which are not necessarily infected. The 
effect of those plants can only observed when investigated for their anti-inflammatory activities 
or in in vivo studies where they may promote wound healing by inducing the proliferation of skin 
cells and not as antimicrobial agents. 
Lastly, the antimicrobial screening should always be followed with phytochemical screening to 
fully comprehend the pharmacological properties of medicinal plants. Phytochemistry usually 
involves the identification and isolation of the active compounds from the most antimicrobial 
active plants. In the current study, phytochemical analysis was qualitative which did not provide 
a full insight of the exact compounds responsible for the observed antimicrobial activity. The 
permeability studies indicated which compounds observed in the crude extracts are able to 
diffuse across the skin. Further studies, however, should be performed on compromised skin 
such as the tape stripped skin for comparative purposes. The permeated compounds also have to 
be identified as well as those that possibly accumulated within the skin in order to obtain their 
quantitative permeability profiles. Isolating and analysing the permeated compounds may 
provide insight for potential future compound efficacy where new compound derivatives could 
possibly be synthesised. The isolated compounds might also be used directly as potential 
antimicrobials for skin infections which are more active and safer, since the compounds are 
usually more effective and pure, compared to the extracts (Rates, 2001). Futhermore, for plants 
that were reported to treat deep skin infections such as S. birrea and S. cordatum, isolation of the 
permeated compounds could be useful in the synthesis of antimicrobials which may have a quick 
therapeutic effect as the compounds can easily permeate the skin in pure form to the site of 
action and treat the core root of the infection (Mabona and Van Vuuren, 2013). 
5.3 Final conclusion 
This study has scientifically supported the ethnobotanical claims of the plants traditionally used 
to treat skin diseases by the lay people of Maputaland. The extensive use of these herbal 
remedies was justified by their antimicrobial properties individually and in combinations against 
the selected dermatological relevant pathogens as well as some compounds that permeated the 
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skin in vitro. These findings serve as the scientific basis for understanding the pharmacological 
properties of the traditionally used medicinal plants and their use against skin diseases.   
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Appendix B: Abstract for publication submitted to the Journal 
Pharmaceutical Biology. 
Abstract 
Context: Medicinal plants in Maputaland are used by the rural inhabitants for the treatment of 
skin diseases. Scientific evidence supporting the ethnobotanical claims of these plants is limited.  
Objective: To establish scientific validity for a selection of the plants used in Maputaland to treat 
skin diseases. 
Materials and methods: Antimicrobial screening was performed on 12 dermatological relevant 
pathogens using the micro-titre plate dilution assay. Since some plants were reported to be 
effective when used in combinations, their effect was evaluated using the fractional inhibitory 
concentration (FIC) determination and those with notable interactions were investigated further 
in varied ratio studies. The most antimicrobially active topically applied plants (organic extracts) 
were subjected to qualitative chemical analysis using phytochemical screening tests, ultra-violet 
visible (UV-Vis) spectrometry and reverse-phase High Performance Liquid Chromatography 
(RP-HPLC). The penetration of compounds from extracts of these topically applied plants was 
investigated in vitro across excised porcine skin using the ILC07 automated system and analysed 
through RP-HPLC. 
Results: When investigated individually, all the organic extracts proved to be antimicrobially 
active with 31.7% displaying broad-spectrum antimicrobial activity (average MIC values <1.00 
mg/mL). The organic extract of Garcinia livingstonei was found to be most antimicrobially 
active displaying a mean MIC of 0.27 mg/mL. The efficacy of the aqueous extracts was mostly 
moderate with 66% exhibiting pathogen specific noteworthy effects (MIC values <1.00 mg/mL). 
The combination of Sclerocarya birrea and Syzygium cordatum displayed notable interactions 
with synergistic effects observed against Staphylococcus aureus, S. epidermis and Pseudomonas 
aeruginosa having the ΣFIC values of 0.13 (aqueous extract combination), 0.34 (organic extract 
combination) and 0.19 (aqueous extract combination) respectively. When combined in various 
ratios, the effect of the selected combinations predominantly displayed additive interactions with 
some of the ratios giving synergistic interactions. The four antimicrobial active topically applied 
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plants phytochemically analysed were found to possess flavonoids and saponins. Two to three 
absorption peaks were obtained between 210 and 360 nm for the crude extracts using UV-Vis 
spectrometry. The extracts of K. africana and S. cordatum were found to have more compounds 
capable of permeating the skin than the extracts of other plants investigated. 
Conclusion: Although most of the aqueous extracts demonstrated only moderate antimicrobial 
activity, more than 80% of the organic extracts tested displayed a correlation between 
antimicrobial efficacy and the reported traditional uses of the plants. Interesting antimicrobial 
effects (synergy) were also noted for selected plant combinations. Furthermore, the traditional 
use of topically applied plant preparations is validated as some compounds from the active plants 
are capable of permeating the skin in vitro. Thus, the current investigation supported the 
ethnobotanical claims of some of the plants used for the treatment of skin diseases in northern 
Maputaland.  
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Appendix C: Abstract for poster presentation at the Postgraduate Symposium 
at UJ, 2013 and Research Day at Wits, 2014. 
 
VALIDATING THE TRADITIONAL USE OF MEDICINAL PLANTS IN 
MAPUTALAND TO TREAT SKIN DISEASES. 
Sibongile Ncikiᵃ, Helene de Wetᵇ and Sandy F. van Vuurenᵃ* 
ᵃDepartment of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the 
Witwatersrand, 7 York Road, Parktown 2193, ᵇDepartment of Botany, University of Zululand, 
Private Bag 1001, KwaDlangezwa 3886 
*Email address: Sandy.Vanvuuren@wits.ac.za 
Medicinal plants are widely used in northern Maputaland to treat various ailments including skin 
diseases. Recently (2013), published information has revealed 47 plant species used by lay 
people of rural Maputaland to treat various skin diseases. Some plant species has for the first 
time been reported in northern Maputaland as a treatment for skin diseases. Thus, their anti-
infective role needed to be explored. The aim of this study was to establish scientific validity of 
these plants by investigating their efficacy against skin-associated pathogens. Aqueous and 
organic (1:1 dichloromethane-methanol) extracts were prepared from plants collected from four 
rural communities of northern Maputaland. Antimicrobial screening was performed on bacteria 
and fungi known to cause skin diseases. The investigation was carried out using the micro-titre 
plate dilution assay with crude extracts at a starting concentration of 32 mg/ml. The most 
antimicrobially active organic extract was that of G. livingstonei with MIC values ranging from 
0.06 to 0.50 mg/ml. For aqueous extracts, the antimicrobial efficacy was mostly moderate with 
Acacia burkei, Annona senegalensis, Brachyleana discolor, Euphorbia tirucalli, Kigelia 
africana, Portulacaria afra, Solanum rigescens and Strychnos madagascariensis displaying 
pathogen specific antimicrobial effects. However, more than 80% of the plants tested displayed a 
significant correlation between antimicrobial efficacy and pathogens responsible for the diseases 
reported to be treated. Six (Acacia. burkei, Brachyleana discolor, Ozoroa engleri, Parinari 
capensis, Portulacaria afra, and Solanum rigescens) of the nine plant species documented for 
the first time in Maputaland also demonstrated positive antimicrobial effects. Thus, the current 
investigation provided scientific evidence that some plant species have potential in the 
management of skin infections as claimed by the rural inhabitants of northern Maputaland. 
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Appendix D: Poster presented at the Postgraduate Symposium at UJ, 2013 
and Research Day at Wits, 2014. 
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Appendix E: Abstract for oral presentation at the IPUF national conference, 
2014. 
PHARMACOLOGICAL EVALUATION OF PLANTS TRADITIONALLY USED TO 
TREAT SKIN DISEASES IN NORTHERN MAPUTALAND, SOUTH AFRICA. 
Sibongile Ncikiᵃ, Helene de Wetᵇ, Armorel D. Van Eykᵃ and Sandy F. van Vuurenᵃ* 
ᵃDepartment of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the 
Witwatersrand, 7 York Road, Parktown 2193, ᵇDepartment of Botany, University of Zululand, 
Private Bag 1001, KwaDlangezwa 3886 
*Email address: Sandy.Vanvuuren@wits.ac.za 
Medicinal plants are widely used in Maputaland to treat various ailments including skin diseases. 
Recently (2013), published information revealed 47 plants used by lay people of rural 
Maputaland to treat various skin diseases. Some plants were reported for the first time in 
Maputaland, as a treatment for skin diseases. Thus, their anti-infective role needed to be 
explored. The aim of this study was to establish scientific validity of these plants by investigating 
their efficacy against skin-associated pathogens. The study also determined the possible group of 
chemical compounds that are capable of permeating the skin from the most antimicrobial active 
plants. Aqueous and organic (1:1 dichloromethane-methanol) extracts were prepared from plants 
collected from four rural communities of Maputaland. Antimicrobial screening was performed 
on dermatologically relevant pathogens using the micro-titre plate dilution assay with crude 
extracts at a starting concentration of 32 mg/ml. Since other plants were reported to be effective 
when used in combinations, their effect was evaluated using the fractional inhibitory 
concentration (∑FIC) assay.  Qualitative chemical analysis of the most active plants (aqueous 
and organic extracts) was performed using phytochemical screening tests, UV-Vis spectrometry 
and a reverse-phase High Performance Liquid Chromatography (RP-HPLC). The penetration of 
compounds was investigated in vitro on porcine skin using the ILC07 automated system and 
qualitatively analysed through RP-HPLC. The most antimicrobially active organic extract was 
that of Garcinia livingstonei with MIC values ranging from 0.06 to 0.50 mg/ml. For aqueous 
extracts, the antimicrobial efficacy was mostly moderate. The combination of Sclerocarya birrea 
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and Syzygium cordatum displayed notable interaction with synergistic effects observed against 
Staphylococcus aureus, Staphylococcus epidermis and Pseudomonas aeruginosa having ∑FIC 
values of 0.125, 0.38 and 0.19 respectively. All the active plants phytochemically analysed were 
found to possess flavonoids and saponins with most of their compounds absorbed between 210 
and 360 nm under UV-VS spectrometry. Kigelia africana had more groups of compounds 
capable of permeating the skin than other extracts. With more than 80% of plants tested 
displaying a correlation between antimicrobial efficacy and the diseases they were reported to 
treat, the current investigation provided scientific evidence that some plants have potential in the 
management of skin infections as claimed by the rural inhabitants of Maputaland. 
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Appendix F: Abstract for poster presentation at the Pharmacology and              
Toxicology Congress at Wits University. 
IN VITRO DIFFUSION CHARECTERISTICS OF FOUR CRUDE MEDICINAL PLANT 
EXTRACTS ACROSS INTACT PORCINE SKIN. 
A.D. van Eyk  ², S. Nciki², S. van Vuuren², H. de Wet³ 
¹Division of Pharmacology, ²Department of Pharmacy and Pharmacology, University of the 
Witwatersrand, Johannesburg, South Africa 
³Department of Botany, University of Zululand, KwaDlangezwa, South Africa 
Background: Medicinal plants are used topically by rural communities in South Africa for the 
treatment of various skin inflictions. It is imperative to know whether any of the compounds 
present within the crude extracts have the ability of diffusing rapidly across intact skin skin and 
as such exert their therapeutic effects. 
Methods: Plant material was collected in the rural arears of Maputaland, from four plants, 
Garcinia livingstonei, Kigelia africana, Sclerocarya birrea and Syzygium cordatum both 
aqueous and organic (dichloromethane: methanol) extracts were prepared. After drying, the plant 
material was solubilised in phosphate buffered saline (PBS) at a concentration of 32mg/ml. 
Preliminay phytochemical screening was performed on both types of extracts using standard 
procedures. The HPLC chemical fingerprint of each plant extract was dertemined using a RP-
HPLC column (C18, 100 x 4.6 mm, 5µm, 260nm, 25°C)  at 1 ml/min, and using methanol (A): 
H₂O (0.1% formic acid) (B) gradient elution  (1%-60%, 45 min). In vitro diffusion studies were 
performed after exposure of intact porcine skin to the extracts for 120 min using a PermeGear 
flow-through diffusion system with PBS as elusion medium (1.5ml/h, 37°C). Fractions collected 
at 10 min time periods were analysed using the RP-HPLC column. 
Results: Preliminary phytochemical analysis indicated the presence of tannins, anthraquinones, 
flavonoids and saponins in all the extracts. Some extracts additionally indicated the presence of 
sterols and alkaloids. HPLC chemical finerprints indicated the presence of a lage number of 
compounds within each extract. Similar HPLC profiles were obtained after skin exposure, 
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indicating the ability of a limited number of compounds capable of diffusing across the skin. 
Most of the compounds may have accumulated within the skin exerting a local therapeutic effect. 
Conclusion: A number of compounds diffused across intact skin within 10 min, further studies 
are required to identify these compounds and those that accumulated within the skin.  
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Appendix G: Ethics clearance certificate for using microbial cultures. 
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Appendix H: HPLC data 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure H.1: Chromatograms obtained at 260 nm when using methanol: water as a mobile 
phase. 
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Figure H.2: Chromatograms obtained at 260 nm when using methanol: water with 0.1% formic acid 
as a mobile phase. 
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        Figure H.3: Chromatograms obtained at 360 nm using methanol: water with 0.1% 
formic acid as a mobile phase. 
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Appendix I: Ethics clearance certificate for using porcine skin tissue samples. 
 
 
